Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,alpha-actinin binding (GO:0051393),0.9151796909384698,2.165324948047986,0.0,0.0,0.0,14/24,4.37%,PDLIM3;SYNPO2;PALLD;MYOT;LDB3;TTN;CACNA1C;PDLIM1;NRAP;PDLIM5;MYPN;KCNA5;KCNN2;PDLIM7
prerank,actin binding (GO:0003779),0.7195991485259976,2.140029208150879,0.0,0.0,0.0,40/170,5.71%,PDLIM3;SYNPO2;TPM2;CAP2;DMD;KCNMA1;TPM1;LDB3;MYOZ2;TNNI2;SMTN;TNNC2;ABRA;PDLIM1;NRAP;PDLIM5;CALD1;LMOD2;ACTN4;TNNT3;MYL2;VCL;MICAL2;SYNPO2L;LMOD3;SYNE1;FERMT2;MYH9;MYL3;LCP1;MYO9B;MRTFA;FHL3;ITGB1;MAP1B;SLC6A2;PDLIM7;UTRN;GC;SYNE2
prerank,transmembrane receptor protein serine/threonine kinase binding (GO:0070696),-0.8046728692714011,-2.0628094705450617,0.0,0.00926492904874737,0.009,4/13,2.23%,BMP6;BMP7;BMP4;CDH5
prerank,muscle alpha-actinin binding (GO:0051371),0.9479594679107795,2.0290738637748236,0.0,0.007886022068835178,0.019,9/15,0.97%,PDLIM3;SYNPO2;PALLD;LDB3;TTN;PDLIM1;NRAP;PDLIM5;MYPN
prerank,BMP receptor binding (GO:0070700),-0.8046742485873447,-2.009374885169988,0.0,0.0102943656097193,0.017,4/12,2.23%,BMP6;BMP7;BMP4;CDH5
prerank,actinin binding (GO:0042805),0.8579416847600236,1.9506307817868616,0.001594896331738437,0.05027339068882426,0.153,9/21,4.13%,SYNPO2;MYOT;TTN;CACNA1C;PDLIM5;CSRP1;CSRP3;KCNA5;KCNN2
prerank,phosphatidylinositol-5-phosphate binding (GO:0010314),0.8724277637279018,1.9418302901938391,0.0,0.04751328296473195,0.178,2/15,0.33%,JPH2;OBSCN
prerank,retinoid binding (GO:0005501),-0.6468101039511026,-1.8763826069075373,0.002881844380403458,0.0634819212599357,0.147,6/22,4.04%,ALDH1A2;RBP1;PTGDS;CYP26B1;ABCA4;RBP4
prerank,titin binding (GO:0031432),0.8810180593138162,1.8628981550024666,0.006802721088435374,0.16396354218119813,0.547,5/13,3.13%,MYBPC1;OBSCN;TCAP;TRIM63;CAMK2D
prerank,myosin binding (GO:0017022),0.716625306248301,1.8521664225794217,0.002560819462227913,0.1644798888642766,0.602,6/55,1.37%,MYBPC1;MYLK2;DMD;CALD1;ACTA1;MYL2
prerank,voltage-gated calcium channel activity (GO:0005245),0.7216743314806745,1.8321841767922618,0.002797202797202797,0.19665767534157727,0.705,7/37,4.26%,CACNB2;RYR1;CACNA1S;CACNA1C;CACNA2D1;CACNA1H;CACNB4
prerank,tropomyosin binding (GO:0005523),0.8472814828174563,1.8182986676378634,0.0017064846416382253,0.2101843937513154,0.767,5/16,1.62%,LMOD1;CALD1;LMOD2;TNNT3;LMOD3
prerank,cell-cell adhesion mediator activity (GO:0098632),0.7089153221767663,1.8165559790579469,0.006587615283267457,0.19419329344506628,0.778,11/42,7.16%,NEXN;PALLD;PDLIM1;PDLIM5;MYPN;ROBO3;ANXA1;JAM3;DSCAM;CD200;CNN3
prerank,high voltage-gated calcium channel activity (GO:0008331),0.9007275406774679,1.808769022278505,0.0017921146953405018,0.19589595730083753,0.802,4/10,4.26%,CACNB2;CACNA1S;CACNA1C;CACNB4
prerank,cell adhesion mediator activity (GO:0098631),0.7674574646503877,1.8032083005860233,0.008995502248875561,0.19082530485316793,0.821,7/24,6.12%,NEXN;PALLD;MYPN;BCAM;ROBO3;JAM3;DSCAM
prerank,phosphatidylinositol-4-phosphate binding (GO:0070273),0.7553610207281832,1.7958633791218728,0.006230529595015576,0.19396581203923452,0.853,2/24,0.33%,JPH2;OBSCN
prerank,monocarboxylic acid transmembrane transporter activity (GO:0008028),-0.5779555177809652,-1.781995016439226,0.0,0.16265097663356495,0.429,9/26,7.82%,SLC6A13;SLC16A12;ABCG2;SLC16A9;SLC6A1;SLC6A12;SLC6A6;SLC16A1;SLC16A11
prerank,intracellular ligand-gated ion channel activity (GO:0005217),0.8773528096777137,1.7623126464141858,0.0,0.2631959865473741,0.935,3/11,1.66%,RYR1;RYR2;ITPR1
prerank,calcium ion transmembrane transporter activity (GO:0015085),0.6646251081593353,1.752308552184065,0.005089058524173028,0.27193632767366643,0.951,17/55,12.46%,CACNB2;RYR1;ATP2A1;RYR2;ATP2B4;ATP2A2;ITPR1;SLC8A2;PKD1L3;TRPV2;ATP2B1;TRPC5;ATP2A3;PANX1;ANXA9;CHRNA7;TRPM2
prerank,ligand-gated calcium channel activity (GO:0099604),0.7770124248408827,1.7494507243657136,0.012718600953895072,0.2610396523879269,0.954,4/19,2.89%,RYR1;RYR2;ITPR1;GRIN2C
prerank,calcium activated cation channel activity (GO:0005227),0.787986140052158,1.748448353480986,0.009787928221859706,0.24788782606081172,0.956,7/17,8.71%,KCNMA1;ANO1;KCNMB1;ANO6;KCNN2;ANO10;TRPM4
prerank,phosphatidylinositol-3-phosphate binding (GO:0032266),0.6751562241866504,1.7415562906284776,0.012534818941504178,0.25038120068551695,0.969,3/38,1.88%,JPH2;OBSCN;HIP1
prerank,adenylate cyclase binding (GO:0008179),0.8785378822950605,1.741172500855165,0.012567324955116697,0.23824087723744172,0.971,6/10,7.46%,CAP2;AKAP6;ADCY5;ADCY2;CALM1;CAP1
prerank,"phosphatidylinositol-3,4,5-trisphosphate binding (GO:0005547)",0.7127460927119503,1.7373193189016602,0.011235955056179775,0.2341162801685444,0.973,4/34,3.71%,JPH2;OBSCN;FERMT2;MYO1B
prerank,mannosyltransferase activity (GO:0000030),-0.5953164799096552,-1.7215740282392484,0.006042296072507553,0.26538874541856355,0.678,9/21,21.47%,TMTC1;TMTC2;DPY19L4;TMTC4;DPY19L1;PIGV;ALG1;ALG12;POMT1
prerank,voltage-gated cation channel activity (GO:0022843),0.6091471993008795,1.7137957084394573,0.002325581395348837,0.2814558828853318,0.99,13/97,5.55%,CACNB2;KCNMA1;RYR1;CACNA1S;CACNA1C;CACNA2D1;GRIN2C;KCNA5;KCNQ5;KCNQ4;CACNB4;KCNB1;KCNH1
prerank,anion transmembrane transporter activity (GO:0008509),-0.6780780799675457,-1.7127622835382952,0.0072992700729927005,0.24174601906824159,0.715,5/12,8.15%,ABCG2;SLCO2B1;SLC39A8;SLC22A6;SLC4A2
prerank,phosphatidic acid binding (GO:0070300),0.7470941387442906,1.6974274871698583,0.03436988543371522,0.31109460922683324,0.994,5/19,7.72%,JPH2;PACSIN2;MARK1;RAPGEF6;OPA1
prerank,calcium-activated potassium channel activity (GO:0015269),0.8317998170205654,1.6963848804930344,0.010309278350515464,0.30061173255874973,0.995,3/11,4.13%,KCNMA1;KCNMB1;KCNN2
prerank,miRNA binding (GO:0035198),-0.5345198262216523,-1.6919733272069932,0.0,0.25824151443810134,0.782,17/30,34.20%,AGO3;MATR3;PUM1;ZC3H7A;TUT4;ZC3H12A;PNPT1;TUT7;FMR1;ZC3H7B;YBX1;AGO4;RBM10;ZC3H10;HNRNPA2B1;ELAVL1;SPOUT1
prerank,GABA-gated chloride ion channel activity (GO:0022851),0.8168434184052202,1.6808439537869704,0.01601423487544484,0.3266538203825322,0.999,6/12,11.95%,GABRE;GABRA4;GABRA5;GABRB2;GABRG1;GABRB3
prerank,GABA-A receptor activity (GO:0004890),0.7505957444335634,1.6756822681112196,0.024350649350649352,0.3273882061876925,0.999,6/18,11.95%,GABRE;GABRA4;GABRA5;GABRB2;GABRG1;GABRB3
prerank,P-type ion transporter activity (GO:0015662),0.8207091734261934,1.659087717205373,0.023255813953488372,0.36040637397282316,1.0,3/12,1.66%,ATP2A1;ATP2B4;ATP2A2
prerank,diacylglycerol kinase activity (GO:0004143),0.8066911296398507,1.6579290068406103,0.02292768959435626,0.35059939781029736,1.0,2/11,0.44%,DGKB;DGKG
prerank,potassium channel regulator activity (GO:0015459),0.635527387489051,1.6524125760068495,0.020618556701030927,0.35388524033897867,1.0,8/49,8.12%,KCNAB1;FLNA;KCNMB1;SLC5A3;KCNE4;KCNIP3;ENSA;WNK2
prerank,extracellular ligand-gated ion channel activity (GO:0005230),0.8224491038041785,1.6496457679459988,0.033582089552238806,0.3488205106482182,1.0,4/10,9.40%,GABRE;GABRA4;GABRA5;GABRG1
prerank,"phosphatidylinositol-3,5-bisphosphate binding (GO:0080025)",0.7197967568647295,1.6413362099915239,0.02936378466557912,0.35914258838486873,1.0,4/23,6.59%,JPH2;HIP1;CLVS1;PHLDA3
prerank,NADPH binding (GO:0070402),0.8073253364934875,1.6380771476562925,0.023333333333333334,0.3554751641431793,1.0,2/13,3.53%,KCNAB1;CRYZ
prerank,phosphatidylinositol kinase activity (GO:0052742),-0.6255490818010598,-1.637946521386605,0.01728395061728395,0.3919579705900624,0.927,5/15,7.32%,PIK3CA;PI4KA;PIK3R3;PI4K2A;PIK3CB
prerank,"phosphatidylinositol-4,5-bisphosphate binding (GO:0005546)",0.5897824847929778,1.6340417936681826,0.013285024154589372,0.3548093835501703,1.0,17/72,11.98%,JPH2;OBSCN;HIP1;CGAS;MYO1B;MARK1;SYTL2;TTPA;PHLDA3;PLCB1;AMER1;PLCD1;ACTN2;SNX18;ANXA9;GRAMD2A;OSBPL2
prerank,filamin binding (GO:0031005),0.7893844167252201,1.6251131696647534,0.03676470588235294,0.36929882892806565,1.0,2/11,1.76%,SYNPO2;DPYSL4
prerank,calcium ion binding (GO:0005509),0.5329091160504859,1.6183990480447903,0.0020242914979757085,0.37644158287410284,1.0,56/323,10.87%,ASPN;SLIT1;SLIT3;RYR1;ATP2A1;TTN;CDH6;RYR2;AOC3;TNNC2;SPARCL1;MYL2;ESYT2;CASQ1;HRC;ATP2A2;ITPR1;FER1L5;PPP3CA;S100G;RASGRP2;DYSF;ASTN2;SLC8A1;CDH13;ANXA1;ASPH;LOXL2;LPL;LCP1;ITSN1;PADI2;STIM1;PITPNM3;CDH4;SYT10;CAMKK2;NUCB1;TESC;CDHR3;CALB1;EML1;CALM1;RASGRP1;TPM4;NCS1;TRPM4;CDH2;GCA;TPD52;AGRN;AOAH;SRI;S100A6;GALNT3;ANXA9
prerank,vinculin binding (GO:0017166),0.7918368889107084,1.6171869829834622,0.03214285714285714,0.36872786044710776,1.0,5/11,7.48%,DMD;ACTN1;UTRN;TLN1;RTCB
prerank,calcium channel activity (GO:0005262),0.5790865480366741,1.6144144911049383,0.015834348355663823,0.36576903748437617,1.0,18/84,12.46%,CACNB2;RYR1;RYR2;CACNA1S;CACNA1C;TRPC6;CACNA2D1;CACNB4;PKD1L3;TRPV2;NCS1;TRPM4;TRPC5;PANX1;ANXA9;CACNA1B;CHRNA7;TRPM2
prerank,alkali metal ion binding (GO:0031420),-0.644729409269369,-1.6142770368651187,0.0182648401826484,0.4329352648087506,0.964,3/13,7.54%,ATP1A2;HDAC4;PDXK
prerank,sialyltransferase activity (GO:0008373),-0.5571464512602345,-1.6092316491724519,0.01881720430107527,0.4050832867424544,0.971,9/20,10.81%,ST3GAL4;ST3GAL6;ST8SIA4;ST3GAL1;ST3GAL5;ST6GALNAC3;ST8SIA1;ST3GAL3;ST8SIA2
prerank,cation channel activity (GO:0005261),0.5752481901538207,1.603576689862215,0.0117096018735363,0.38596216794329474,1.0,23/94,12.46%,CACNB2;RYR1;RYR2;TMEM38B;ASIC3;TRPC6;ANO1;ANO6;KCNQ4;PKD1L3;TRPV2;CALHM5;ANO10;TRPM4;TRPC5;ABCC8;TMEM38A;PANX1;ANXA9;KCNK3;KCNA2;CHRNA7;TRPM2
prerank,phosphatidylinositol bisphosphate binding (GO:1902936),0.5648293436399162,1.5942354940352246,0.017321016166281754,0.403484168614021,1.0,22/91,11.98%,JPH2;OBSCN;HIP1;CGAS;MYO1B;MARK1;TTPAL;KCNH1;SYTL2;TTPA;MAPT;CLVS1;PHLDA3;PLCB1;AMER1;PLCD1;ACTN2;SNX18;ANXA9;GRAMD2A;WDR45;OSBPL2
prerank,cation:chloride symporter activity (GO:0015377),-0.6866552553066537,-1.5919716230619934,0.024444444444444446,0.42487654425568755,0.983,5/10,18.12%,SLC12A2;SLC6A1;SLC12A7;SLC12A6;SLC12A8
prerank,G protein-coupled peptide receptor activity (GO:0008528),0.5725283787108204,1.5804539866101484,0.019184652278177457,0.4341103494623212,1.0,8/73,5.46%,LHCGR;EDNRA;HCRTR1;CRHR2;EDNRB;VIPR2;TSHR;CYSLTR2
prerank,carbohydrate:cation symporter activity (GO:0005402),0.7759500652728106,1.579452101019562,0.054104477611940295,0.4267077253808785,1.0,5/11,9.00%,SLC5A3;SLC2A10;SLC23A2;SLC23A1;SLC5A11
prerank,BMP binding (GO:0036122),0.7773917893025973,1.5784767075759376,0.04181818181818182,0.41913726440854776,1.0,3/11,2.99%,TCAP;HJV;GREM2
prerank,histone demethylase activity (GO:0032452),-0.5170213510902284,-1.5757356931811861,0.009375,0.44488816710003576,0.988,12/27,26.24%,KDM7A;KDM5C;KDM5B;KDM2A;KDM3B;JMJD6;RIOX2;KDM1A;KDM4D;KDM6A;FBXL19;HR
prerank,superoxide-generating NAD(P)H oxidase activity (GO:0016175),0.7952228674608651,1.56962439371933,0.043875685557586835,0.43610171446734075,1.0,1/10,0.36%,NCF2
prerank,gated channel activity (GO:0022836),-0.6175748363915783,-1.5650500324552672,0.01818181818181818,0.45049727656687,0.992,9/14,25.79%,PIEZO1;PIEZO2;TMC7;TMEM63A;TMEM266;TMC4;TMC6;TMEM63B;PACC1
prerank,"DNA binding, bending (GO:0008301)",-0.6107506740073751,-1.5533817617735801,0.03125,0.45912870619348084,0.996,8/14,26.96%,LEF1;FOXD1;HMGB1;FOXL1;HMGA2;SAP30L;HHEX;HMGB2
prerank,secondary active transmembrane transporter activity (GO:0015291),-0.42776751136013025,-1.5527859644986683,0.009009009009009009,0.4303044824862668,0.996,19/51,18.27%,SLC22A8;SLCO2B1;SLCO1C1;SLCO2A1;SLC7A5;MCU;SLC25A3;SLC22A6;SLC35E2A;SLC35E2B;SLCO3A1;CLCN4;SLC25A14;SLC22A4;SLC5A5;SLC25A30;SLC25A11;SLC35D1;SLC35D2
prerank,MAP kinase kinase kinase activity (GO:0004709),0.7725933501892923,1.5510896883502017,0.05291005291005291,0.4818955520610009,1.0,2/11,1.24%,MAP3K20;MAP3K5
prerank,damaged DNA binding (GO:0003684),-0.44933096607069384,-1.548800255144973,0.011494252873563218,0.41698614697869246,0.997,29/44,39.46%,HMGB1;ERCC5;XRCC1;DDB1;NBN;EP300;CRY2;XPA;DCLRE1A;ERCC2;ERCC1;RAD1;ERCC4;DCLRE1B;HMGB2;OGG1;RPA3;TDG;SDE2;APTX;FANCG;NEIL3;ERCC3;RAD18;RPA2;RPA1;DCLRE1C;NTHL1;XPC
prerank,ubiquitination-like modification-dependent protein binding (GO:0140035),-0.6625939109948942,-1.544843455551822,0.029748283752860413,0.40444745827832485,0.997,4/10,12.21%,ANKRD13A;PML;FAN1;DNAJB2
prerank,aldehyde dehydrogenase [NAD(P)+] activity (GO:0004030),-0.5804770975290362,-1.5431698711803405,0.030612244897959183,0.3871253378454997,0.998,5/15,8.08%,ALDH1A2;ALDH1A1;ALDH4A1;ALDH3A2;ALDH7A1
prerank,calcium-release channel activity (GO:0015278),0.7057507125837413,1.5418291471713805,0.0628099173553719,0.5015465228835602,1.0,3/17,1.66%,RYR1;RYR2;ITPR1
prerank,R-SMAD binding (GO:0070412),-0.5620372389321345,-1.5327849087254293,0.04871794871794872,0.3970374273053844,0.998,10/18,19.33%,LDLRAD4;SMAD3;DDX5;SMAD6;RANBP3;RGCC;TRIM33;SMAD2;SMAD4;PMEPA1
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines (GO:0016813)",0.7466723136736921,1.5312159419267393,0.0737410071942446,0.522733735079483,1.0,2/11,3.29%,PADI3;PADI2
prerank,mechanosensitive ion channel activity (GO:0008381),-0.6349523178647252,-1.5309279570647407,0.01978021978021978,0.38238421057302346,0.998,7/12,21.66%,PIEZO1;PIEZO2;TMC7;TMEM63A;TMC4;TMC6;TMEM63B
prerank,aldehyde dehydrogenase (NAD+) activity (GO:0004029),-0.5920211479999259,-1.5159846053844936,0.04275534441805225,0.4097157512668282,0.999,7/13,17.47%,ALDH1A2;ALDH1A1;ALDH4A1;ALDH3A2;ALDH7A1;ADH5;ALDH1L1
prerank,pyrophosphate hydrolysis-driven proton transmembrane transporter activity (GO:0009678),0.6625995466465602,1.5156437283477888,0.07772795216741404,0.5630148310176811,1.0,6/22,13.29%,ATP2A1;ATP2A2;ATP6V0A2;ATP6V1C1;ATP2A3;ATP6V0D2
prerank,calcium channel regulator activity (GO:0005246),0.5950367764036096,1.5142066387454522,0.06695156695156695,0.5566986270560962,1.0,10/37,10.67%,PRKG1;ITPR1;INAFM2;PACSIN3;RRAD;STIM1;GEM;CALM1;SRI;REM1
prerank,ubiquitin-dependent protein binding (GO:0140036),-0.6540962423434633,-1.5131873458181955,0.04487179487179487,0.3999828965085482,0.999,4/10,12.21%,ANKRD13A;FAN1;DNAJC2;DNAJB2
prerank,GABA receptor activity (GO:0016917),0.6554324825346703,1.5031782743332804,0.062402496099843996,0.5834218774831734,1.0,6/21,11.95%,GABRE;GABRA4;GABRA5;GABRB2;GABRG1;GABRB3
prerank,"oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0016616)",0.5511422951078214,1.4991863658096105,0.04257907542579075,0.5852957297721701,1.0,14/75,11.07%,KCNAB1;HSD17B10;DHRS4;HIBADH;MDH1;ME3;HSD17B7;DHRS3;HSD17B4;LDHD;CBR1;HADHB;NSDHL;PTGR1
prerank,Wnt-activated receptor activity (GO:0042813),0.6997608887342275,1.4958295836963904,0.08193979933110368,0.5851625525627424,1.0,7/15,11.78%,ROR1;FZD5;FZD4;FZD8;FZD9;LRP5;TSPAN12
prerank,sodium channel regulator activity (GO:0017080),0.5982670305588697,1.495282363693321,0.0723055934515689,0.5758535673941336,1.0,7/37,7.46%,FGF13;ATP2B4;FGF14;SNTA1;CAMK2D;NEDD4;PRSS8
prerank,voltage-gated chloride channel activity (GO:0005247),0.7319382074306864,1.490923419365877,0.08944543828264759,0.578978091409529,1.0,3/10,6.00%,ANO1;ANO6;CLCN6
prerank,intracellular calcium activated chloride channel activity (GO:0005229),0.6850140131192055,1.4907319891929176,0.06199021207177814,0.5581186081772379,1.0,5/16,10.05%,ANO1;ANO6;TTYH1;ANO10;ANO3
prerank,intracellular chloride channel activity (GO:0061778),0.6850140131192055,1.4907319891929176,0.06199021207177814,0.5581186081772379,1.0,5/16,10.05%,ANO1;ANO6;TTYH1;ANO10;ANO3
prerank,glucuronosyltransferase activity (GO:0015020),0.6567195586151227,1.4891570385178556,0.07028753993610223,0.553114834241642,1.0,3/19,3.69%,LARGE1;CSGALNACT1;EXT2
prerank,lysine-acetylated histone binding (GO:0070577),-0.5334240524902991,-1.4850076441799784,0.045454545454545456,0.4525660481172848,1.0,7/20,7.55%,MLLT3;ATAD2B;CARM1;BRD9;ZMYND8;TRIM24;BRDT
prerank,acetylation-dependent protein binding (GO:0140033),-0.5334240524902991,-1.4850076441799784,0.045454545454545456,0.4525660481172848,1.0,7/20,7.55%,MLLT3;ATAD2B;CARM1;BRD9;ZMYND8;TRIM24;BRDT
prerank,ion gated channel activity (GO:0022839),0.6343417605979981,1.4839465884637064,0.06717557251908397,0.5604708541779287,1.0,8/24,10.05%,ANO1;ANO6;KCNT2;TTYH1;ANO10;TRPM4;KCNT1;ANO3
prerank,protein heterodimerization activity (GO:0046982),0.5011116993913806,1.483499222853988,0.017857142857142856,0.5519523691862798,1.0,38/178,11.70%,TPM2;TPM1;AGTR1;AOC3;MEF2C;RALGAPA2;UBA2;HIP1;PDGFB;ITGA3;NR4A1;FZD4;ITGB1;EXT2;BCL2;KCNB1;MEF2A;ATP1B1;SAE1;TAF1;TP53;TUBB2B;ADD2;BCL2L2;FZD9;RALGAPA1;TPM4;RALGAPB;GCA;NR4A2;HIF1A;DGKD;SRI;TOP2B;PDGFA;ABCG1;ATF3;BOK
prerank,phospholipase C activity (GO:0004629),0.6246364752895334,1.4692219964709177,0.09523809523809523,0.5877465844492633,1.0,7/25,9.57%,EDNRA;PLCE1;PLCB4;PLCL1;CCL5;PLCB1;PLCD1
prerank,cadherin binding involved in cell-cell adhesion (GO:0098641),0.6581749377513413,1.4691062519429587,0.0748829953198128,0.5781523467584164,1.0,5/18,9.09%,PDLIM1;PDLIM5;ANXA1;CNN3;PPP1CA
prerank,calmodulin-dependent protein kinase activity (GO:0004683),0.6324746886735818,1.468649133110511,0.07401812688821752,0.5700443910882796,1.0,5/24,6.37%,MYLK2;CAMK2G;CAMK2D;PHKA2;MAPKAPK2
prerank,metal ion binding (GO:0046872),0.47536850300587585,1.456852979849528,0.004012036108324975,0.5992568778250306,1.0,73/477,10.60%,ASPN;SLIT1;SLIT3;RYR1;ATP2A1;TTN;CDH6;MAP3K20;RYR2;AOC3;TNNC2;SPARCL1;STK38L;MAP3K5;MYL2;ESYT2;UBA2;CASQ1;HRC;DYRK2;ATP2A2;ITPR1;FER1L5;ADCY2;PPP3CA;S100G;RASGRP2;DYSF;ASTN2;SLC8A1;CDH13;ANXA1;ASPH;LOXL2;LPL;LCP1;ITSN1;PADI2;CSGALNACT1;STIM1;PITPNM3;GEM;CDH4;SYT10;CAMKK2;MARK1;NUCB1;TESC;CDHR3;TPPP;CALB1;EML1;CALM1;STK26;RASGRP1;OPA1;DIS3L2;PRKACB;PAPOLA;TPM4;NCS1;TRPM4;CDH2;BRSK1;GCA;AASDHPPT;RAP2A;TPD52;AGRN;AOAH;SRI;S100A6;GALNT3
prerank,L-glutamate transmembrane transporter activity (GO:0005313),-0.5651721238703987,-1.446295770230632,0.0705596107055961,0.5631841537765235,1.0,9/14,31.52%,SLC7A11;SLC1A3;SLC17A6;SLC38A7;SLC1A1;SLC25A22;SLC1A2;SLC25A18;SLC1A6
prerank,phosphatidylinositol phosphate binding (GO:1901981),0.5079983188432876,1.4444778665423297,0.04827586206896552,0.6308340677926882,1.0,19/100,12.19%,JPH2;OBSCN;HIP1;FERMT2;MYO1B;TTPAL;KCNH1;TTPA;MAPT;DAB2IP;CLVS1;PHLDA3;ANKFY1;GAP43;FCHSD2;DENND1A;MYO10;WDR45;SNX13
prerank,glucose transmembrane transporter activity (GO:0005355),0.6565886971514832,1.443671553769349,0.09045226130653267,0.623699852551268,1.0,4/17,9.00%,SLC2A4;SLC5A3;SLC2A10;SLC5A11
prerank,phosphatidylglycerol binding (GO:1901611),-0.5662276832683639,-1.4434054618996877,0.06904761904761905,0.5519363715364887,1.0,8/13,25.50%,PITPNA;PLTP;GSDME;PITPNC1;GSDMD;STOML2;PLEKHN1;MME
prerank,death receptor binding (GO:0005123),0.6714621239677576,1.4426316365388923,0.10689655172413794,0.6173738722365635,1.0,3/15,6.31%,NTF3;MYD88;DAB2IP
prerank,protein kinase A catalytic subunit binding (GO:0034236),0.676808562289277,1.4412191718898015,0.13412563667232597,0.6125922604779389,1.0,4/13,8.60%,RYR2;SOX9;PKIA;PRKAR1B
prerank,sodium-independent organic anion transmembrane transporter activity (GO:0015347),-0.6081196567985729,-1.4355694833100336,0.07029478458049887,0.559708470928442,1.0,5/10,8.37%,SLCO2B1;SLCO1C1;SLCO2A1;SLC22A6;SLCO3A1
prerank,transmembrane receptor protein phosphatase activity (GO:0019198),-0.5330138979686234,-1.4332569800315744,0.09523809523809523,0.5281719514034947,1.0,8/16,19.95%,PTPRB;PTPRG;PTPRN2;PTPRM;PTPRZ1;PTPRD;PTPRO;PTPRU
prerank,transmembrane receptor protein tyrosine phosphatase activity (GO:0005001),-0.5330138979686234,-1.4332569800315744,0.09523809523809523,0.5281719514034947,1.0,8/16,19.95%,PTPRB;PTPRG;PTPRN2;PTPRM;PTPRZ1;PTPRD;PTPRO;PTPRU
prerank,"3',5'-cyclic-AMP phosphodiesterase activity (GO:0004115)",0.6761832806519656,1.4330480143968838,0.13298791018998274,0.6298810771003523,1.0,2/12,5.11%,PDE3A;PDE4A
prerank,actin monomer binding (GO:0003785),0.6209703393620137,1.431012362467457,0.1021671826625387,0.6274095617600884,1.0,5/22,3.34%,LMOD2;MYL2;LMOD3;MYL3;MRTFA
prerank,insulin-like growth factor receptor binding (GO:0005159),-0.5901546332198493,-1.42974254325812,0.07673267326732673,0.5220615946208981,1.0,6/12,13.87%,IGF1;ARRB1;GNAS;SOCS2;IGF2;INSR
prerank,antiporter activity (GO:0015297),-0.5034777164495436,-1.4282064565122596,0.07605633802816901,0.509438267157109,1.0,11/20,29.30%,SLC35E2A;SLC35E2B;CLCN4;SLC25A14;SLC25A30;SLC25A11;SLC35D1;SLC35D2;SLC35E3;SLC35E4;SLC35C2
prerank,NADP binding (GO:0050661),0.5961351636393933,1.4225952146338159,0.11354309165526676,0.6462624078138625,1.0,3/32,4.69%,KCNAB1;CRYZ;ME3
prerank,chemoattractant activity (GO:0042056),0.5958834014412626,1.420297551114939,0.10407239819004525,0.6442680022432248,1.0,5/26,6.96%,NTF3;PDGFB;CCL5;VEGFA;GDNF
prerank,transaminase activity (GO:0008483),0.6985509459595101,1.4192269068731709,0.14109347442680775,0.6387537053933838,1.0,3/11,7.92%,BCAT2;GOT1;GOT2
prerank,voltage-gated anion channel activity (GO:0008308),0.6478476981537762,1.4159613743293171,0.11274509803921569,0.6406004546761536,1.0,4/15,8.87%,ANO1;ANO6;CLCN6;VDAC1
prerank,phosphatidylinositol phospholipase C activity (GO:0004435),0.6067429102634355,1.415917386825653,0.11093990755007704,0.6318538272548826,1.0,6/23,9.57%,EDNRA;PLCE1;PLCB4;CCL5;PLCB1;PLCD1
prerank,polynucleotide adenylyltransferase activity (GO:0004652),0.6788047081769439,1.4148493733308467,0.12568306010928962,0.6267226990732506,1.0,3/12,8.34%,TENT5B;TENT4A;PAPOLA
prerank,growth factor activity (GO:0008083),0.5143991462989569,1.414220960234621,0.0771055753262159,0.6202516208937561,1.0,9/74,7.19%,NTF3;FGF1;PDGFB;THPO;JAG1;IL2;VEGFA;GDNF;AREG
prerank,cAMP response element binding (GO:0035497),-0.6014917783190808,-1.4141785336523414,0.08172043010752689,0.5394569278418218,1.0,6/10,19.99%,CREB5;ATF2;CREB1;ATF7;CREB3L1;HMGA2
prerank,androgen receptor binding (GO:0050681),-0.46446571196969555,-1.41385857413254,0.06353591160220995,0.5240144045820145,1.0,11/25,19.56%,NSD1;PRKCB;FOXP1;DDX5;RNF6;PRMT2;SNW1;EP300;CALR;KDM1A;PARK7
prerank,motor activity (GO:0003774),0.5258424106990557,1.4129485638228205,0.07979407979407979,0.6158326067254539,1.0,20/60,14.72%,MYO1E;MYL6;KIF27;MYH9;KIF2A;DYNLRB1;KIF3B;DNAH17;KIF1A;PIN1;KIF5B;KIF1C;CENPE;KIF5C;DYNC1I2;KIF5A;APPBP2;KIF20B;KIF18A;KIF6
prerank,"3',5'-cyclic-nucleotide phosphodiesterase activity (GO:0004114)",0.6224846996828928,1.4101021343282087,0.10989010989010989,0.616705084386359,1.0,3/21,5.11%,PDE3A;PDE5A;PDE4A
prerank,serine-type endopeptidase inhibitor activity (GO:0004867),0.5567219575536623,1.4091327450612723,0.08888888888888889,0.6119604333351611,1.0,3/38,3.30%,SERPINB8;SERPINI1;SERPINE2
prerank,transforming growth factor beta binding (GO:0050431),0.6051822690669896,1.4073914279560593,0.1152073732718894,0.6095111512145062,1.0,5/23,3.56%,LTBP1;VASN;CD36;LRRC32;TGFB3
prerank,hexose transmembrane transporter activity (GO:0015149),0.681910334342835,1.4068642884172606,0.12248628884826325,0.6034179449791146,1.0,2/12,2.87%,SLC2A4;SLC5A3
prerank,potassium channel activity (GO:0005267),0.5087804448558039,1.4067532197847776,0.06990521327014218,0.5962448779513523,1.0,18/89,11.36%,KCNMA1;TMEM38B;KCNMB1;KCNA5;KCNQ5;KCNQ4;KCNN2;KCNB1;CCDC51;KCNH1;KCNT2;GRIK5;KCNT1;ABCC8;TMEM38A;KCNH8;KCNK3;KCNA2
prerank,fatty acid synthase activity (GO:0004312),-0.5916057987262832,-1.4029774262648433,0.09925558312655088,0.5429672308208713,1.0,7/10,34.22%,ELOVL7;ELOVL4;ELOVL6;ELOVL1;ELOVL5;OXSM;MCAT
prerank,"oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor (GO:0016620)",-0.5209898214225435,-1.4021206393657053,0.08100558659217877,0.5298068792224965,1.0,4/18,6.40%,ALDH1A2;ALDH1A1;FAR2;ALDH3A2
prerank,metalloaminopeptidase activity (GO:0070006),0.6285460085422842,1.3976552698369673,0.13486842105263158,0.6163388698706137,1.0,4/16,7.23%,MMP17;LNPEP;RNPEP;ENPEP
prerank,Lys48-specific deubiquitinase activity (GO:1990380),-0.5510120190018973,-1.3881083182896596,0.09290953545232274,0.5607283756694049,1.0,5/14,14.72%,ATXN3;MINDY3;OTUD7B;USP7;MINDY1
prerank,L-amino acid transmembrane transporter activity (GO:0015179),-0.38374914706834906,-1.3856449745546215,0.05504587155963303,0.5542542089492384,1.0,26/53,29.78%,SLC7A11;SLC1A3;SLC47A1;SLC3A2;SLC7A5;CTNS;SLC6A9;SLC43A2;SLC17A6;SLC66A1;SLC38A5;SLC38A6;SLC25A38;SLC38A7;SLC15A4;SLC7A7;SLC1A4;SLC36A1;SLC43A1;SLC1A1;SLC25A22;SLC1A2;SLC25A15;SLC7A6;SLC25A18;SLC38A9
prerank,chemorepellent activity (GO:0045499),-0.46419385679322556,-1.3851747786962842,0.07523510971786834,0.5413752693279751,1.0,9/25,13.33%,SEMA3D;EPHA7;SEMA3C;SEMA6A;SEMA7A;SEMA3A;SEMA4D;SEMA6D;DPP4
prerank,microtubule plus-end binding (GO:0051010),0.6164976266841365,1.3811445044794095,0.1302250803858521,0.6617406354011739,1.0,11/20,17.60%,CLASP2;STIM1;DST;MAPRE2;CLIP3;FBXW11;CLASP1;KIF18A;MAPRE3;KNSTRN;DCTN1
prerank,"oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor (GO:0050664)",0.6586417820068775,1.3756421671166177,0.14261460101867574,0.6707394312643609,1.0,2/14,6.81%,NCF2;KMO
prerank,E-box binding (GO:0070888),-0.42307788664569185,-1.3745544935603766,0.08561643835616438,0.562151549718441,1.0,14/34,27.44%,TCF4;ZEB1;MAX;AHR;HES1;BHLHE41;PER1;BHLHE40;PPARG;ATOH8;TAL1;TFAP4;TWIST1;SNAI1
prerank,Toll-like receptor binding (GO:0035325),0.6575124373817381,1.3718978179564454,0.16283185840707964,0.6747242929609337,1.0,3/11,6.31%,CD36;MYD88;DAB2IP
prerank,cyclic-nucleotide phosphodiesterase activity (GO:0004112),0.5970423152914768,1.3704697824622285,0.12403100775193798,0.671286031518317,1.0,3/23,5.11%,PDE3A;PDE5A;PDE4A
prerank,protein kinase A regulatory subunit binding (GO:0034237),0.6042646733550561,1.369842916859217,0.1419457735247209,0.6655894324027924,1.0,2/21,0.93%,RYR2;AKAP6
prerank,dicarboxylic acid transmembrane transporter activity (GO:0005310),-0.43527843690439727,-1.3684394609296253,0.08,0.5691240027333315,1.0,15/29,31.80%,SLC13A3;SLC26A7;SLC25A14;SLC26A2;SLC25A30;SLC25A11;SLC38A7;SLC1A4;SLC1A1;SLC25A22;SLC26A6;SLC25A21;SLC25A18;SLC1A6;SLC13A5
prerank,solute:anion antiporter activity (GO:0140323),-0.5324783338235595,-1.3659169094006434,0.0966183574879227,0.5628758249724081,1.0,4/14,10.63%,SLC7A11;SLC26A7;SLC4A2;SLC26A2
prerank,protein homodimerization activity (GO:0042803),0.44802797624082424,1.363278304558391,0.002,0.6789117188829529,1.0,120/589,15.08%,MYOM1;TPM2;SOX6;PLN;FLNA;TPM1;ATP2A1;RBPMS;ACTN1;RBPMS2;TRPC6;CAMK2G;ACTN4;MAP3K5;RBM44;MYOM3;ANO1;CHMP4C;HIP1;HSPB6;SYNE1;PDGFB;PDGFC;MYH9;PIP4K2A;LPL;CAMK2D;MYO9B;PADI2;FZD4;CCL5;EXT2;ACP3;NACC2;KCNN2;NR2F2;BCL2;TBX18;BMPR1A;LHPP;ATG7;TYW5;TESC;HSD17B4;ZDHHC2;CRPPA;TPPP;TERT;DAB2IP;VEGFA;ZBTB38;GRHL1;GDNF;SFPQ;STK26;ADD2;BCL2L2;PLEK;GLA;FZD9;TGFB2;RELA;MAP3K10;DAPK3;TPM4;TRIM68;MVD;GCA;PTH1R;LRRFIP1;MGLL;DGKD;HOOK1;ST6GAL1;TPD52;RAB11FIP4;S100A6;RAB11FIP3;DNM1L;PDGFA;GGCT;ABCG1;ATF3;TERF2;BOK;DUSP29;AIMP1;TSG101;GSTA4;GBP2;CHRNA7;SNX9;PDCD10;POU3F3;NR6A1;DROSHA;KIF20B;HPS4;ST3GAL2;MKLN1;TMEM192;DGCR8;CEP43;LRRK2;MTCL1;PDK2;STK10;HM13;EPRS1;TNNC1;MCL1;SPPL2B;GLB1;ZBTB4;STAT1;EXD2;SNX1;KNSTRN;KARS1;MLXIPL
prerank,ankyrin binding (GO:0030506),0.6076749376449472,1.3611423757062384,0.14057507987220447,0.6775706007098046,1.0,3/19,4.13%,OBSCN;SLC8A1;FLNC
prerank,UDP-galactosyltransferase activity (GO:0035250),-0.576098621036349,-1.3589173096348803,0.13785557986870897,0.5713618017337301,1.0,7/10,36.08%,B4GALT1;B4GALT6;B4GALT7;B3GALT2;B3GALT1;A3GALT2;B3GALT6
prerank,bHLH transcription factor binding (GO:0043425),-0.4838557635562542,-1.3541972749835292,0.12090680100755667,0.5728694759883096,1.0,9/19,26.53%,SMAD3;FHL2;PSMD9;BHLHE41;BHLHE40;KDM1A;LMO2;USF1;TWIST1
prerank,C2H2 zinc finger domain binding (GO:0070742),-0.5581712887672806,-1.3481364693496292,0.12589073634204276,0.5784731584097949,1.0,2/11,0.83%,SRRM2;LEF1
prerank,histone methyltransferase activity (H3-K9 specific) (GO:0046974),0.6680612818775278,1.3479906160642354,0.17375231053604437,0.7121565266600624,1.0,3/10,6.94%,PRDM16;SUV39H2;ASH1L
prerank,"phosphatidylinositol-3,4-bisphosphate binding (GO:0043325)",0.5766920145280777,1.3459444841072503,0.14683153013910355,0.7114068130763647,1.0,6/25,10.13%,OBSCN;HIP1;TTPA;PHLDA3;PLEK;FCHSD2
prerank,metal ion transmembrane transporter activity (GO:0046873),0.5723029438638715,1.3446959500090145,0.16767371601208458,0.7077704806779573,1.0,9/27,10.53%,ATP2B4;CNNM2;ITPR1;SLC8A2;SLC4A8;ATP2B1;SLC23A1;MRS2;ATP2A3
prerank,glutamate receptor activity (GO:0008066),-0.4822607745008077,-1.3409197771003913,0.1099476439790576,0.5883344327794688,1.0,7/19,19.19%,GRM3;GRM7;GRIK3;GRIN2D;GRM5;GRID2;GRIK1
prerank,mannose binding (GO:0005537),0.6433204857279595,1.3351177950479491,0.18782608695652173,0.7310749616558331,1.0,2/12,7.80%,CLN5;MBL2
prerank,histone acetyltransferase binding (GO:0035035),0.5716573481795083,1.3344975918657027,0.16826923076923078,0.7252808415082204,1.0,9/21,14.65%,MEF2A;TP53;TRIM68;HIF1A;SIRT2;ZBTB7A;KANSL1;CITED2;STAT1
prerank,sulfate transmembrane transporter activity (GO:0015116),-0.5142280020757551,-1.332987297765389,0.13801452784503632,0.5999377244899022,1.0,5/14,17.12%,SLC26A7;SLC25A14;SLC26A2;SLC25A30;SLC25A11
prerank,solute:sodium symporter activity (GO:0015370),0.5658926580697353,1.329457152336544,0.15406562054208273,0.733588813568213,1.0,5/27,9.00%,SLC5A3;SLC4A8;SLC20A2;SLC4A7;SLC5A11
prerank,FMN binding (GO:0010181),-0.5661958361401298,-1.3239505515355052,0.13176470588235295,0.6169172377943699,1.0,3/11,8.92%,POR;PPCDC;NOS3
prerank,1-phosphatidylinositol-3-kinase activity (GO:0016303),-0.5677687519423595,-1.3206108777023489,0.14965986394557823,0.6147880928504448,1.0,3/10,7.32%,PIK3CA;PIK3R3;PIK3CB
prerank,sodium channel activity (GO:0005272),0.5205819554864887,1.3191460110153301,0.17433751743375175,0.7593927961943455,1.0,3/37,1.96%,SCN4A;ASIC3;CACNA1H
prerank,phosphatidylinositol 3-kinase activity (GO:0035004),-0.5458937995000996,-1.3187405375503156,0.17142857142857143,0.6080398560744816,1.0,5/12,18.99%,PIK3CA;PIK3R3;PIK3CB;PIK3R6;ATM
prerank,sodium ion transmembrane transporter activity (GO:0015081),0.5443679185725476,1.3164577167754146,0.1589895988112927,0.7604261072000755,1.0,6/27,8.14%,ASIC3;SLC8A1;SLC8A2;SLC4A8;SLC9A8;SLC23A1
prerank,neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential (GO:0099529),0.5739574267758394,1.3138661544548271,0.189873417721519,0.7608893432472892,1.0,5/19,9.40%,GABRE;GABRA4;GABRA5;GRIK5;GABRG1
prerank,leak channel activity (GO:0022840),-0.4855304174103508,-1.3138595833198676,0.1394736842105263,0.6102088158817214,1.0,3/18,6.30%,KCNK2;NALCN;KCNK5
prerank,cholesterol binding (GO:0015485),-0.377157550586506,-1.3081223370769663,0.116,0.6157039886142506,1.0,17/47,23.76%,OSBPL8;ABCA1;PTCH1;OSBPL10;GRAMD1C;ANXA6;APOD;SCARB2;SIDT1;PROM1;SOAT1;GRAMD1A;STARD4;SYP;STARD3NL;NPC1;STARD5
prerank,amino acid:sodium symporter activity (GO:0005283),-0.5476558603672402,-1.30394928017898,0.1673913043478261,0.6168304685916038,1.0,4/11,3.61%,SLC6A13;SLC1A3;SLC6A1;SLC6A12
prerank,ATPase activator activity (GO:0001671),-0.4617171768897018,-1.2998284573475634,0.14080459770114942,0.6175648199264625,1.0,7/20,12.21%,ATP1B3;DNAJC10;TOR1AIP2;TOR1AIP1;ATP1B2;DNAJC19;DNAJB2
prerank,voltage-gated potassium channel activity (GO:0005249),0.47252251033373793,1.2957534510604252,0.1375598086124402,0.813688608719838,1.0,13/80,11.36%,KCNMA1;KCNJ12;KCNA5;KCNQ5;KCNQ4;KCNN2;KCNE4;KCNB1;KCNH1;KCNT2;KCNT1;KCNH8;KCNA2
prerank,receptor antagonist activity (GO:0048019),0.5819665167896465,1.2944519187903125,0.21043771043771045,0.8099502262213747,1.0,3/17,5.81%,FST;CCL5;PXDN
prerank,ligand-gated anion channel activity (GO:0099095),0.5939207703754847,1.2905770682670674,0.20165289256198346,0.8148133727348089,1.0,6/17,11.95%,GABRE;GABRA4;GABRA5;GABRB2;GABRG1;GABRB3
prerank,hyaluronic acid binding (GO:0005540),-0.558886345994481,-1.289842174976073,0.15904139433551198,0.6358105218802929,1.0,4/10,14.55%,CEMIP;CD44;LAYN;IMPG2
prerank,"phosphotransferase activity, alcohol group as acceptor (GO:0016773)",0.46938174180972714,1.2896575398859684,0.16028708133971292,0.8098788505840882,1.0,7/74,4.67%,DGKB;DGKG;NMRK2;FAM20A;HK2;GNE;ADPGK
prerank,C4-dicarboxylate transmembrane transporter activity (GO:0015556),-0.481364281973286,-1.2875958187702068,0.145985401459854,0.6309884607906492,1.0,11/16,31.80%,SLC13A3;SLC25A14;SLC25A30;SLC25A11;SLC38A7;SLC1A4;SLC1A1;SLC25A22;SLC25A18;SLC1A6;SLC13A5
prerank,calcium channel inhibitor activity (GO:0019855),0.633132473216991,1.287312200231559,0.23105360443622922,0.8099698475626781,1.0,3/11,7.15%,ITPR1;PACSIN3;CALM1
prerank,carboxy-lyase activity (GO:0016831),-0.44064274555945365,-1.282897589640827,0.150997150997151,0.6342983667202937,1.0,9/23,20.81%,PPCDC;UXS1;ECHDC1;AMD1;PCK2;AZIN1;DDC;ODC1;GAD1
prerank,platelet-derived growth factor receptor binding (GO:0005161),0.6244758001587968,1.2811119295290303,0.24451939291736932,0.8229025747168982,1.0,7/13,10.90%,PDGFB;PDGFC;PDGFD;VEGFA;ITGB3;PDGFRB;PDGFA
prerank,aminopeptidase activity (GO:0004177),0.5357667710502115,1.2809352934995417,0.19815668202764977,0.8156061454341327,1.0,5/26,7.23%,MMP17;LNPEP;RNPEP;BLMH;ENPEP
prerank,glycine binding (GO:0016594),-0.5266664859820234,-1.2805428570899913,0.1793103448275862,0.6298887532810177,1.0,5/11,20.56%,GLRB;GRIN3A;GLRA2;SRR;GLRA1
prerank,monocarboxylic acid binding (GO:0033293),0.5723429723534923,1.2801531870581806,0.2251655629139073,0.8106267399471934,1.0,2/18,4.22%,NR1H4;NR2F2
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides (GO:0016811)",-0.35526302608896615,-1.2770840388662128,0.10576923076923077,0.6297134439090191,1.0,19/54,20.14%,NGLY1;ASPA;ACER2;NAAA;HDAC4;PIGL;SIRT7;HINT1;ASAH2;SUDS3;UPB1;NTAQ1;ASRGL1;HINT3;ASPG;HDAC2;NADSYN1;MIER1;AMDHD2
prerank,protein tyrosine phosphatase activity (GO:0004725),-0.33441664368462826,-1.2753470412453867,0.06818181818181818,0.6250773694376169,1.0,12/71,5.91%,EYA2;PTPN13;EYA1;PTPRB;PTPRG;EYA4;PTPN14;CDC14B;PTPN11;PTPRN2;PTPRM;PTPRZ1
prerank,"N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity (GO:0008532)",-0.5084945612619013,-1.2728979310075794,0.14903846153846154,0.6217968401030619,1.0,9/12,44.49%,B3GALNT1;B3GNT2;B3GALT2;B3GALT1;B3GNT9;B3GNT3;B3GNT8;B3GNT6;B4GAT1
prerank,kinase binding (GO:0019900),0.4164373424748572,1.2726890377534368,0.03842264914054601,0.8279114230214499,1.0,53/434,9.72%,MYOM1;ACTA2;FLNA;ARHGEF7;TTN;PPP1R12A;INKA2;MYOM2;PRKAB2;LIMS1;CCNA2;FERMT2;FZD5;CCND2;CSPG4;FAM83D;KCNA5;BCAR3;RHOBTB3;LAX1;PARN;TSKS;ACTB;UTRN;DOK7;LYST;MAPT;CAV1;DAB2IP;PPP2R5A;PARP1;DUSP3;TP53;PTPN1;TPX2;CALM1;ADD2;BTG1;RAD9A;RELA;RHOF;TRIM68;CCND1;VDAC1;PPP1CB;PAK2;SKI;TOM1L2;ADCY6;HIF1A;DGKD;PDGFRB;CEP192
prerank,RNA polymerase II-specific DNA-binding transcription factor binding (GO:0061629),0.43279158160322834,1.272123087026826,0.1010752688172043,0.8219980363222184,1.0,29/181,11.59%,MYOCD;HEY2;ACTN4;NR1H4;SMARCD3;PRRX1;TEAD3;ARID1A;ANKRD2;ACTB;PIAS4;MEF2A;SETD6;NCOA7;MTDH;SMARCB1;TAF1;TP53;AR;MED1;PPARGC1A;RELA;PPARA;MTA3;HIF1A;PIAS2;RB1;TACC2;BAZ2A
prerank,DNA-binding transcription factor binding (GO:0140297),0.43242783742237273,1.2684986373771867,0.12210526315789473,0.826225103836919,1.0,26/189,9.27%,MYOCD;PRDM16;MEF2C;HEY2;CRTC1;PRRX1;TEAD3;GABPA;RUNX1T1;CRTC3;HDAC9;BCL2;ANKRD2;PIAS4;MEF2A;MTDH;TAF1;TP53;YAP1;AR;RELA;MAP3K10;DAPK3;PPARA;MTA3;SKI
prerank,transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential (GO:1904315),0.5253532125916098,1.267974052913858,0.2155688622754491,0.8203904724476874,1.0,8/28,17.23%,GABRE;GABRA4;GABRA5;GRIK5;GABRG1;CHRNA7;CHRNA4;GRIK4
prerank,CXCR chemokine receptor binding (GO:0045236),-0.5291015382230677,-1.266597124193402,0.18604651162790697,0.6296945311400923,1.0,2/11,9.48%,ITCH;YARS1
prerank,ephrin receptor activity (GO:0005003),-0.47482667056091743,-1.2621191292942073,0.1937984496124031,0.6219757659815166,1.0,8/17,22.58%,EPHA7;EPHA4;EPHA3;EPHA8;EPHA10;EPHB4;EFNB3;EPHB2
prerank,transmembrane-ephrin receptor activity (GO:0005005),-0.47482667056091743,-1.2621191292942073,0.1937984496124031,0.6219757659815166,1.0,8/17,22.58%,EPHA7;EPHA4;EPHA3;EPHA8;EPHA10;EPHB4;EFNB3;EPHB2
prerank,GTPase inhibitor activity (GO:0005095),-0.5134379294120057,-1.2577762604819314,0.18024691358024691,0.625157521542735,1.0,3/13,4.05%,CPEB2;SLIT2;PDE6D
prerank,receptor tyrosine kinase binding (GO:0030971),0.47337545925126545,1.2558497520733642,0.191969887076537,0.8531062828511039,1.0,10/56,6.67%,ANGPT2;ANGPT1;ANGPT4;SOCS5;PITPNM3;ARHGEF16;IRS1;DUSP3;TP53;PTPN1
prerank,water transmembrane transporter activity (GO:0005372),-0.5299271312197906,-1.2555135388502765,0.17982456140350878,0.6222864823647551,1.0,1/11,1.67%,PDPN
prerank,lipoprotein particle binding (GO:0071813),0.5552404408031106,1.2514330414747017,0.21473354231974923,0.8598428251675222,1.0,4/20,6.20%,CD36;CDH13;LPL;MAPT
prerank,regulatory RNA binding (GO:0061980),-0.3691371810987558,-1.2475758694423733,0.1520912547528517,0.6350687729777743,1.0,17/38,34.20%,AGO3;MATR3;PUM1;ZC3H7A;TUT4;ZC3H12A;PNPT1;TUT7;FMR1;ZC3H7B;YBX1;AGO4;RBM10;ZC3H10;HNRNPA2B1;ELAVL1;SPOUT1
prerank,RNA polymerase II core promoter sequence-specific DNA binding (GO:0000979),0.603446488984832,1.2453249979418,0.2585278276481149,0.872408794092724,1.0,6/12,21.41%,TAF1;RELA;STAT1;HDAC1;POU2F1;H3-3A
prerank,voltage-gated sodium channel activity (GO:0005248),0.5473055115561336,1.2444235939616113,0.23248407643312102,0.8678637074559035,1.0,2/22,1.96%,SCN4A;CACNA1H
prerank,gamma-tubulin binding (GO:0043015),0.5385306578391988,1.2437599082210398,0.24378881987577639,0.8622742551581625,1.0,4/21,9.01%,ARHGEF7;TUBGCP6;NDRG1;BRSK1
prerank,inhibitory extracellular ligand-gated ion channel activity (GO:0005237),0.597743289146056,1.2434046302611275,0.2638888888888889,0.8558648320728112,1.0,4/13,9.40%,GABRE;GABRA4;GABRA5;GABRG1
prerank,endopeptidase inhibitor activity (GO:0004866),0.4436962333009206,1.2412069811472926,0.17809867629362214,0.8555569136511391,1.0,7/82,6.91%,SERPINB8;SERPINI1;ROCK1;ITIH4;SERPINE2;LXN;TIMP4
prerank,5'-3' exonuclease activity (GO:0008409),-0.48363789783976313,-1.2409833234746264,0.21149425287356322,0.6439970748742907,1.0,7/14,25.50%,MRE11;FAN1;TRIR;DCP2;DCLRE1A;DCLRE1B;EXOG
prerank,NAD+ ADP-ribosyltransferase activity (GO:0003950),0.5298304416911339,1.2404862195316955,0.24041297935103245,0.8505361259305345,1.0,5/25,9.73%,ART1;SIRT3;PARP1;ART4;SIRT2
prerank,protein kinase C activity (GO:0004697),-0.4922624187067584,-1.2403009068920896,0.19950124688279303,0.6360555457240537,1.0,4/14,7.51%,PRKCB;PRKCH;SMG1;PRKCE
prerank,transmembrane receptor protein serine/threonine kinase activity (GO:0004675),0.5581013339854096,1.239750984279693,0.256198347107438,0.845775866882573,1.0,4/18,5.12%,HJV;LTBP1;ACVR2A;BMPR1A
prerank,carbohydrate kinase activity (GO:0019200),0.6011594609933875,1.2378457495579465,0.26846846846846845,0.8448895177634919,1.0,3/11,7.64%,HK2;GNE;FGGY
prerank,purine ribonucleotide transmembrane transporter activity (GO:0005346),-0.5247042515255955,-1.2336386715593937,0.22716627634660422,0.6462026922518436,1.0,8/11,36.77%,SLC25A17;SLC35B3;LRRC8A;SLC25A24;SLC35B2;SLC17A9;SLC25A25;SLC19A1
prerank,neutral amino acid transmembrane transporter activity (GO:0015175),-0.38578710136634825,-1.2312288530886193,0.18088737201365188,0.6438390377050157,1.0,14/32,22.23%,SLC6A6;SLC3A2;SLC7A5;SLC6A9;SFXN2;SLC43A2;SLC38A5;SLC38A6;SLC25A38;SLC38A7;SLC1A4;SLC36A1;SLC43A1;SLC1A1
prerank,calcium-dependent phospholipase A2 activity (GO:0047498),0.568545341187797,1.2311763804607316,0.2655172413793103,0.8602335740087708,1.0,3/15,15.20%,PLA2G3;PLA2G4A;PLA2G4C
prerank,Hsp70 protein binding (GO:0030544),-0.38767184391906406,-1.2304461027593958,0.16358024691358025,0.6370327428572214,1.0,8/31,14.18%,DNAJB12;DNAJC10;PRKN;DNAJC2;STUB1;ERN1;DNAJB2;SNCA
prerank,organic anion transmembrane transporter activity (GO:0008514),-0.29503409350754434,-1.2302329129564513,0.07228915662650602,0.6287140818835928,1.0,26/134,8.63%,SLC6A13;SLC16A12;SLC13A3;SLC1A3;ABCG2;PDPN;GJA1;SLCO2B1;SLC6A1;SLC6A6;SLC26A7;SLC16A1;SLCO1C1;SLC25A17;SLCO2A1;SLC3A2;SLC25A32;SLC52A1;SLC7A5;SLC39A8;CTNS;SLC22A6;SLC16A11;SLC6A9;SLCO3A1;ABCC4
prerank,delayed rectifier potassium channel activity (GO:0005251),0.5059020151366438,1.229884075250269,0.22529069767441862,0.8571568305500965,1.0,6/32,5.55%,KCNA5;KCNQ5;KCNQ4;KCNE4;KCNB1;KCNH1
prerank,MAP kinase activity (GO:0004707),-0.46920442320561034,-1.2283917308795962,0.21717171717171718,0.6249667056048493,1.0,7/14,26.34%,MAPK14;MAPK4;MAPK9;MAPK6;MAPK7;MAPK10;MAPK8
prerank,SH2 domain binding (GO:0042169),0.5017022409329047,1.2257465921888204,0.21961932650073207,0.8629295808704184,1.0,7/31,11.44%,DLC1;LAX1;NUP62;IRS1;INPPL1;PAG1;ARHGAP5
prerank,sterol transfer activity (GO:0120015),-0.4526676919811265,-1.2255451100191894,0.21105527638190955,0.6239359350831356,1.0,7/17,23.76%,PLTP;ABCA1;GRAMD1C;GRAMD1A;STARD4;OSBP;STARD5
prerank,adenylyltransferase activity (GO:0070566),0.5409292932911235,1.2252125823784625,0.24285714285714285,0.8578212847377146,1.0,7/21,15.04%,NMNAT2;TENT4A;PAPOLA;COASY;NMNAT1;OASL;KARS1
prerank,"steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0033764)",0.5473718790358958,1.2251606458553617,0.25801282051282054,0.8510464642934981,1.0,2/18,4.74%,HSD17B10;HSD17B7
prerank,potassium ion leak channel activity (GO:0022841),-0.4777005789954471,-1.2251081717213859,0.22660098522167488,0.6167834840511287,1.0,2/15,6.30%,KCNK2;KCNK5
prerank,transferrin receptor binding (GO:1990459),0.6272341433629578,1.223430797820829,0.2824858757062147,0.84965578974044,1.0,1/10,0.60%,HJV
prerank,ADP binding (GO:0043531),0.5263310910031066,1.221511589024593,0.2468354430379747,0.8491634140609515,1.0,8/25,11.25%,ACTA1;MYH9;MYO9B;MYO18A;COQ8A;MIEF1;LONP1;ABCG1
prerank,cysteine-type endopeptidase activity involved in apoptotic process (GO:0097153),-0.505398908992589,-1.2206767910176837,0.22818791946308725,0.6205877036511835,1.0,7/11,40.03%,CASP8;CASP9;CASP4;CASP12;CASP6;PYCARD;CASP1
prerank,acid-thiol ligase activity (GO:0016878),0.582800740194315,1.2195757228981687,0.2844677137870855,0.8485468411725082,1.0,1/13,0.92%,ACSS1
prerank,tau-protein kinase activity (GO:0050321),0.5339817029657281,1.217434700668495,0.24405705229793978,0.8484173762278956,1.0,5/20,10.78%,ROCK1;MARK1;DYRK1A;BRSK1;ROCK2
prerank,adenine nucleotide transmembrane transporter activity (GO:0000295),-0.5037138920023662,-1.2173034946911003,0.23798076923076922,0.6213786036474463,1.0,8/12,36.77%,SLC25A17;SLC35B3;LRRC8A;SLC25A24;SLC35B2;SLC17A9;SLC25A25;SLC19A1
prerank,I-SMAD binding (GO:0070411),-0.49713219459138885,-1.215886072066573,0.24644549763033174,0.6173847805859733,1.0,7/13,17.44%,SMAD3;SMAD6;SMAD9;CTNNB1;TGFBR1;SMAD2;SMAD4
prerank,chloride channel inhibitor activity (GO:0019869),-0.5331873216597643,-1.2158603208163317,0.2535211267605634,0.6096219067335419,1.0,6/10,17.90%,WNK1;WNK4;WNK3;STX1A;VAMP8;STX8
prerank,sequence-specific mRNA binding (GO:1990825),0.60251681971348,1.215819320880838,0.29349736379613356,0.8470290719400235,1.0,1/10,0.83%,RBM24
prerank,WW domain binding (GO:0050699),0.5193246596035559,1.2153879489315302,0.2462686567164179,0.8418859348428496,1.0,7/26,20.08%,ENAH;WBP1;KIF20B;TCEAL3;TCEAL6;TCEAL9;NDFIP2
prerank,histone demethylase activity (H3-K36 specific) (GO:0051864),-0.5199813582466892,-1.2120426294686464,0.2605042016806723,0.6119228277557395,1.0,3/10,12.50%,KDM7A;KDM2A;RIOX2
prerank,zinc ion transmembrane transporter activity (GO:0005385),-0.4312634889320894,-1.2117713398079215,0.23180592991913745,0.6049909705178615,1.0,7/20,15.68%,SLC39A10;SLC30A10;SLC39A11;SLC39A8;SLC30A1;SLC39A1;SLC39A6
prerank,transforming growth factor beta receptor binding (GO:0005160),-0.4316972369863223,-1.2086877743705986,0.20506329113924052,0.6059238489671976,1.0,7/18,12.27%,TGFBR3;SMAD3;SMAD6;ENG;FKBP1A;TGFB1;TGFBR1
prerank,microtubule binding (GO:0008017),0.4020707734127156,1.2082936379220093,0.16857440166493237,0.8567771686618068,1.0,71/222,19.01%,FGF13;KIF27;CLASP2;FAM83D;KIF2A;HOOK2;STIM1;MAP1B;TOGARAM2;HAUS8;KIF3B;DST;MAP7D3;ARHGEF2;CEP290;MAPRE2;TUBGCP6;TPPP;KIF1A;MAPT;NDRG1;EML1;EML5;TPX2;HDGFL3;CCDC170;RMDN3;TOGARAM1;KIF5B;OPA1;WHAMM;SUN2;HOOK1;KIF1C;CCDC181;CENPE;DNM1L;KIF5C;FHDC1;CLIP3;FBXW11;KIF5A;KIF20B;CLASP1;MAST1;LRRK2;MTCL1;MAP4;KIF18A;HAUS7;KIF6;MAPRE3;UXT;KNSTRN;DNM2;ABRAXAS2;CCDC66;MAP9;GAS2L3;KIF7;S100A8;S100A9;DCTN1;STARD9;MAP1A;MAP1S;SGIP1;MAP6;CEP295;HAUS4;HDAC6
prerank,MHC class I protein binding (GO:0042288),-0.464943075342776,-1.2075553313154415,0.24355971896955503,0.6018979140651421,1.0,7/13,44.62%,DERL1;ABCB9;TAP1;TAPBP;ATP5F1B;TAP2;LILRB1
prerank,nucleoside-diphosphatase activity (GO:0017110),0.5696820422762685,1.2054491846539233,0.30329289428076256,0.859688422861967,1.0,2/12,6.97%,ENTPD1;ENTPD7
prerank,GDP binding (GO:0019003),0.44567628751263294,1.204952034951675,0.22860791826309068,0.8548922269809445,1.0,8/63,9.50%,RASL12;RAP1A;RERG;GEM;RAP2C;RRAS;MIEF1;RAP2A
prerank,alanine transmembrane transporter activity (GO:0022858),-0.49988676217784467,-1.2045968312089785,0.22950819672131148,0.6020978361970348,1.0,6/12,21.55%,SLC6A6;SLC3A2;SLC38A5;SLC38A7;SLC1A4;SLC36A1
prerank,beta-tubulin binding (GO:0048487),0.4818941881936506,1.203669526565753,0.24751066856330015,0.8525805034624915,1.0,4/31,5.57%,FGF13;DLEC1;TTLL7;GABARAP
prerank,chloride channel activity (GO:0005254),0.4433170237855775,1.1945431800048714,0.2440251572327044,0.875662430149001,1.0,11/59,11.95%,ANO1;GABRE;ANO6;CLCN6;GABRA4;TTYH1;GABRA5;GABRB2;GABRG1;ANO3;GABRB3
prerank,MAP kinase phosphatase activity (GO:0033549),0.5709795690192994,1.193311906498343,0.292894280762565,0.8729710459287767,1.0,4/12,12.88%,DUSP5;DUSP3;DUSP29;DUSP16
prerank,monocarboxylate:sodium symporter activity (GO:0140161),-0.5058846497410583,-1.1923888926140236,0.2510460251046025,0.6271206419257355,1.0,3/10,3.61%,SLC6A13;SLC6A1;SLC6A12
prerank,kinase activity (GO:0016301),0.4151296184847883,1.1914989962933047,0.23636363636363636,0.8722041141990251,1.0,21/109,14.35%,DGKB;DGKG;CKM;NMRK2;CKMT2;SEPHS2;ADPGK;SEPHS1;TAF1;COQ8A;PSTK;PKN2;DGKD;ITPKC;COASY;PRKD3;PIK3C3;LRRK2;DGKZ;CHKB;CKB
prerank,protein serine/threonine kinase activity (GO:0004674),0.3890642277021444,1.190467575268321,0.13604060913705585,0.8692410684189168,1.0,77/334,17.20%,MYLK2;MYLK;TTN;MAP3K20;MYLK4;CAMK2G;STK38L;MAP3K5;MAST4;ROCK1;KALRN;PRKAB2;DYRK2;CDK6;FAM20A;CAMK2D;ACVR2A;MARK1;BMPR1A;DYRK1A;PRKCQ;MAP4K3;MAP4K5;TAF1;MAPKAPK2;RPS6KA2;DYRK1B;NUAK1;CHEK1;WNK2;MAP3K10;DAPK3;MAP2K1;BRSK1;PKN2;PAK2;CDK7;STK33;STK24;EIF2AK2;ROCK2;PRKCD;ACVR1B;STK36;CDK12;DMPK;BMPR1B;TNIK;BCR;CDC42BPB;TAOK3;PRKD3;CDK15;MAST1;CPNE3;LRRK2;SGK1;STK10;MAPK1;CSNK1E;PRKAA2;PRKCA;PRKACA;CSNK1A1;SRPK2;MAPK12;RAF1;HIPK2;PLK4;MAST3;EIF2AK3;CDK14;MAP3K2;MAP3K13;ATP23;MARK2;BRD4
prerank,CoA-ligase activity (GO:0016405),0.5584925584479559,1.189768706448403,0.289198606271777,0.8651363347314219,1.0,1/14,0.92%,ACSS1
prerank,potassium ion antiporter activity (GO:0022821),-0.44959334575371845,-1.1874187404497485,0.25440806045340053,0.6333548590416952,1.0,7/15,25.78%,SLC24A3;SLC9A2;SLC9A6;SLC9A9;SLC9A5;SLC24A4;SLC24A2
prerank,metalloexopeptidase activity (GO:0008235),0.4506335821691232,1.187156764664297,0.2506393861892583,0.8668428115521757,1.0,7/51,7.40%,MMP17;AGBL1;LNPEP;RNPEP;ENPEP;CPA4;CPA3
prerank,protein serine/threonine phosphatase activity (GO:0004722),0.4464176311933479,1.1861785900217432,0.2572509457755359,0.8636033103892482,1.0,13/60,13.77%,LRRC2;CAMK2G;PPM1L;PPM1J;PPP3CA;PPM1E;PPM1A;PPP1CB;PPP1CA;CTDSP2;CTDSP1;PPP3CB;LRRK2
prerank,histone demethylase activity (H3-K9 specific) (GO:0032454),-0.4885392784509465,-1.1849189500579782,0.24663677130044842,0.6327011764566676,1.0,4/12,18.22%,KDM7A;KDM3B;KDM1A;KDM4D
prerank,tubulin binding (GO:0015631),0.38948553711782896,1.1835649302924687,0.1535312180143296,0.865379851321297,1.0,80/295,17.95%,ARHGEF7;FGF13;AGBL1;DLEC1;KIF27;CLASP2;FAM83D;KIF2A;HOOK2;TTLL7;MAP1B;TOGARAM2;HAUS8;KIF3B;DST;PRUNE1;MAP7D3;ARHGEF2;MAPRE2;GABARAP;TUBGCP6;RABGAP1;TPPP;KIF1A;MAPT;IFT81;NDRG1;EFHC1;EML1;EML5;TPX2;HDGFL3;CCDC170;RMDN3;TOGARAM1;KIF5B;OPA1;WHAMM;SUN2;WASHC1;BRSK1;HOOK1;KIF1C;CCDC181;CENPE;NCALD;DNM1L;KIF5C;TBCD;ALDOA;FHDC1;UNC5C;CLIP3;KIF5A;KIF20B;CLASP1;MAST1;LRRK2;MTCL1;MAP4;KIF18A;STMN2;KIF6;MAPRE3;UXT;DNM2;ABRAXAS2;CCDC66;INO80;MAP9;GAS2L3;KIF7;S100A8;S100A9;DCTN1;STARD9;MAP1A;MAP1S;SGIP1;VBP1
prerank,"inositol 1,4,5 trisphosphate binding (GO:0070679)",0.5885479139315767,1.181583125642723,0.3160621761658031,0.865608109445544,1.0,2/11,1.66%,TRPC6;ITPR1
prerank,K63-linked polyubiquitin modification-dependent protein binding (GO:0070530),-0.40401780386610836,-1.1804288013193587,0.27520435967302453,0.6371276460997183,1.0,13/22,32.47%,OTUD7B;PARP10;OPTN;IKBKG;TAB2;ATRIP;WDR81;ZBTB1;PRPF8;IKBKE;SQSTM1;TNFAIP3;MINDY2
prerank,cholesterol transfer activity (GO:0120020),-0.44174302729639003,-1.1781295449327174,0.26004728132387706,0.635983594027872,1.0,5/16,16.86%,PLTP;ABCA1;GRAMD1C;GRAMD1A;STARD4
prerank,frizzled binding (GO:0005109),-0.3657700226445441,-1.1753912910919542,0.22857142857142856,0.6365235020169661,1.0,13/34,32.91%,WNT4;WNT5A;WNT9A;SDCBP;RNF43;WNT6;MYOC;ZNRF3;WNT16;DVL2;WNT11;CCDC88C;BAMBI
prerank,protein tyrosine kinase activity (GO:0004713),0.40781763751428124,1.174630292927244,0.23883928571428573,0.8809754549710718,1.0,11/108,5.41%,TTN;NTRK3;DYRK2;MERTK;MST1R;ROR1;FRK;MUSK;PEAK1;CAMKK2;DYRK1A
prerank,pentosyltransferase activity (GO:0016763),0.4758806174401744,1.1734886410381093,0.27520435967302453,0.8784552704040305,1.0,8/36,13.93%,ART1;LARGE1;SIRT3;PARP1;ART4;SIRT2;PPAT;SIRT4
prerank,store-operated calcium channel activity (GO:0015279),0.588224500970185,1.1696508447268021,0.3087971274685817,0.8835315478833661,1.0,2/10,8.91%,TRPC6;TRPC5
prerank,transmitter-gated ion channel activity (GO:0022824),0.4788779421672986,1.1653532761150636,0.29765395894428154,0.8903359150521393,1.0,7/29,11.95%,GABRE;GABRA4;GABRA5;GRIK5;GABRB2;GABRG1;GABRB3
prerank,microtubule motor activity (GO:0003777),0.444412692132288,1.1631321042159877,0.2651413189771198,0.8911804382028851,1.0,16/51,14.72%,KIF27;KIF2A;DYNLRB1;KIF3B;DNAH17;KIF1A;KIF5B;KIF1C;CENPE;KIF5C;DYNC1I2;KIF5A;APPBP2;KIF20B;KIF18A;KIF6
prerank,cysteine-type endopeptidase activity involved in execution phase of apoptosis (GO:0097200),-0.4970388864943637,-1.1628555527159177,0.3080357142857143,0.6617014589113309,1.0,6/10,40.03%,CASP8;CASP9;CASP4;CASP12;CASP6;CASP1
prerank,ribosomal large subunit binding (GO:0043023),-0.4864836223368857,-1.1618951087765985,0.2962138084632517,0.6570602640960076,1.0,4/11,14.01%,CPEB2;NMD3;LTN1;NEMF
prerank,protein phosphatase binding (GO:0019903),0.40822526299489803,1.1618666962328434,0.2497175141242938,0.8886528039867013,1.0,13/117,7.73%,MYOZ2;ATP2B4;PPP1R3A;MAP3K5;ITGA1;STRN3;MFHAS1;AKAP11;MAPT;DAB2IP;TP53;TRAF3;ENSA
prerank,N-acetyltransferase activity (GO:0008080),0.5233277397644469,1.1600239795942233,0.3080495356037152,0.8879200831554396,1.0,7/19,14.95%,NAT10;SAT2;NAT8L;NAT8;NAT14;NAT2;NAT1
prerank,histone deacetylase binding (GO:0042826),0.4202008023603502,1.1597918173592177,0.25934579439252337,0.8827579157401486,1.0,21/88,14.30%,MEF2C;HEY2;GMNN;NACC2;PRDM1;HDAC9;MEF2A;TP53;SFPQ;RAD9A;RELA;CCND1;MTA3;PKN2;SIRT2;TOP2B;ANKRA2;KPNA2;CHD4;MEF2B;MTA1
prerank,telomeric DNA binding (GO:0042162),-0.3579160306469289,-1.157706144311897,0.22837370242214533,0.6604001576789926,1.0,12/32,18.36%,UPF2;XRCC5;STN1;SMG1;RAD50;BLM;XRCC6;HNRNPD;CTC1;TERF2IP;KDM1A;SMG6
prerank,"oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor (GO:0016655)",0.5502286049391203,1.153633363662364,0.3338842975206612,0.8954980142524408,1.0,3/12,8.66%,DHRS4;CRYZ;CBR1
prerank,voltage-gated ion channel activity (GO:0005244),0.5454467780479427,1.1472960874557137,0.33691756272401435,0.9096242971947925,1.0,3/14,8.87%,CACNA1H;ANO6;VDAC1
prerank,cadherin binding (GO:0045296),0.37792826128062407,1.145915463360043,0.2236976506639428,0.9080255134892468,1.0,47/315,9.90%,CTNNA3;FLNA;NOTCH3;CDH6;PDLIM1;PDLIM5;CALD1;VASN;VCL;ESYT2;PFKP;CNN2;MYH9;PHLDB2;COBLL1;CDH13;ANXA1;PACSIN2;BZW2;ITGB1;MYO1B;TAGLN2;CDH4;ARHGEF16;CDHR3;MPP7;EPN2;DAB2IP;NDRG1;CHMP5;PTPN1;KTN1;TLN1;CNN3;KIF5B;CDH2;PPP1CA;PKN2;PAK2;ARHGAP1;LRRFIP1;ANLN;EPHA2;BAG3;PARVA;IST1;STK24
prerank,exonuclease activity (GO:0004527),-0.33412299802082795,-1.1454980719637262,0.21311475409836064,0.6861523222461203,1.0,22/46,27.26%,REXO5;MRE11;ENPP2;RAD50;FAN1;ENPP3;TRIR;EXOSC1;REXO1;ISG20L2;ENPP1;EXOSC9;ZC3H12A;EXOSC2;RAD1;DCLRE1B;AEN;EXOSC3;EXOSC7;EXOG;EXD1;EXOSC5
prerank,galactosyltransferase activity (GO:0008378),-0.4703401011852587,-1.1434248551826212,0.29571106094808125,0.6841743745962707,1.0,8/11,36.08%,B4GALT1;B4GALT6;B4GALT4;B4GALT7;B4GALT3;B4GALT2;A3GALT2;B3GALT6
prerank,growth factor receptor binding (GO:0070851),0.4023521876306274,1.139766868994837,0.28243398392652125,0.9215516353907756,1.0,16/95,10.90%,FGF1;HIP1;PDGFB;PDGFC;IL2;PDGFD;ATXN2;VEGFA;IL12RB1;AREG;PIBF1;ITGB3;ADAM17;PDGFRB;HBEGF;PDGFA
prerank,ubiquitin-protein transferase activity (GO:0004842),-0.23684531153243446,-1.1385988016667428,0.05555555555555555,0.6894329668184199,1.0,90/346,17.61%,RNF220;TTC3;KCMF1;RNF145;NEDD4L;SH3RF1;TRIP12;FBXL5;RNF146;AREL1;ITCH;RNF38;FBXO10;CUL3;RNF185;SEL1L;RNF20;PPIL2;MYCBP2;UBE2D3;RNF135;BIRC6;RNF144B;RC3H2;SHPRH;RNF217;TRIM24;RNF6;PML;UBR2;BIRC2;RNF13;RNF25;FBXO9;HERC2;LTN1;RNF213;PELI1;MDM2;UBE2E3;FBXO4;TOPORS;WWP1;CDC23;UBE2E2;RBCK1;TRIM25;FBXO7;PRKN;RNF31;UBE3A;MGRN1;SMURF2;RNF144A;FBXO25;RMND5B;MKRN2;RNF181;SH3RF3;FBXO3;TRIM5;RNF34;STUB1;RMND5A;DZIP3;DTX1;TRIM14;RNF125;VPS18;RNF166;DTX3L;SH3RF2;FBXW8;SIAH1;HECW1;RNF115;UBE2H;RNF10;OBI1;NHLRC3;RNF43;BIRC3;BCOR;TRIM56;DTX3;UBA7;RNF130;ANAPC4;UBE2S;CDC42
prerank,"oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen (GO:0016702)",0.5270582177978413,1.1363088450993866,0.351027397260274,0.926234776339687,1.0,4/16,8.56%,ALOX5;ETHE1;HGD;ADI1
prerank,leucine zipper domain binding (GO:0043522),0.5749338003807096,1.1361839769430921,0.33459357277882795,0.9207307486164539,1.0,5/10,18.34%,MRTFA;DAPK3;PAWR;PMF1;DDIT3
prerank,gap junction channel activity (GO:0005243),0.4900631031169345,1.1340362864058855,0.3302325581395349,0.9218285638913554,1.0,4/22,11.58%,GJD3;GJC1;PANX1;GJA4
prerank,protein tyrosine kinase activator activity (GO:0030296),0.49427862550081253,1.1318431860642704,0.31587301587301586,0.9227575775969805,1.0,4/19,9.18%,ANGPT4;CCL5;ERCC6;PAK2
prerank,cation transmembrane transporter activity (GO:0008324),-0.3165841701950099,-1.1307019691763995,0.2330508474576271,0.7032537496165459,1.0,18/48,22.23%,SLC41A1;SLC6A6;SLC3A2;SLC7A5;SLC6A9;SFXN2;SLC39A1;SLC66A1;SLC38A5;SLC38A6;SLC25A38;SLC8B1;SLC38A7;MMGT1;SLC15A4;SLC1A4;SLC36A1;SLC1A1
prerank,U6 snRNA binding (GO:0017070),0.5294815869434986,1.1291501731655225,0.35798319327731093,0.9253199535472065,1.0,3/14,11.17%,LSM8;EIF5A;PRPF4
prerank,carboxylic acid binding (GO:0031406),-0.339372515694568,-1.129026992838374,0.26855123674911663,0.7004580485584718,1.0,14/38,25.23%,GRM7;UBR2;NOS3;GLRB;GRIN3A;GLRA2;PHYH;SRR;HIF1AN;GLRA1;EPDR1;PSAP;SESN2;GCLC
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides (GO:0016812)",0.5530532386804312,1.1277818045275945,0.3508137432188065,0.9237115616917368,1.0,2/10,11.33%,DPYSL4;OPLAH
prerank,transcription regulatory region nucleic acid binding (GO:0001067),0.3735406035292073,1.1273823662577935,0.2854122621564482,0.9193178905893183,1.0,22/188,9.11%,SOX6;PRDM16;SOX5;MEF2C;GABPA;ARID5B;HINFP;MTERF3;TBX18;KLF15;SUV39H2;JUND;ARID5A;TP53;GRHL1;SFPQ;YAP1;AR;RELA;KMT2D;RUNX1;NR1D1
prerank,syntaxin-1 binding (GO:0017075),0.4884909862699408,1.1253095700198474,0.3376,0.9196952286520305,1.0,2/22,1.37%,STXBP2;SYPL2
prerank,2-oxoglutarate-dependent dioxygenase activity (GO:0016706),-0.3548069480219879,-1.1239769954522778,0.2912621359223301,0.7066718048853775,1.0,9/32,12.50%,KDM7A;KDM2A;TET3;TET2;EGLN3;BBOX1;PHYH;EGLN2;RIOX2
prerank,histone-lysine N-methyltransferase activity (GO:0018024),0.4465329484863681,1.1213878046779162,0.3369713506139154,0.9257180113303686,1.0,7/44,8.86%,PRDM16;SMYD1;SUV39H2;ASH1L;KMT2D;SETD3;NSD3
prerank,wide pore channel activity (GO:0022829),0.4864196176177754,1.1209202015909105,0.3416536661466459,0.9216011639262519,1.0,4/23,11.58%,GJD3;GJC1;PANX1;GJA4
prerank,nuclear localization sequence binding (GO:0008139),0.5019711968886668,1.1147610748973213,0.3710691823899371,0.9345529978532703,1.0,7/18,14.50%,CABP1;KPNA4;NUP153;RANBP6;KPNA2;KPNA3;IPO4
prerank,protein phosphatase 1 binding (GO:0008157),0.4962658044814336,1.1130412217313301,0.352755905511811,0.9339564684441963,1.0,2/21,5.73%,PPP1R3A;AKAP11
prerank,TBP-class protein binding (GO:0017025),-0.38259703265025374,-1.1118384686592893,0.2962962962962963,0.7311264343334843,1.0,11/21,26.56%,YEATS2;ESR1;AHR;DR1;PSMC5;PSMC2;TAF12;TAF13;GTF2A2;DRAP1;HHEX
prerank,G protein-coupled receptor activity (GO:0004930),0.3675000225872265,1.111498851369357,0.27049180327868855,0.9330208535950063,1.0,18/239,9.75%,AGTR1;LHCGR;GPR20;HCRTR1;CRHR2;S1PR3;VIPR2;ADRA1D;TSHR;TAPT1;CYSLTR2;CXCR6;NTSR2;GPR17;XPR1;PTH1R;PDGFRB;ADGRL2
prerank,peptide hormone receptor binding (GO:0051428),-0.46460456336917155,-1.1054565958526652,0.32450331125827814,0.7405827774279252,1.0,5/11,37.43%,PSMC5;PTHLH;ADCYAP1;GNRH1;CCK
prerank,acidic amino acid transmembrane transporter activity (GO:0015172),-0.42315533832921426,-1.1049067790992753,0.32142857142857145,0.7348259467431888,1.0,9/15,31.52%,SLC1A3;SLC17A6;SLC38A7;SLC1A4;SLC1A1;SLC25A22;SLC1A2;SLC25A18;SLC1A6
prerank,carboxylic acid transmembrane transporter activity (GO:0046943),-0.30609348434805184,-1.104060620684828,0.2689075630252101,0.7297605819021985,1.0,14/55,9.68%,SLC6A13;SLC16A12;SLC13A3;PDPN;SLC16A9;SLC6A12;SLC6A6;SLC16A1;SLC7A14;SLC25A32;SLC7A5;SLC16A11;SLC38A10;SLC22A4
prerank,solute:proton symporter activity (GO:0015295),-0.41199025909990866,-1.1005917856523517,0.3163265306122449,0.7316423404253866,1.0,4/16,7.62%,SLC2A13;SLC25A3;SLC39A8;CTNS
prerank,low-density lipoprotein particle binding (GO:0030169),0.5057084519009004,1.0978881411225756,0.3627450980392157,0.9674842518591371,1.0,2/16,2.72%,CD36;CDH13
prerank,pyridoxal phosphate binding (GO:0030170),0.48334595489722765,1.096504004422462,0.36801242236024845,0.9659797179759211,1.0,2/20,4.77%,PYGM;PYGB
prerank,active ion transmembrane transporter activity (GO:0022853),-0.33070901207918807,-1.0958476873275738,0.31338028169014087,0.7372236400217551,1.0,11/37,12.23%,SLC22A8;SLCO2B1;SLCO1C1;SLCO2A1;CYB5A;SLC22A6;UQCRC1;SLCO3A1;SLC22A4;COX10;ATP13A3
prerank,thyroid hormone receptor binding (GO:0046966),-0.3568573961048312,-1.095648241441794,0.32063492063492066,0.7308611116273921,1.0,6/28,6.45%,NSD1;MED13;TRIP12;TACC1;MED17;PRMT2
prerank,double-stranded DNA binding (GO:0003690),-0.2197298126450768,-1.0919718642366625,0.0,0.7338150917290844,1.0,121/531,20.09%,TCF4;FLI1;NFAT5;HLF;ZBTB20;RBMS1;LEF1;NFATC3;HOXB6;ELF1;FOXP1;ZIC1;HMGB1;KDM5B;PKNOX2;CREM;KLF12;ZIC4;E2F3;ERG;CREB5;RUNX2;GLI2;PKNOX1;EGFR;JDP2;PRKDC;XRCC5;CUX1;HOXB4;ARNT2;MTF1;ELK3;PRRX2;HOXA5;TBX15;MRE11;WDR48;MEOX2;ELK4;MBD1;POLR3F;CRY1;KLF3;ZFP1;FOXC2;GLIS1;POU6F1;RAD50;MAU2;TFEB;FBH1;ERCC5;CAMTA1;TFCP2;HSF2;MAX;NR3C1;RFX2;OSR1;ESR1;AHR;MEIS2;MAFG;ATF2;SIX1;ZNF740;ZNF177;TEAD2;DDX60;HES1;ZIC5;CREB1;IRF9;TARDBP;XRCC6;SOX4;BHLHE41;KLF2;ZNF76;GMEB2;CEBPB;ELF2;ELK1;KLF10;MAF;TEF;ATF7;ARNT;NFIB;GLIS2;KLF5;BHLHE40;KLF13;VSX1;TFE3;RARA;CREB3L1;LHX6;XPA;PPARG;NPAS2;SMAD2;RORB;KLF11;TGIF1;TFCP2L1;E2F4;HSF1;HOXB8;MECP2;NFATC2;CAMTA2;THRB;HOXA9;PARK7;ONECUT2;HOXB9;SATB1;FOXQ1;MSH6
prerank,protein kinase binding (GO:0019901),0.35720024853530963,1.0910847557027223,0.29518072289156627,0.9762584030873129,1.0,61/479,9.72%,ACTA2;ARHGEF7;TTN;PPP1R12A;RYR2;INKA2;PDLIM5;PRKAB2;LIMS1;CCNA2;FERMT2;FZD5;CCND2;DUSP5;CSPG4;FAM83D;KCNA5;ITGB1;RHOBTB3;LAX1;PARN;HDAC9;ANKRD2;TSKS;ACTB;UTRN;DOK7;IRS1;LYST;MAPT;CAV1;DAB2IP;MAPKAPK2;PARP1;DUSP3;TP53;PTPN1;PIN1;TPX2;CALM1;ADD2;PLEK;RAD9A;SOX9;RELA;PKIA;TNIP1;RHOF;TRIM68;PRKAR1B;CCND1;VDAC1;PPP1CB;GSTP1;PAK2;SKI;TOM1L2;ADCY6;HIF1A;PDGFRB;CEP192
prerank,monovalent cation:proton antiporter activity (GO:0005451),-0.43847565248939113,-1.0897497316287248,0.34467120181405897,0.7331018087121492,1.0,6/12,25.33%,SLC9B2;SLC9A2;LETM1;SLC9A6;SLC9A9;SLC9A5
prerank,ferrous iron binding (GO:0008198),-0.3799371815152411,-1.0886223248397677,0.36684782608695654,0.729341636890434,1.0,10/21,22.30%,TET2;EGLN3;FTL;FTH1;PHYH;EGLN2;SNCA;CDO1;HIF1AN;ISCU
prerank,platelet-derived growth factor binding (GO:0048407),0.5460188209008008,1.0856986864935463,0.3856893542757417,0.9863717196388699,1.0,5/11,11.31%,COL4A1;PDGFB;PDGFRB;PDGFA;COL3A1
prerank,poly-purine tract binding (GO:0070717),0.4594977204705605,1.0855430101769767,0.36773255813953487,0.981137384416712,1.0,7/27,11.00%,RBPMS;RBMS3;MCRS1;ATXN1;PPIE;HNRNPU;DDX1
prerank,copper ion binding (GO:0005507),0.42653253092681387,1.0818255341193952,0.3697705802968961,0.9867215156257846,1.0,11/42,18.06%,AOC3;LOXL2;RNF7;TP53;SUMF1;ATP7B;SNCG;MT3;SOD3;SNCB;P2RX4
prerank,ATP binding (GO:0005524),0.3610285392798812,1.0804834232184242,0.32714138286893707,0.9849472577787949,1.0,45/266,14.02%,RYR1;MAP3K20;STK38L;MAP3K5;ACTA1;UBA2;DYRK2;PFKP;CDK6;MYH9;PDK4;MYO9B;RHOBTB3;MYO1B;PEAK1;KSR1;MARK1;BMPR1A;MYO18A;MAP4K3;MAP4K5;ABCE1;STK26;ERCC6;WNK2;DAPK3;PRKACB;PAPOLA;ABCD4;BRSK1;LONP1;HNRNPU;ABCG1;PFKM;DDX25;ACVR1B;STK36;DMPK;BMPR1B;CDC42BPB;SMARCA5;MAST1;ATP7B;PDK2;SARS2
prerank,RNA polymerase II CTD heptapeptide repeat kinase activity (GO:0008353),0.5140192081640999,1.0790984302059476,0.3880070546737213,0.9834171966706586,1.0,6/12,19.50%,CDK6;CDK7;CDK12;MAPK1;BRD4;CDK13
prerank,amino acid binding (GO:0016597),-0.33885327696631656,-1.0787007542386156,0.3282208588957055,0.7479605296596324,1.0,11/31,21.68%,GRM7;NOS3;GLRB;DDAH1;GRIN3A;GLRA2;SRR;AARS1;DDAH2;GLRA1;ASS1
prerank,magnesium ion binding (GO:0000287),0.368553222267535,1.0785779884098752,0.3574561403508772,0.9793425810611563,1.0,18/135,9.50%,MAP3K20;STK38L;MAP3K5;UBA2;DYRK2;ADCY2;GEM;MARK1;TESC;TPPP;STK26;OPA1;DIS3L2;PRKACB;PAPOLA;BRSK1;AASDHPPT;RAP2A
prerank,ligand-gated cation channel activity (GO:0099094),0.38639505542787994,1.078432579889968,0.3515151515151515,0.9742061602802954,1.0,9/75,12.46%,ASIC3;KCNJ12;GRIN2C;KCNN2;CCDC51;GRIK5;TRPM4;CHRNA7;TRPM2
prerank,heparan sulfate sulfotransferase activity (GO:0034483),0.4890944124234434,1.0755231288791207,0.3737704918032787,0.977327050667723,1.0,3/15,9.53%,NDST3;HS2ST1;HS6ST1
prerank,polyubiquitin modification-dependent protein binding (GO:0031593),-0.3005097838948733,-1.0743510753004233,0.3411764705882353,0.7526294165095049,1.0,20/49,24.87%,UBQLN1;OTUD7B;UBL7;UFD1;PARP10;OPTN;IKBKG;BRCC3;TAB2;EPS15;DZIP3;MINDY1;UBXN1;UBQLN2;ATRIP;SHARPIN;WDR81;ZBTB1;PRPF8;RAD23B
prerank,protein serine/threonine kinase inhibitor activity (GO:0030291),0.4410246080153622,1.0741006037579766,0.3857791225416036,0.9759390422520693,1.0,5/29,8.60%,INKA2;HEXIM1;PKIB;PKIA;PRKAR1B
prerank,deubiquitinase activity (GO:0101005),-0.2631547196072844,-1.0729101289616991,0.2866666666666667,0.7497790895064663,1.0,24/88,19.37%,USP53;ATXN3;USP46;USP11;MINDY3;OTUD7B;USP45;UFD1;USP19;USP7;USP12;BRCC3;USP3;USP29;MINDY1;PAN2;USP37;VCPIP1;OTUD3;EIF3F;USP24;ZC3H12A;USP10;USP32
prerank,purine ribonucleoside triphosphate binding (GO:0035639),0.35158982213860807,1.07255987013209,0.32630522088353414,0.974936708998937,1.0,72/431,14.56%,RYR1;RASL12;MAP3K20;RAP1A;STK38L;MAP3K5;TUBA1C;ACTA1;UBA2;DYRK2;PFKP;CDK6;MYH9;PDK4;RRAD;MYO9B;RERG;RHOBTB3;MYO1B;GEM;PEAK1;MFHAS1;KSR1;MARK1;SEPHS1;BMPR1A;MYO18A;MAP4K3;MAP4K5;RAP2C;RANBP17;RRAS;TUBB2B;RHOJ;ABCE1;STK26;ERCC6;WNK2;DAPK3;PRKACB;PAPOLA;RHOF;ABCD4;BRSK1;LONP1;RAP2A;RRAGB;HNRNPU;REM1;ABCG1;PFKM;DDX25;RHOH;ACVR1B;STK36;DRG2;DMPK;BMPR1B;GBP2;CDC42BPB;SMARCA5;ADSS1;MAST1;LSG1;ATP7B;LRRK2;PDK2;TUBD1;SARS2;RAB14;DIRAS2;ATP1A3
prerank,translation elongation factor activity (GO:0003746),0.5002634612405403,1.069931193852795,0.40836012861736337,0.97694056224039,1.0,7/14,18.35%,EEFSEC;GFM2;EIF5A;EIF5AL1;TSFM;GTPBP2;EEF2
prerank,nucleotidyltransferase activity (GO:0016779),0.4743584064642114,1.0693766938845712,0.40264026402640263,0.9732881035037931,1.0,4/19,8.33%,CGAS;CRPPA;TERT;TENT4A
prerank,potassium ion transmembrane transporter activity (GO:0015079),0.4451915811585524,1.0689450003575172,0.4060693641618497,0.969214613138029,1.0,6/31,11.36%,TMEM38B;KCNQ4;ABCC8;TMEM38A;KCNK3;KCNA2
prerank,retinoid X receptor binding (GO:0046965),-0.4462634555989152,-1.0685802773272843,0.39606126914660833,0.7539119649539208,1.0,3/11,8.09%,NSD1;TACC1;MED25
prerank,inward rectifier potassium channel activity (GO:0005242),0.45480188755818035,1.068186866707901,0.3997050147492625,0.9661069725450763,1.0,3/24,9.48%,KCNJ12;KCNN2;ABCC8
prerank,retinoic acid receptor binding (GO:0042974),0.4723174152525195,1.0647921449614168,0.4148397976391231,0.9704788905920433,1.0,5/17,9.29%,ACTN4;ASXL1;ARID5A;MED1;NR4A2
prerank,nuclear receptor binding (GO:0016922),0.36819775338825195,1.0624116735031042,0.3762486126526082,0.9720471052762081,1.0,24/111,11.64%,ACTN4;NR1H4;SMARCD3;NR4A1;RERG;PADI2;TGFB1I1;ARID1A;NCOA7;ASXL1;ARID5A;TAF1;HMGN3;MED1;PPARGC1A;PPARGC1B;MED12;TRIM68;NR4A2;HIF1A;MED14;TACC2;BAZ2A;ZBTB7A
prerank,phosphatidylinositol phosphate kinase activity (GO:0016307),0.4998142209730504,1.0575986886928614,0.4105263157894737,0.9802000342886418,1.0,2/13,2.58%,PIP5K1B;PIP4K2A
prerank,lipase activator activity (GO:0060229),0.5267140268343034,1.0541827115056792,0.41144901610017887,0.9848139464533457,1.0,2/10,4.80%,CCL5;ARHGAP6
prerank,sterol binding (GO:0032934),-0.2933540196313485,-1.0541580592369941,0.3577586206896552,0.7850176189032702,1.0,19/56,23.76%,OSBPL8;ABCA1;PTCH1;OSBPL10;GRAMD1C;ANXA6;APOD;SCARB2;SIDT1;PROM1;SOAT1;GRAMD1A;INSIG1;STARD4;OSBP;SYP;STARD3NL;NPC1;STARD5
prerank,estrogen receptor binding (GO:0030331),-0.32859865688486284,-1.054134210519392,0.3522012578616352,0.7782629917170485,1.0,8/32,10.46%,NSD1;LEF1;TACC1;NCOA1;PRMT2;CTNNB1;ESR1;TRIP4
prerank,iron ion binding (GO:0005506),-0.3036306713789064,-1.0539585437635945,0.32644628099173556,0.7720064251040529,1.0,13/48,14.86%,AGMO;KDM7A;FBXL5;AOX1;TET2;JMJD6;EGLN3;FTL;FTH1;PHYH;EGLN2;SNCA;CDO1
prerank,metalloendopeptidase activity (GO:0004222),0.38113153767304625,1.0538027556566791,0.3879003558718861,0.9807565485699972,1.0,14/76,13.50%,MMP17;ADAMTS14;ADAMTS5;ADAMTS19;AFG3L2;TRABD2B;ADAM17;MIPEP;PHEX;THSD4;ADAMTS20;ADAMTS16;PMPCB;ADAM19
prerank,protein tyrosine kinase binding (GO:1990782),0.3889917923545277,1.0528001903184854,0.4082125603864734,0.9783518714010535,1.0,10/71,6.67%,ANGPT2;ANGPT1;ANGPT4;SOCS5;ITGB1;PITPNM3;ARHGEF16;DUSP3;TP53;PTPN1
prerank,voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization (GO:0086008),0.4943396632894016,1.0526324624764618,0.42680776014109345,0.9737029579562488,1.0,2/14,4.18%,KCNA5;KCNE4
prerank,semaphorin receptor binding (GO:0030215),-0.36224176317763784,-1.052065077740219,0.3588235294117647,0.7703792903334983,1.0,7/23,10.54%,SEMA3D;SEMA3C;SEMA6A;SEMA7A;SEMA3A;SEMA4D;SEMA6D
prerank,ubiquitin-like protein-specific protease activity (GO:0019783),-0.3723301374774036,-1.0517242053957743,0.40524781341107874,0.7646183676812274,1.0,4/20,7.75%,SENP1;SENP3;COPS2;USP7
prerank,nuclear import signal receptor activity (GO:0061608),0.4943572366028811,1.0511358612097301,0.4290375203915171,0.9726059834715077,1.0,8/15,21.00%,KPNA4;RANBP6;KPNA2;KPNA3;TNPO3;IPO4;IPO9;HIKESHI
prerank,tRNA (guanine) methyltransferase activity (GO:0016423),0.501484968092137,1.0494957297966998,0.39676840215439857,0.9721249807766809,1.0,3/13,5.62%,WDR4;FTSJ1;TRMT10C
prerank,nucleoside-triphosphatase activity (GO:0017111),0.3451611123682657,1.0479756365927437,0.3981385729058945,0.971507367456976,1.0,56/248,16.97%,RASL12;RAP1A;MYO1E;MYL6;MYH9;KIF2A;RERG;RHOBTB3;GEM;GNAO1;GNAZ;MYO18A;TPPP;KIF1A;NKIRAS2;RAP2C;RRAS;ABCA3;RHOJ;PIN1;ENTPD7;RAB3A;ATP2B1;OPA1;RHOF;GNA12;GNG11;RAP2A;RRAGB;KIF1C;GFM2;ATAD1;DNM1L;GSPT1;MFN2;RHOH;RUVBL1;DRG2;KIF5A;GBP2;CLU;KIF20B;LSG1;LRRK2;GNAQ;RAB14;DIRAS2;RAB8B;RHOG;DNM2;VWA8;RHOT1;RAB8A;AGAP2;DHX9;RAB38
prerank,mRNA 3'-UTR AU-rich region binding (GO:0035925),0.4615640323116912,1.0445464715720654,0.4152139461172742,0.975834878808643,1.0,5/22,12.85%,RBM24;RBMS3;CPEB1;ZFP36L1;CPEB3
prerank,mitogen-activated protein kinase kinase kinase binding (GO:0031435),-0.43796489907417296,-1.0442412989635945,0.42152466367713004,0.7779166617260571,1.0,2/11,5.32%,SASH1;STK38
prerank,telomerase RNA binding (GO:0070034),0.44122831223049497,1.0409629511846297,0.4228395061728395,0.9809290750546785,1.0,8/22,18.98%,PARN;TERT;NAF1;HNRNPU;HNRNPC;TEP1;SNRPD3;EXOSC10
prerank,metal ion:proton antiporter activity (GO:0051139),-0.407352894822153,-1.0396111166181357,0.3890160183066362,0.783589952935817,1.0,6/13,25.33%,SLC9B2;SLC9A2;LETM1;SLC9A6;SLC9A9;SLC9A5
prerank,adenyl ribonucleotide binding (GO:0032559),0.34640325670113076,1.0395293984912946,0.39775051124744376,0.9799826199820615,1.0,49/291,14.02%,RYR1;MAP3K20;STK38L;MAP3K5;ACTA1;UBA2;DYRK2;PFKP;CDK6;MYH9;PDK4;MYO9B;RHOBTB3;MYO1B;PEAK1;KSR1;MARK1;PDE4A;BMPR1A;MYO18A;MAP4K3;MAP4K5;COQ8A;ABCE1;STK26;ERCC6;MIEF1;WNK2;DAPK3;PRKACB;PAPOLA;ABCD4;BRSK1;LONP1;HNRNPU;ABCG1;PDE4D;PFKM;DDX25;ACVR1B;STK36;DMPK;BMPR1B;CDC42BPB;SMARCA5;MAST1;ATP7B;PDK2;SARS2
prerank,thiol-dependent deubiquitinase (GO:0004843),-0.2601103565568338,-1.0370263080222364,0.38666666666666666,0.7833331609782522,1.0,22/83,19.37%,USP53;ATXN3;USP46;USP11;MINDY3;OTUD7B;USP45;UFD1;USP19;USP7;USP12;BRCC3;USP3;USP29;PAN2;USP37;VCPIP1;OTUD3;USP24;ZC3H12A;USP10;USP32
prerank,DNA-(apurinic or apyrimidinic site) endonuclease activity (GO:0003906),-0.43840599378972156,-1.0366887948540444,0.4188235294117647,0.7778152638556763,1.0,9/11,50.41%,HMCES;HMGA2;NEIL1;NEIL3;NTHL1;NEIL2;APEX1;APEX2;APLF
prerank,serine-type peptidase activity (GO:0008236),0.36730143968299056,1.0366024907172864,0.41965317919075146,0.9832660858163603,1.0,7/96,10.52%,TMPRSS4;KLK2;HTRA1;APEH;PRSS8;MASP2;MBTPS1
prerank,anion channel activity (GO:0005253),0.3846949438822615,1.0358004152775848,0.41051314142678347,0.9806219154958615,1.0,10/61,11.95%,ANO1;GABRE;ANO6;GABRA4;GABRA5;VDAC1;GABRB2;GABRG1;ANO3;GABRB3
prerank,semaphorin receptor activity (GO:0017154),-0.43585444764889236,-1.0347644974065766,0.4462242562929062,0.7761867975699006,1.0,4/11,7.77%,PLXNA2;NRP2;NRP1;PLXNA4
prerank,chloride channel regulator activity (GO:0017081),-0.40571565548574373,-1.0341773815487803,0.4209245742092457,0.7716374196182096,1.0,6/14,17.90%,WNK1;WNK4;WNK3;STX1A;VAMP8;STX8
prerank,PDZ domain binding (GO:0030165),0.3830270843644406,1.0328982202135253,0.4069912609238452,0.983717497933647,1.0,15/61,15.32%,ATP2B4;SDC2;CRIM1;FZD4;ARHGEF16;FZD8;SYNJ2;ATP2B1;ADAM17;SLC22A5;TMEM88;NSF;TMEM88B;PLEKHA1;PTEN
prerank,MAP-kinase scaffold activity (GO:0005078),-0.43358607623268475,-1.0313701574102183,0.46774193548387094,0.7723244855035808,1.0,4/11,11.35%,AKAP13;SH3RF1;MAPK8IP3;MAP2K2
prerank,amino acid transmembrane transporter activity (GO:0015171),-0.2944456437766888,-1.0303598782625603,0.3875,0.768482562896982,1.0,11/47,9.68%,SLC7A11;SLC6A13;SLC47A1;PDPN;SLC6A1;SLC6A6;SLC7A14;SLC3A2;SLC7A5;SLC38A10;SLC22A4
prerank,metallopeptidase activity (GO:0008237),0.35589414196452757,1.02924712451118,0.4201117318435754,0.9888124961273923,1.0,19/113,13.50%,MMP17;PAPPA2;ADAMTS14;ADAMTS5;ADAMTS19;LNPEP;RNPEP;AFG3L2;TRABD2B;ADAM17;MIPEP;PHEX;ADAM18;THSD4;ADAMTS20;EIF3H;ADAMTS16;PMPCB;ADAM19
prerank,endonuclease activity (GO:0004519),-0.2877100918650917,-1.0268066280173567,0.3702290076335878,0.7713397929569126,1.0,18/49,27.24%,AGO3;ZC3H12B;MRE11;N4BP2;TSNAX;ERCC5;DIS3;ERN1;ZC3H12C;SMG6;ZC3H12A;RNASEL;INTS11;KHNYN;ERCC4;EXOG;SND1;OGG1
prerank,GTP binding (GO:0005525),0.3443760383588866,1.0267363656399093,0.44350580781414994,0.9908466238446734,1.0,34/172,16.97%,RASL12;RAP1A;TUBA1C;RRAD;RERG;RHOBTB3;GEM;MFHAS1;SEPHS1;RAP2C;RANBP17;RRAS;TUBB2B;RHOJ;RHOF;RAP2A;RRAGB;REM1;RHOH;DRG2;GBP2;ADSS1;LSG1;LRRK2;TUBD1;RAB14;DIRAS2;RHOG;DNM2;RHOT1;RAB8A;AGAP2;ARL4D;RAB38
prerank,cyclic nucleotide binding (GO:0030551),0.45567222328573503,1.026010556859635,0.434850863422292,0.9880576804958401,1.0,4/21,11.32%,PDE5A;PDE4A;KCNH1;PDE4D
prerank,"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen (GO:0016709)",-0.33726898890466284,-1.0215665525406554,0.42485549132947975,0.7785837814932155,1.0,6/25,8.92%,POR;CYP27A1;CYP26B1;FMO1;FMO2;NOS3
prerank,endoribonuclease activity (GO:0004521),-0.3197648375716815,-1.0204927972647782,0.4329268292682927,0.7752614919524189,1.0,12/32,25.71%,AGO3;ZC3H12B;TSNAX;ERN1;ZC3H12C;SMG6;ZC3H12A;RNASEL;INTS11;KHNYN;EXOG;SND1
prerank,tRNA binding (GO:0000049),0.39560016287874933,1.018573313327446,0.43342391304347827,1.0,1.0,14/43,16.00%,HSD17B10;NAT10;TYW5;TRMT10C;TERT;PSTK;SEPSECS;AIMP1;NSUN2;RPUSD4;SARS2;KARS1;SARS1;FARS2
prerank,small GTPase binding (GO:0031267),0.34073589939582305,1.016174632064027,0.4483870967741935,1.0,1.0,43/169,15.56%,FLNA;RNF152;PLCE1;MYO9B;UNC13D;RHOBTB3;STRN3;TBC1D20;TNFAIP1;BICD2;ARHGEF16;KIF3B;ARHGEF2;MTSS2;RUSC2;RABGAP1;CAV1;NDRG1;CYFIP1;RAPGEF6;PEX5L;WHAMM;DAPK3;EVI5;DENND10;PAK2;ARHGAP1;ANKFY1;RAB11FIP4;RAB11FIP3;DNM1L;SH3BP4;RHOH;XPO5;HPS4;MYO5B;TNPO3;LRRK2;RAB34;ANKRD27;MLPH;GGA2;RAF1
prerank,protein-arginine N-methyltransferase activity (GO:0016274),-0.4262604261555518,-1.0148484960004098,0.4520547945205479,0.7835754352407265,1.0,3/11,7.56%,CARM1;PRMT2;PRMT3
prerank,double-stranded RNA binding (GO:0003725),0.3693119315535551,1.0127908882622585,0.45714285714285713,1.0,1.0,21/70,19.68%,ACTN1;VIM;MTDH;DICER1;EIF4A1;LRRFIP1;MBNL1;HNRNPU;EIF2AK2;OASL;DROSHA;DGCR8;DHX30;RFTN1;STAU2;DHX9;ILF3;CLTC;ADARB1;AGO1;PRKRA
prerank,ribonuclease activity (GO:0004540),-0.27786050443581145,-1.0125671373192666,0.39906103286384975,0.7834247977827145,1.0,22/56,27.89%,AGO3;ZC3H12B;TSNAX;SAMHD1;EXOSC1;RNASE4;ERN1;ZC3H12C;EXOSC9;SMG6;ZC3H12A;EXOSC2;RNASEL;PPP1R8;INTS11;KHNYN;EXOSC3;EXOSC7;EXOG;SND1;EXOSC5;ELAC2
prerank,5'-nucleotidase activity (GO:0008253),0.4788596337718486,1.0119165462994142,0.45869947275922673,1.0,1.0,5/13,20.04%,ACP3;NT5C2;NT5M;NT5C3A;NT5C
prerank,cytokine receptor binding (GO:0005126),0.36468593455442055,1.0106482831743493,0.4684466019417476,1.0,1.0,12/83,10.34%,LIFR;CRLF1;IL2;CCL5;PXDN;VEGFA;IL12RB1;PIBF1;IL22;TGFB2;ADAM17;IL13RA1
prerank,omega peptidase activity (GO:0008242),-0.24854568224365586,-1.0105493666643408,0.42028985507246375,0.7825823529079565,1.0,29/89,25.42%,USP53;ATXN3;USP46;USP11;MINDY3;OTUD7B;USP45;UFD1;USP19;USP7;USP12;BRCC3;USP3;ASRGL1;USP29;PAN2;USP37;VCPIP1;OTUD3;USP24;ZC3H12A;USP10;USP32;MPND;CYLD;USP25;OTUD1;GGT7;UCHL1
prerank,nuclear receptor coactivator activity (GO:0030374),0.3845785765885756,1.0104340009582093,0.4483695652173913,1.0,1.0,9/52,10.42%,ACTN1;ACTN4;NCOA7;MED1;PPARGC1A;PPARGC1B;MED12;SFR1;MED14
prerank,fibroblast growth factor receptor binding (GO:0005104),0.44098623107719775,1.009631096624235,0.45638629283489096,0.9980583167378759,1.0,1/21,1.47%,FGF1
prerank,"DNA-binding transcription repressor activity, RNA polymerase II-specific (GO:0001227)",0.3386024172103662,1.0093056424918097,0.46914893617021275,0.9941688552698407,1.0,27/173,13.22%,PRDM16;HEY2;ZFHX3;TBX2;ZEB2;HEYL;ETS2;ZNF436;NACC2;PRDM1;OSR2;TBX18;KCNIP3;SNAI2;RELA;PPARA;NR1D1;SKI;LRRFIP1;ZBTB33;ZNF3;SREBF2;ATF3;NFX1;BCL6;ZFP69;ZBTB5
prerank,single-stranded telomeric DNA binding (GO:0043047),-0.4175750966502143,-1.0086335244353581,0.4594594594594595,0.7814507115209551,1.0,4/11,16.97%,STN1;RAD50;CTC1;TERF2IP
prerank,poly(A) binding (GO:0008143),0.44571523790655154,1.0075975738425067,0.4422187981510015,0.9939025736649718,1.0,5/21,11.00%,RBPMS;RBMS3;PPIE;HNRNPU;DDX1
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines (GO:0016814)",0.5116701814685849,1.006675921252229,0.4830827067669173,0.9914599906974387,1.0,1/10,3.60%,DCTD
prerank,microtubule minus-end binding (GO:0051011),0.47748055718543836,1.0057665172317232,0.4619377162629758,0.9889438466043446,1.0,5/13,19.35%,CEP290;TUBGCP6;HAUS7;HAUS4;CAMSAP1
prerank,snRNA binding (GO:0017069),0.38834921916940857,1.0025288264945553,0.43956043956043955,0.9925389361601602,1.0,10/42,16.17%,LSM8;HEXIM1;SF3B3;CCNT1;HNRNPU;EIF5A;PRPF4;SNRPB2;RBM41;LSM10
prerank,protein phosphatase 2A binding (GO:0051721),0.42831290077191864,0.9999779358430739,0.4841628959276018,0.994560936479669,1.0,6/23,7.73%,STRN3;MFHAS1;MAPT;DAB2IP;TP53;ENSA
prerank,tumor necrosis factor receptor superfamily binding (GO:0032813),0.4262442029454925,0.9991014826404669,0.4528023598820059,0.9924314596340245,1.0,7/28,14.88%,MYD88;DAB2IP;TRAF3;TRAF5;CASP8AP2;STAT1;FEM1B
prerank,sulfotransferase activity (GO:0008146),-0.3135369192090572,-0.9950664080911533,0.46402877697841727,0.808914348414473,1.0,5/33,8.34%,UST;CHST11;HS3ST3A1;CHST9;TPST1
prerank,protein tyrosine/serine/threonine phosphatase activity (GO:0008138),0.4242549067074126,0.9937974138914949,0.45788667687595713,1.0,1.0,8/22,18.60%,DUSP5;DUSP3;DUSP29;SBF1;DUSP16;DUSP23;MTMR3;DUSP12
prerank,exoribonuclease activity (GO:0004532),-0.40722061985415314,-0.9932871115337691,0.49665924276169265,0.8075586675304468,1.0,7/12,27.26%,EXOSC1;EXOSC9;ZC3H12A;EXOSC2;EXOSC3;EXOSC7;EXOSC5
prerank,insulin-like growth factor I binding (GO:0031994),-0.3978140492226016,-0.991198212955354,0.4575,0.8071009719614265,1.0,6/13,13.87%,IGFBP2;ITGA6;IGFBP3;ITGAV;IGFBP6;INSR
prerank,phosphatidylcholine transporter activity (GO:0008525),0.4445543472058509,0.9881551404524135,0.4774193548387097,1.0,1.0,8/17,15.42%,ATP8B1;ABCB4;PITPNB;ABCA3;ABCG1;ATP10A;MTTP;PITPNM2
prerank,SUMO binding (GO:0032183),0.47631770902385573,0.9880889969380074,0.4660714285714286,1.0,1.0,3/13,10.75%,UBA2;CBX4;CASP8AP2
prerank,serine-type endopeptidase activity (GO:0004252),0.3558014985034218,0.9870508562216651,0.5023474178403756,1.0,1.0,5/80,10.52%,TMPRSS4;KLK2;APEH;MASP2;MBTPS1
prerank,lysophospholipase activity (GO:0004622),-0.3502269271835132,-0.9860665338566122,0.4859335038363171,0.814344432812649,1.0,9/20,26.08%,LYPLA1;ENPP2;PLA2G6;GDPD1;ABHD12;ASPG;GDE1;PNPLA6;LYPLA2
prerank,ATPase regulator activity (GO:0060590),0.3947166818532824,0.9815656272600094,0.48728246318607765,1.0,1.0,11/38,19.21%,PLN;ATP1B1;BAG3;DNAJC1;FNIP2;BAG2;HSPBP1;DNAJA2;DNAJB6;BRSK2;SIL1
prerank,pseudouridine synthase activity (GO:0009982),0.47099897257042,0.9785006724458118,0.48853615520282184,1.0,1.0,5/13,17.45%,RPUSD3;PUS7L;RPUSD4;TRUB1;TRUB2
prerank,hormone activity (GO:0005179),-0.2679507608445566,-0.9783337607362086,0.4954545454545455,0.8273686076124545,1.0,21/54,40.45%,IGF1;CHGB;METRNL;PPY;PTHLH;ADCYAP1;SST;EDN3;PENK;VGF;INHA;INHBB;EDN1;GNRH1;NPPC;C1QTNF12;CCK;SPX;GRP;NPFF;PNOC
prerank,hexosaminidase activity (GO:0015929),-0.3915186742249342,-0.9767119436861644,0.5162037037037037,0.8254377834757299,1.0,4/12,20.47%,CEMIP;HEXA;CEMIP2;NAGA
prerank,cardiolipin binding (GO:1901612),-0.41974824493381935,-0.9762750405741707,0.5021739130434782,0.8205344702775549,1.0,5/10,25.50%,GSDME;GSDMD;STOML2;PLEKHN1;MME
prerank,peptidoglycan binding (GO:0042834),-0.4237485267205722,-0.9740239672815744,0.5294117647058824,0.820139696479857,1.0,8/10,51.85%,NOD1;PGLYRP1;NOD2;RNASE7;JCHAIN;NLRP3;TLR2;HK1
prerank,ion channel inhibitor activity (GO:0008200),0.39029527696314326,0.9726380243889909,0.5028089887640449,1.0,1.0,7/35,8.12%,ITPR1;PACSIN3;CAMK2D;NEDD4;CALM1;ENSA;WNK2
prerank,DNA secondary structure binding (GO:0000217),0.4031326429927368,0.9715462864838867,0.4992867332382311,1.0,1.0,3/31,6.20%,MEF2C;RAD51AP1;MAPT
prerank,guanyl ribonucleotide binding (GO:0032561),0.3246386557350704,0.9706917204047483,0.5283613445378151,1.0,1.0,37/196,16.97%,RASL12;RAP1A;TUBA1C;PDE5A;RRAD;RERG;RHOBTB3;GEM;MFHAS1;SEPHS1;RAP2C;RANBP17;RRAS;TUBB2B;RHOJ;MIEF1;RHOF;RAP2A;RRAGB;REM1;RHOH;DRG2;GBP2;ADSS1;LSG1;LRRK2;TUBD1;RAB14;DIRAS2;RAB8B;RHOG;DNM2;RHOT1;RAB8A;AGAP2;ARL4D;RAB38
prerank,CARD domain binding (GO:0050700),-0.37144185807259267,-0.9676408724097036,0.5103092783505154,0.8302550855303542,1.0,4/14,12.34%,NOD1;CARD10;IRGM;CARD14
prerank,protease binding (GO:0002020),0.3403998196902247,0.9667822120480404,0.52479815455594,1.0,1.0,16/99,11.72%,TTN;ITGA3;ADRM1;STIM1;ITGB1;BCL2;TP53;TIMP4;ITGB3;AMFR;SRI;NFRKB;ANXA9;LONP2;COL3A1;POLG
prerank,Tat protein binding (GO:0030957),0.4813022747686986,0.9662039340192191,0.5109612141652614,1.0,1.0,2/10,6.15%,ACTB;SMARCB1
prerank,phospholipid transfer activity (GO:0120014),-0.33622746874735066,-0.965267116231946,0.48412698412698413,0.8298122544282124,1.0,10/21,23.73%,PITPNA;PLTP;PITPNC1;CERT1;PLEKHA3;TNFAIP8L3;PRELID3B;C2CD2L;PRELID2;PRELID3A
prerank,transmembrane receptor protein tyrosine kinase activity (GO:0004714),0.3600877502638917,0.9644181310335175,0.5104039167686658,1.0,1.0,10/60,9.85%,NTRK3;MERTK;CRIM1;MST1R;ROR1;MUSK;IGF2R;EPHA2;PDGFRB;AXL
prerank,Notch binding (GO:0005112),-0.333055667519785,-0.9620952950167626,0.5039787798408488,0.831513084395063,1.0,9/22,19.73%,SNED1;AAK1;CUL3;CCN3;SNW1;DTX1;JAG2;NOTCH4;HIF1AN
prerank,5'-3' RNA polymerase activity (GO:0034062),0.40625429590120754,0.960508072938983,0.5081240768094535,1.0,1.0,7/27,14.22%,POLR2L;POLR2I;POLR2G;TERT;POLR1H;POLR2J;POLR3K
prerank,death domain binding (GO:0070513),-0.40228923494559266,-0.9601795930557812,0.5152941176470588,0.8302654348925748,1.0,6/11,17.30%,BCL2L1;DAP;IRGM;DAPL1;CRADD;BAX
prerank,tau protein binding (GO:0048156),0.3772761676964233,0.9586719753172726,0.5173370319001387,1.0,1.0,15/40,19.72%,ROCK1;ACTB;MARK1;DYRK1A;PIN1;BRSK1;ROCK2;CLU;BAG2;MARK2;DCTN1;MAP1A;BRSK2;HDAC6;MARK3
prerank,hydro-lyase activity (GO:0016836),0.3739551214476928,0.9571695713185637,0.513550135501355,1.0,1.0,8/41,9.72%,CA3;ENO3;TBXAS1;HSD17B4;HACD1;CDYL;ACO2;HADHB
prerank,GTPase binding (GO:0051020),0.31531928758964867,0.9529603625864126,0.5619747899159664,1.0,1.0,45/194,14.38%,FLNA;RNF152;PLCE1;LCP1;MYO9B;UNC13D;RHOBTB3;STRN3;TBC1D20;TNFAIP1;BICD2;ARHGEF16;KIF3B;ARHGEF2;MTSS2;RUSC2;RABGAP1;CAV1;NDRG1;CYFIP1;RAPGEF6;PEX5L;WHAMM;DAPK3;EVI5;DENND10;PAK2;ARHGAP1;ANKFY1;RRAGB;RAB11FIP4;RAB11FIP3;DNM1L;SH3BP4;RHOH;AIMP1;XPO5;HPS4;MYO5B;TNPO3;LRRK2;IARS1;EPRS1;RAB34;ANKRD27
prerank,neuropeptide binding (GO:0042923),-0.34302641510994203,-0.9527951097962386,0.5376884422110553,0.8418675788145651,1.0,11/18,53.80%,GPR149;GPR37;NMUR2;OPRL1;SSTR2;SORL1;MC4R;SSTR1;OPRD1;OPRM1;NMUR1
prerank,AMP binding (GO:0016208),-0.39899285421180686,-0.9517655986704279,0.5194174757281553,0.838472577426736,1.0,2/11,0.64%,MPPED2;PRKAG2
prerank,transcription cis-regulatory region binding (GO:0000976),0.3090067124009305,0.9509074437862596,0.595166163141994,1.0,1.0,44/406,10.49%,SOX6;PRDM16;SOX5;MEF2C;ACTN4;NR1H4;ALX4;RORA;SIM2;GABPA;ARID5B;HINFP;ZNF436;RBAK;FOSL2;MTERF3;VEZF1;OSR2;TBX18;MEF2A;GBX1;DBP;KLF15;SUV39H2;JUND;ARID5A;TP53;GRHL1;SNAI2;SFPQ;YAP1;AR;SOX9;RELA;KMT2D;CUX2;BBX;RUNX1;NR1D1;LONP1;HIF1A;ZNF3;TEAD1;NR2C2
prerank,ATPase binding (GO:0051117),0.3494301692360965,0.9508951287128453,0.5417170495767836,1.0,1.0,8/71,7.20%,PLN;HRC;PPP3CA;SNTA1;ATP1B1;ATP6V0A2;CAV1;AR
prerank,kinase activator activity (GO:0019209),0.39467533020678075,0.9507895349847437,0.5179340028694405,1.0,1.0,3/30,6.89%,FGF13;IL2;TPX2
prerank,glycerophospholipid flippase activity (GO:0140333),0.45814727051213466,0.9505757550653195,0.5,1.0,1.0,4/11,11.60%,ATP8B1;ABCB4;ABCA3;ATP10A
prerank,inorganic cation transmembrane transporter activity (GO:0022890),0.36466891202330226,0.9488889861982465,0.5271002710027101,1.0,1.0,6/48,8.71%,ASIC3;TRPC6;PKD1L3;TRPV2;CALHM5;TRPM4
prerank,LRR domain binding (GO:0030275),0.4415437730720394,0.9482687497813445,0.5033898305084745,1.0,1.0,8/14,18.34%,MRTFA;DAPK3;ZXDC;PAWR;POLR2J;LRRFIP2;PMF1;DDIT3
prerank,carboxylic ester hydrolase activity (GO:0052689),-0.2398818501715845,-0.9471558862331917,0.6026490066225165,0.8438736652043006,1.0,28/85,26.60%,PAFAH1B2;DDHD2;LYPLA1;ABHD5;ENPP2;CA2;PLA2G6;PLAAT3;GDPD1;NOTUM;ABHD12;ASPG;PLA2G7;ABHD3;LIPE;AARS1;GDE1;TARS2;PLA2G12A;APMAP;PNPLA6;ABHD6;LIPA;DAGLB;ABHD8;LYPLA2;PGLS;PNPLA2
prerank,calcium-dependent phospholipid binding (GO:0005544),0.36117845310832025,0.9469922060979419,0.5525291828793775,1.0,1.0,5/49,4.51%,ESYT2;FER1L5;DYSF;ANXA1;SYT10
prerank,sodium:proton antiporter activity (GO:0015385),-0.38748803900293227,-0.9465904128486193,0.5444444444444444,0.8394260623152184,1.0,5/11,25.33%,SLC9B2;SLC9A2;SLC9A6;SLC9A9;SLC9A5
prerank,lysophosphatidic acid acyltransferase activity (GO:0042171),-0.3630425773979652,-0.9455770684286435,0.5425,0.8361083748214017,1.0,8/15,30.33%,AGPAT4;ABHD5;LPCAT2;AGPAT5;AGPAT1;ABHD8;AGPAT2;LCLAT1
prerank,cytokine activity (GO:0005125),-0.22512239822948643,-0.9445025012753248,0.5977011494252874,0.8332709476910936,1.0,10/131,7.05%,BMP6;WNT4;BMP7;HMGB1;IL15;BMP4;IL18;WNT5A;CXCL16;WNT9A
prerank,"racemase and epimerase activity, acting on carbohydrates and derivatives (GO:0016857)",-0.4136049374228479,-0.9426051842951326,0.5381165919282511,0.832116599104054,1.0,4/10,12.86%,DSE;RENBP;DSEL;GLCE
prerank,ephrin receptor binding (GO:0046875),-0.32966622322842243,-0.9424045397300872,0.5449871465295629,0.8271018141644276,1.0,5/21,13.91%,EFNB2;GRB2;ANKS1A;LYN;EFNB1
prerank,UDP-glycosyltransferase activity (GO:0008194),0.3520263967019788,0.9417217666582671,0.5411042944785276,1.0,1.0,7/70,6.60%,LARGE1;CHSY3;CSGALNACT1;EXT2;GCNT2;HAS2;RFNG
prerank,neuropeptide receptor activity (GO:0008188),0.389060840231112,0.9408080636034261,0.5415430267062314,1.0,1.0,2/29,4.17%,NPY1R;TACR3
prerank,ATP hydrolysis activity (GO:0140603),0.3683422591089187,0.9407181349908219,0.5241286863270778,1.0,1.0,9/41,12.64%,MYO1E;RHOBTB3;MYO18A;ABCA3;ATP2B1;ATAD1;RUVBL1;CLU;KIF20B
prerank,pyrophosphatase activity (GO:0016462),0.35890527303173675,0.9390503641108253,0.5348226018396847,1.0,1.0,8/50,8.94%,ENTPD1;NUDT7;NUDT4;PRUNE1;LHPP;ENTPD7;BNIPL;ATCAY
prerank,phospholipase activator activity (GO:0016004),0.47036991935648215,0.9362500342147515,0.549469964664311,1.0,1.0,2/10,4.80%,CCL5;ARHGAP6
prerank,hormone receptor binding (GO:0051427),-0.36771552108291805,-0.9334946588471824,0.5506172839506173,0.8419320445091857,1.0,6/14,37.43%,SOCS2;PTHLH;ADCYAP1;NCOA6;NPPC;CCK
prerank,ubiquitin-like protein ligase binding (GO:0044389),-0.2081682437697865,-0.933385696386274,0.76,0.8367127537055851,1.0,85/269,24.16%,SNCAIP;SMAD3;ARRB1;UBXN7;FZD6;ATXN3;ITCH;SMAD6;POLR2A;CUL3;EGFR;XRCC5;RNF20;FOXO1;NFKBIA;SHPRH;NAE1;DERL1;PML;PRR5L;HSPA5;HSP90AB1;CASP8;PCBP2;SLF2;USP7;HERC2;PRKAR2B;BAG4;UQCRC1;PTPN22;MDM2;IKBKG;FBXO7;PRKN;RNF31;BAG1;SLF1;TRIP4;UBC;BLZF1;RNF34;STUB1;AMBRA1;STAT2;DTX1;RTN4;DTX3L;DBT;SLC22A18;PER1;SYT11;CALR;UBXN1;HGS;GABARAPL2;HSPA9;SMAD2;WRAP53;CHEK2;NEK6;PRKAR2A;RALB;SPOPL;ARRDC1;TRIB1;RPL11;SCAMP3;SUMO3;SUMO2;ARIH1;ABI2;HSPD1;UBB;DET1;UBE2B;TXNIP;AXIN1;TMBIM6;MAGEC2;PTPRN;USP25;YWHAZ;MAP1LC3A;CDKN1A
prerank,transmembrane receptor protein kinase activity (GO:0019199),0.3484714678924983,0.9329378724244033,0.5570552147239264,1.0,1.0,11/60,12.26%,NTRK3;MERTK;MST1R;ROR1;ACVR2A;MUSK;EPHA2;PDGFRB;AXL;ACVR1B;BMPR1B
prerank,symporter activity (GO:0015293),-0.39981747544017887,-0.9318390031922442,0.5384615384615384,0.8350380247560834,1.0,3/10,27.69%,SLC5A5;MFSD2A;SLC5A6
prerank,phosphatidylinositol binding (GO:0035091),0.33099130911647323,0.9308520942487818,0.5679156908665105,1.0,1.0,24/91,17.93%,MYO1E;ESYT2;ITPR1;HIP1;PITPNB;MAPT;MREG;ANKFY1;GAP43;DENND1A;GRAMD2A;WDR45;SNX13;SNX9;SNX17;PARD3B;SNX1;PITPNM2;PHF12;SNAP91;SNX4;ZFYVE16;ESYT1;RPH3A
prerank,guanyl-nucleotide exchange factor activity (GO:0005085),0.3191125810556005,0.9293977577607363,0.5949781659388647,1.0,1.0,27/147,12.89%,ARHGEF7;RAP1A;KALRN;ABR;PLCE1;ARHGEF17;RASGRP2;DOCK8;ITSN1;DOCK10;ARHGEF16;ARHGEF2;NUCB1;RCC1L;RAPGEF6;RASGRP1;DNMBP;RIN2;DENND10;ARHGEF4;DOCK1;VAV1;DENND1A;FRMD7;BCR;SBF1;HPS4
prerank,quaternary ammonium group transmembrane transporter activity (GO:0015651),0.45581185507671745,0.9287297307756104,0.5545927209705372,1.0,1.0,2/11,11.97%,SLC25A29;SLC22A5
prerank,G protein-coupled receptor binding (GO:0001664),0.3198614191208452,0.9259799440790324,0.5986696230598669,1.0,1.0,6/132,5.29%,FLNA;AGTR1;CCL5;GNAO1;SAG;GNAZ
prerank,MAP kinase tyrosine/serine/threonine phosphatase activity (GO:0017017),0.46077443560346165,0.9250428796125963,0.5508021390374331,1.0,1.0,2/10,12.88%,DUSP5;DUSP16
prerank,protein tyrosine/threonine phosphatase activity (GO:0008330),0.46077443560346165,0.9250428796125963,0.5508021390374331,1.0,1.0,2/10,12.88%,DUSP5;DUSP16
prerank,tumor necrosis factor receptor binding (GO:0005164),0.4529158933235883,0.9244097764945641,0.5667244367417678,1.0,1.0,3/12,14.65%,TRAF3;TRAF5;STAT1
prerank,"DNA-binding transcription activator activity, RNA polymerase II-specific (GO:0001228)",0.3056780794327287,0.9230829867100934,0.6339468302658486,1.0,1.0,29/254,9.58%,PRDM16;MEF2C;NR1H4;SMARCD3;ALX4;NR4A1;PRRX1;GABPA;HINFP;FOSL2;VEZF1;SP7;OSR2;KLF7;MEF2A;FOXJ3;DBP;KLF15;TP53;GRHL1;HOXC4;AR;SOX9;ZFP62;RELA;PPARA;RUNX1;NR4A2;HIF1A
prerank,m7G(5')pppN diphosphatase activity (GO:0050072),0.4436850692451978,0.9224242232971974,0.5282651072124757,1.0,1.0,2/11,4.41%,NUDT7;NUDT4
prerank,hexosyltransferase activity (GO:0016758),-0.22166713748484904,-0.9221578039346602,0.6818181818181818,0.8516915527246238,1.0,29/101,24.92%,TMTC1;TMTC2;MGAT4C;B4GALT1;CHSY1;DPY19L4;B4GALT6;GBE1;TMTC4;DPY19L1;MGAT4B;HEXA;OGT;B3GALNT1;PIGV;B4GALT4;CHPF2;ALG1;B4GALT7;GBA2;ALG12;B3GNT2;POMT1;GYG1;B3GALT2;LFNG;B4GALT3;MFNG;GCNT1
prerank,NADH dehydrogenase (quinone) activity (GO:0050136),0.36810170337631554,0.9216091496288782,0.5613793103448276,1.0,1.0,9/34,14.85%,NDUFS1;NDUFA2;NDUFC1;NDUFB6;NDUFS3;NDUFB8;NDUFV2;NDUFS2;NDUFA1
prerank,NADH dehydrogenase (ubiquinone) activity (GO:0008137),0.36810170337631554,0.9216091496288782,0.5613793103448276,1.0,1.0,9/34,14.85%,NDUFS1;NDUFA2;NDUFC1;NDUFB6;NDUFS3;NDUFB8;NDUFV2;NDUFS2;NDUFA1
prerank,acetylcholine receptor activity (GO:0015464),0.39727512319718133,0.9214445704776834,0.5345622119815668,1.0,1.0,5/22,15.53%,HRH3;ANXA9;CHRNA7;CHRFAM7A;CHRNA4
prerank,tRNA-specific ribonuclease activity (GO:0004549),-0.3566920396640787,-0.9208521311792528,0.5806451612903226,0.8490962155849551,1.0,6/14,35.18%,POP1;TSEN34;ELAC2;POP4;RPP38;RPP21
prerank,phosphatase binding (GO:0019902),-0.22678912865586062,-0.9193601910321286,0.6166666666666667,0.8472262896798985,1.0,31/105,21.60%,SMAD3;DLG1;MAPK14;CDH5;PXN;WNK1;EGFR;PTK2;MAGI2;CRY1;CTNNB1;MTMR4;PPME1;DZIP3;SIRPA;HSP90B1;SH3RF2;PDLIM4;SH3YL1;CRY2;PPP6R3;TERF2IP;SMAD2;ANAPC4;SNX3;STAT6;NFATC2;CEACAM1;CARHSP1;MVP;FLT4
prerank,transition metal ion transmembrane transporter activity (GO:0046915),-0.2878949528769565,-0.9167366284356565,0.5875,0.8477281400033722,1.0,8/30,15.68%,SLC39A10;SLC30A10;SLC39A11;SLC39A8;SLC30A1;SLC25A28;SLC39A1;SLC39A6
prerank,phosphoric diester hydrolase activity (GO:0008081),0.3665852282078994,0.9165894686381977,0.5647887323943662,1.0,1.0,4/35,3.66%,PLCE1;PLCB4;PLCL1;PLCXD1
prerank,metalloendopeptidase inhibitor activity (GO:0008191),-0.3614738502902447,-0.9165325755701182,0.5995145631067961,0.8429295109906243,1.0,3/14,5.31%,SPOCK2;COL4A3;RECK
prerank,1-acylglycerol-3-phosphate O-acyltransferase activity (GO:0003841),-0.36265156154241796,-0.9163092666076146,0.5768321513002365,0.8382028334047125,1.0,7/13,30.33%,AGPAT4;ABHD5;LPCAT2;AGPAT5;AGPAT1;AGPAT2;LCLAT1
prerank,phospholipase binding (GO:0043274),-0.36910320871430274,-0.9146059527095887,0.5843230403800475,0.8367045638481241,1.0,5/13,18.27%,PDPK1;PAFAH1B1;PRKN;DGKQ;BLNK
prerank,metallocarboxypeptidase activity (GO:0004181),0.38569226912233756,0.9115953786300874,0.5611940298507463,1.0,1.0,3/26,7.40%,AGBL1;CPA4;CPA3
prerank,GTPase activity (GO:0003924),0.3038605435527608,0.9074949706783094,0.6570820021299254,1.0,1.0,38/192,16.47%,RASL12;RAP1A;RERG;RHOBTB3;GEM;GNAO1;GNAZ;TPPP;NKIRAS2;RAP2C;RRAS;RHOJ;ENTPD7;RAB3A;OPA1;RHOF;GNA12;GNG11;RAP2A;RRAGB;GFM2;DNM1L;GSPT1;MFN2;RHOH;DRG2;GBP2;LSG1;LRRK2;GNAQ;RAB14;DIRAS2;RAB8B;RHOG;DNM2;RHOT1;RAB8A;AGAP2
prerank,single-stranded DNA helicase activity (GO:0017116),0.4036279409378555,0.9059807371601708,0.5524590163934426,1.0,1.0,3/19,8.36%,WRNIP1;CHTF18;HELQ
prerank,ion channel activity (GO:0005216),0.3250924322914617,0.9055002040806359,0.6090133982947625,1.0,1.0,11/80,12.46%,ASIC3;TRPC6;GRIN2C;PKD1L3;TRPV2;CALHM5;GRIK5;TRPM4;KCNK3;CHRNA7;TRPM2
prerank,protein phosphatase regulator activity (GO:0019888),0.34947635820945155,0.9051256426447767,0.6113161131611317,1.0,1.0,12/53,12.97%,RCAN2;PPP2R1B;SET;SAG;PPP2R5A;RCAN3;CALM1;ENSA;EIF2AK2;DMPK;CABIN1;ARPP19
prerank,carboxypeptidase activity (GO:0004180),0.3661596044237031,0.9044313813166382,0.5740740740740741,1.0,1.0,4/35,7.40%,AGBL1;BLMH;CPA4;CPA3
prerank,1-phosphatidylinositol-3-kinase regulator activity (GO:0046935),0.4237042229903597,0.9023442782228355,0.5602836879432624,1.0,1.0,3/15,5.04%,SOCS5;SOCS6;SOCS4
prerank,peptidase inhibitor activity (GO:0030414),-0.2756236336692056,-0.9021926305846916,0.6081504702194357,0.8589957625568642,1.0,6/33,10.51%,TFPI;PROS1;RECK;ITIH2;RENBP;SERPIND1
prerank,neurexin family protein binding (GO:0042043),-0.38630665023761246,-0.9009042082344457,0.6053215077605322,0.8567657351449051,1.0,4/10,17.11%,NLGN1;NLGN2;NLGN3;SYTL4
prerank,"phosphotransferase activity, for other substituted phosphate groups (GO:0016780)",-0.38045336929239476,-0.8979734771716441,0.5932203389830508,0.8578431293930547,1.0,4/11,12.38%,SGMS1;SGMS2;PTDSS2;GNPTAB
prerank,3'-5' DNA helicase activity (GO:0043138),-0.3310246492646962,-0.8979257780406301,0.6184538653366584,0.852792644258088,1.0,3/16,11.76%,NAV2;FBH1;BLM
prerank,alcohol dehydrogenase (NADP+) activity (GO:0008106),0.43860516127655974,0.8976637396993652,0.5765124555160143,1.0,1.0,4/11,19.50%,AKR1B1;AKR1B10;RDH11;RDH13
prerank,acylglycerol lipase activity (GO:0047372),-0.3734897139522329,-0.8938191537405626,0.6238317757009346,0.8566444086930761,1.0,4/11,22.27%,ABHD12;ABHD3;LIPE;ABHD6
prerank,alpha-tubulin binding (GO:0043014),0.3697624449411688,0.8886170946767956,0.5879828326180258,1.0,1.0,4/31,8.84%,DLEC1;TTLL7;EFHC1;WASHC1
prerank,histone methyltransferase binding (GO:1990226),-0.3709691447929655,-0.8881496671133149,0.632420091324201,0.8635510824811102,1.0,2/11,7.18%,HSP90AB1;CTNNB1
prerank,GTPase activator activity (GO:0005096),0.2913772998884936,0.8873539204980614,0.7100712105798576,1.0,1.0,52/313,11.69%,ARHGEF7;RAP1A;RALGAPA2;DLC1;TBC1D1;RGS6;KALRN;ABR;PLCE1;ARHGEF17;RASGRP2;DOCK8;MYO9B;ITSN1;ELMOD1;DOCK10;TBC1D20;ARHGAP10;ELMOD2;ARHGEF16;CHN1;ARHGEF2;MTSS2;LARS1;NUCB1;RABGAP1;RCC1L;RAPGEF6;RASGRP1;ARHGAP17;DNMBP;PLCB1;RALGAPA1;RIN2;EVI5;DENND10;ARHGAP39;ARHGAP30;ARHGEF4;RALGAPB;ARHGAP1;NPRL2;ASAP2;DOCK1;ARHGAP15;VAV1;DNM1L;TBCD;DENND1A;ARHGAP35;FRMD7;HTR2B
prerank,aminoacyl-tRNA ligase activity (GO:0004812),0.3526991919748319,0.8867012317143419,0.6069444444444444,1.0,1.0,14/37,20.15%,NARS2;HARS2;LARS1;IARS2;IARS1;SARS2;EPRS1;KARS1;LARS2;SARS1;FARS2;GARS1;AARS2;CARS2
prerank,acetylglucosaminyltransferase activity (GO:0008375),0.346664187097396,0.8857119066798697,0.6062176165803109,1.0,1.0,5/46,6.60%,LARGE1;EXT2;GCNT2;PIGA;RFNG
prerank,sulfuric ester hydrolase activity (GO:0008484),-0.36408802348537056,-0.8841635078259574,0.609375,0.8665494194802598,1.0,6/12,32.88%,SULF1;ARSI;GALNS;SULF2;SGSH;ARSB
prerank,ubiquitin binding (GO:0043130),-0.2312704578289283,-0.8780548778871884,0.7391304347826086,0.8742986652044059,1.0,36/73,33.57%,SMAD3;UBXN7;RNF185;WDR48;ILRUN;BIRC2;UBAP1;MDM2;IKBKG;RBCK1;FBXO7;PRKN;RNF31;DNAJB2;BUB3;TOLLIP;UBXN1;MVB12B;RNFT1;UBAP1L;SHARPIN;USP25;MVB12A;RAD23B;UCHL1;TRIM32;RNF19B;SQSTM1;USPL1;MARK4;VPS28;GGA3;PLAA;TNFAIP3;TOP2A;OTULINL
prerank,oxidoreduction-driven active transmembrane transporter activity (GO:0015453),0.3206490051504899,0.8771997033471841,0.6171284634760705,1.0,1.0,17/57,18.72%,COX7A2L;NDUFS1;NDUFA2;COX8A;NDUFC1;NDUFB6;NDUFS3;NDUFB8;NDUFV2;NDUFS2;NDUFA1;CYB561A3;UQCRFS1;UQCRH;COX5B;NDUFV3;UQCRQ
prerank,acylglycerol O-acyltransferase activity (GO:0016411),-0.30832404448478423,-0.873735350506899,0.6524216524216524,0.878588194211834,1.0,9/20,31.63%,AGPAT4;LPGAT1;ABHD5;LPCAT2;AGPAT5;AGPAT1;AGPAT2;LCLAT1;DGAT2
prerank,thioesterase binding (GO:0031996),0.4254942723491967,0.8734610877124774,0.578397212543554,1.0,1.0,4/11,17.64%,TRAF3;TRAF5;HAUS7;ADRA2A
prerank,cysteine-type peptidase activity (GO:0008234),0.3139927262646809,0.8701706777550856,0.6394799054373522,1.0,1.0,13/73,14.39%,TINAGL1;USP2;BLMH;CAPN2;USP1;ATG4D;USP13;USP50;ATG4A;USP35;USP20;USP30;USP42
prerank,poly(U) RNA binding (GO:0008266),-0.30918352617448047,-0.8690279480588664,0.6766304347826086,0.8830364008008758,1.0,6/20,10.17%,RBMS1;RBMS2;KHDRBS1;SSB;PABPC1;DAZAP1
prerank,ubiquitin conjugating enzyme binding (GO:0031624),-0.28615660687513245,-0.8684758531964528,0.6728971962616822,0.8791624882783265,1.0,11/27,20.07%,DCUN1D3;ZMYM2;RNF144B;RNF217;PRKN;RNF144A;RNF125;SIAH1;TOLLIP;SIAH2;ARIH1
prerank,phosphoric ester hydrolase activity (GO:0042578),0.33313057595668966,0.8679751932296819,0.6466666666666666,1.0,1.0,11/49,12.88%,DUSP5;PLCXD1;ACP3;PRUNE1;LHPP;SACM1L;DUSP3;PPP1CB;PPP1CA;SBF1;DUSP16
prerank,acetylgalactosaminyltransferase activity (GO:0008376),0.3646259699629816,0.8663558762497867,0.6083707025411061,1.0,1.0,2/26,3.35%,CHSY3;CSGALNACT1
prerank,protein-lysine N-methyltransferase activity (GO:0016279),0.3556743993347441,0.8649783921731969,0.6205923836389281,1.0,1.0,9/34,15.26%,SMYD1;SETD6;SETD3;NSD3;ATPSCKMT;VCPKMT;N6AMT1;KMT5B;EEF1AKMT2
prerank,G protein-coupled photoreceptor activity (GO:0008020),-0.3524795982423101,-0.8649587805966185,0.6577017114914425,0.8813035810953864,1.0,12/12,64.78%,ELOVL4;OPN3;GPR88;RRH;OPN1MW3;OPN1MW;RHO;OPN5;OPN1SW;GNAT2;OPN4;GPR52
prerank,single-stranded DNA binding (GO:0003697),-0.22057277972459385,-0.8647239523154844,0.7445255474452555,0.8767757982368882,1.0,31/93,27.63%,RBMS1;HMGB1;STN1;WDR48;TDP2;PCBP2;FUBP1;FBH1;ERCC5;SAMHD1;PURB;BLM;RTF1;HMCES;CTC1;CRY2;SSBP2;PMS2;PARK7;POLR2H;HSPD1;POLR3C;ERCC1;NUCKS1;ERCC4;IGHMBP2;RAD23B;TOP1;HMGB2;WBP11;RPA3
prerank,death receptor activity (GO:0005035),0.4236320136322136,0.8636573541601671,0.5898366606170599,1.0,1.0,3/11,13.82%,TNFRSF11A;TNFRSF25;TNFRSF10B
prerank,"2 iron, 2 sulfur cluster binding (GO:0051537)",-0.3552947412227921,-0.8623141344432957,0.6486486486486487,0.8766321159639329,1.0,3/12,3.36%,CISD2;AOX1;XDH
prerank,calcium:sodium antiporter activity (GO:0005432),0.4343096537298817,0.8598876757971062,0.6305506216696269,1.0,1.0,2/10,2.72%,SLC8A1;SLC8A2
prerank,"4 iron, 4 sulfur cluster binding (GO:0051539)",0.4073220526060684,0.857997717729534,0.6182136602451839,1.0,1.0,7/14,21.60%,NDUFS1;ACO2;RSAD1;ISCA2;IREB2;NFU1;RSAD2
prerank,mRNA 5'-UTR binding (GO:0048027),-0.2931276574571872,-0.8577560465700774,0.6748466257668712,0.8810993792170478,1.0,6/24,19.17%,DDX3X;RPS13;RSL1D1;GNL3;RPS7;FMR1
prerank,postsynaptic neurotransmitter receptor activity (GO:0098960),0.37806945069294356,0.8573930206275767,0.6246105919003115,1.0,1.0,4/21,15.53%,ANXA9;CHRNA7;CHRFAM7A;CHRNA4
prerank,cyclin-dependent protein serine/threonine kinase regulator activity (GO:0016538),0.33269975836191396,0.8545173609137267,0.6412614980289093,1.0,1.0,6/42,8.81%,CCNA2;CCND2;CCNQ;HEXIM1;CCND1;CCNT1
prerank,poly-pyrimidine tract binding (GO:0008187),0.3671349452797759,0.852404079962273,0.6288819875776398,1.0,1.0,7/23,11.87%,RBMS3;MCRS1;ATXN1;U2AF2;DIS3L2;HNRNPU;HNRNPC
prerank,palmitoyltransferase activity (GO:0016409),0.36230292389490926,0.8501891872110846,0.6432748538011696,1.0,1.0,11/28,18.42%,GOLGA7B;ZDHHC2;HHAT;ZDHHC1;ZDHHC14;ZDHHC17;ZDHHC13;ZDHHC4;ZDHHC8;ZDHHC5;ZDHHC3
prerank,SH3 domain binding (GO:0017124),0.313749628991235,0.8501067072572752,0.6584766584766585,1.0,1.0,6/62,7.58%,ENAH;MYPN;SYNJ2;MAPT;DAB2IP;RAD9A
prerank,cysteine-type endopeptidase activity (GO:0004197),-0.21968688168903183,-0.8496767875924033,0.8116883116883117,0.8922224441661799,1.0,19/78,23.97%,USP46;USP11;CAPNS1;CTSL;CTSH;CASP8;USP7;USP12;USP29;CTSB;CASP9;USP37;CAPN10;USP24;USP10;CTSS;CASP4;USP25;CASP12
prerank,lipoprotein particle receptor binding (GO:0070325),-0.2806586498301937,-0.8486130471162714,0.7009345794392523,0.8892558968275803,1.0,3/27,6.85%,LRP1;APOE;SYT1
prerank,inorganic anion transmembrane transporter activity (GO:0015103),-0.2777669863768103,-0.8478851932644244,0.7049689440993789,0.885616879660896,1.0,9/27,17.12%,SLC22A8;SLC26A7;SLC39A8;SLC22A6;SLC25A14;SLC5A5;SLC26A2;SLC25A30;SLC25A11
prerank,protein phosphatase inhibitor activity (GO:0004864),0.3680809552502573,0.8477749560204335,0.6546762589928058,1.0,1.0,8/26,12.97%,PABIR1;SET;SAG;PPP1R14C;ENSA;PPP1R14A;CABIN1;ARPP19
prerank,phospholipase A2 activity (GO:0004623),0.35365749115743894,0.8473954103488908,0.6376360808709176,1.0,1.0,6/26,17.02%,PLA2G3;PLB1;PNPLA3;PLA2G4A;PLA2G4C;PRDX6
prerank,transmembrane receptor protein tyrosine kinase adaptor activity (GO:0005068),-0.3445450719739759,-0.8471469490171987,0.6705336426914154,0.8822327889977846,1.0,2/12,6.96%,GAB2;FRS2
prerank,cytokine receptor activity (GO:0004896),0.2988699630460402,0.846066901070266,0.6764705882352942,1.0,1.0,9/83,10.96%,LIFR;CRLF1;FZD4;IL12RB2;IL10RA;IL12RB1;GPR17;IL13RA1;GFRA1
prerank,NAD-retinol dehydrogenase activity (GO:0004745),0.39995126418541405,0.8428994139907502,0.6221033868092691,1.0,1.0,2/14,15.73%,DHRS3;RDH11
prerank,protein phosphorylated amino acid binding (GO:0045309),0.32108944644953197,0.8428809990302228,0.66484268125855,1.0,1.0,10/42,13.42%,BCAR3;SHD;IRS1;FBXW7;PIN1;NEDD4;SAMSN1;VAV1;NCK2;LDLRAP1
prerank,phospholipase activity (GO:0004620),0.3107573218686394,0.8417607474680658,0.7028714107365793,1.0,1.0,5/67,3.63%,PLCE1;PLCB4;LPL;PLCL1;PITPNM3
prerank,protein serine/threonine phosphatase inhibitor activity (GO:0004865),0.42005367374279456,0.8415794197501181,0.6422628951747088,1.0,1.0,3/11,10.38%,PABIR1;PPP1R14C;PPP1R14A
prerank,intracellular cyclic nucleotide activated cation channel activity (GO:0005221),0.41077145188625963,0.84131120191373,0.6240601503759399,1.0,1.0,11/11,58.95%,HCN2;CNGA1;KCNA10;CNGA3;CNGA4;CNGA2;AQP1;HCN1;CNGB3;HCN4;CNGB1
prerank,four-way junction DNA binding (GO:0000400),-0.30503350568269255,-0.8408525123285058,0.6863753213367609,0.8893038059425762,1.0,6/17,28.26%,HMGB1;BLM;MSH6;RAD51C;HMGB2;XRCC2
prerank,cGMP binding (GO:0030553),0.4230357360202563,0.8367708238892199,0.6605166051660517,1.0,1.0,1/11,2.77%,PDE5A
prerank,receptor ligand activity (GO:0048018),0.27676648708869966,0.8366976876659151,0.7909836065573771,1.0,1.0,17/245,7.78%,NTF3;FGF1;PDGFB;SEMA5A;CRLF1;GREM2;THPO;JAG1;IL2;TNFSF13B;CCL5;TGFB3;SEMA6C;VEGFA;GDNF;AREG;TGFB2
prerank,DNA-directed 5'-3' RNA polymerase activity (GO:0003899),0.3554746278771636,0.8348566390937049,0.6413690476190477,1.0,1.0,6/27,14.22%,POLR2L;POLR2I;POLR2G;POLR1H;POLR2J;POLR3K
prerank,fibroblast growth factor binding (GO:0017134),-0.29604655610351926,-0.8336668746798361,0.6905444126074498,0.8979596088912759,1.0,10/21,30.07%,RPS19;ITGAV;FGFR2;FIBP;FGFR4;KL;GPC1;CEP57;FGFRL1;FGFBP3
prerank,SUMO transferase activity (GO:0019789),0.3871080533190814,0.8331172931107315,0.6340640809443507,1.0,1.0,7/16,19.48%,PIAS4;CBX4;PIAS2;MUL1;TRIM28;PIAS1;UBE2I
prerank,G protein-coupled serotonin receptor activity (GO:0004993),0.3551283870525886,0.8330972210473141,0.6477794793261868,1.0,1.0,3/22,11.69%,HTR1B;HRH3;HTR2B
prerank,G protein-coupled amine receptor activity (GO:0008227),0.3551283870525886,0.8330972210473141,0.6477794793261868,1.0,1.0,3/22,11.69%,HTR1B;HRH3;HTR2B
prerank,serotonin receptor activity (GO:0099589),0.3551283870525886,0.8330972210473141,0.6477794793261868,1.0,1.0,3/22,11.69%,HTR1B;HRH3;HTR2B
prerank,vitamin D receptor binding (GO:0042809),-0.32086870498638537,-0.8322493539223037,0.6877828054298643,0.8957544856163104,1.0,9/14,30.55%,MED13;MED17;SNW1;MED24;MED16;MED30;TAF7;RXRA;THRAP3
prerank,general transcription initiation factor binding (GO:0140296),-0.27304363820788985,-0.8317501803186876,0.7162921348314607,0.8919071571891801,1.0,8/25,14.95%,YEATS2;ESR1;AHR;DR1;PSMC5;PSMC2;TAF12;TAF13
prerank,transition metal ion binding (GO:0046914),0.27064373050449586,0.8310032532532775,0.837865055387714,1.0,1.0,33/397,7.48%,AOC3;CRIP1;PAPPA2;TRIM54;MSRB3;CSRP1;DYRK2;POLR2L;LIMS1;TRIM2;ADCY2;LARGE1;LOXL2;RBAK;SIRT3;ITGB1BP2;ALOX5;ATAD3A;PIAS4;ARHGEF2;ETHE1;RNF7;KLF7;LNPEP;RNPEP;TYW5;SUV39H2;TP53;CALB1;PTPN1;ABCE1;ENPEP;RASGRP1
prerank,rRNA binding (GO:0019843),0.3259926655581556,0.8288877981965865,0.6711590296495957,1.0,1.0,6/42,10.68%,CAVIN1;FASTKD5;RCC1L;CIRBP;RPL5;MRPL16
prerank,protein serine/threonine/tyrosine kinase activity (GO:0004712),0.3497126467717284,0.8248017683377358,0.6651090342679128,1.0,1.0,8/28,15.10%,RPS6KA2;MAP2K1;MAP2K3;LRRK2;SGK1;PRKAA2;PRKACA;MAP2K4
prerank,methyltransferase activity (GO:0008168),-0.23648878732098,-0.8231430232610975,0.7875,0.9030470743229754,1.0,23/46,37.88%,COQ5;PRMT3;AS3MT;METTL3;EEF1AKMT1;TRMT11;BUD23;ARMT1;NSUN3;RRP8;SUV39H1;FTSJ3;COQ3;AMT;NDUFAF7;METTL27;GCSH;MRM2;GAMT;BCDIN3D;NTMT1;DNMT3B;PRMT8
prerank,nucleotidase activity (GO:0008252),0.37560821602271416,0.8219688540614807,0.674457429048414,1.0,1.0,5/15,20.04%,ACP3;NT5C2;NT5M;NT5C3A;NT5C
prerank,lipase activity (GO:0016298),-0.24127622303993176,-0.8202946162369414,0.7615062761506276,0.9031389318292835,1.0,14/43,26.60%,DDHD2;LYPLA1;PLA1A;SEC23IP;ABHD5;DDHD1;ABHD12;ABHD3;LIPE;ABHD6;LIPA;DAGLB;PNPLA8;PNPLA2
prerank,ionotropic glutamate receptor binding (GO:0035255),-0.3600652668822426,-0.8202755987011825,0.6959459459459459,0.8983822059796251,1.0,2/10,5.80%,GNAS;SHANK3
prerank,phosphatidylinositol monophosphate phosphatase activity (GO:0052744),0.38158224600511853,0.8198349203880972,0.6837748344370861,1.0,1.0,5/16,17.81%,MTMR7;SACM1L;MTMR14;PTEN;MTMR3
prerank,transforming growth factor beta-activated receptor activity (GO:0005024),0.39755568818269,0.8172632498593964,0.6690391459074733,1.0,1.0,2/12,5.12%,LTBP1;BMPR1A
prerank,cyclin-dependent protein kinase activity (GO:0097472),0.3465321285717531,0.8167415058355026,0.6794478527607362,1.0,1.0,7/21,19.76%,CDK6;CDK7;CDK12;CDK15;CDK14;CDK13;CDKL2
prerank,cyclin-dependent protein serine/threonine kinase activity (GO:0004693),0.3465321285717531,0.8167415058355026,0.6794478527607362,1.0,1.0,7/21,19.76%,CDK6;CDK7;CDK12;CDK15;CDK14;CDK13;CDKL2
prerank,acyl-CoA hydrolase activity (GO:0047617),-0.30428796353792326,-0.8145581968846136,0.6839506172839506,0.9037748654002354,1.0,4/17,12.82%,PPT1;ACOT8;ACOT9;PLA2G6
prerank,ubiquitin-like protein conjugating enzyme binding (GO:0044390),0.32901112765041,0.8128031406025457,0.691114245416079,1.0,1.0,6/33,8.66%,UBA2;DCUN1D2;DCUN1D1;AUP1;RNF180;PPARA
prerank,heme binding (GO:0020037),0.2990288828655464,0.8102473506693788,0.7223618090452262,1.0,1.0,15/65,16.75%,GUCY1B1;PTGIS;HMOX2;TBXAS1;SDHC;PXDN;HEBP2;NR1D1;THAP4;RSAD1;DGCR8;SLC48A1;JAK2;NOS1;PGRMC1
prerank,nuclear export signal receptor activity (GO:0005049),0.3949784378390615,0.8092689465442428,0.660245183887916,1.0,1.0,3/11,16.79%,RANBP17;XPO5;XPO1
prerank,H4 histone acetyltransferase activity (GO:0010485),-0.3539841562819451,-0.8091106068147952,0.7161862527716186,0.9082055841868955,1.0,4/10,13.76%,ATF2;NAA50;EP300;NAA60
prerank,protein kinase C binding (GO:0005080),0.31992438997788436,0.8079558724140451,0.702523240371846,1.0,1.0,6/43,10.34%,PDLIM5;HDAC9;IRS1;PLEK;ADCY6;TOP2B
prerank,ubiquitin-specific protease binding (GO:1990381),-0.28263432768039315,-0.8071622798386723,0.7598944591029023,0.9069979500013312,1.0,5/19,19.56%,DERL1;PRKN;SART3;SYVN1;PARK7
prerank,epidermal growth factor receptor binding (GO:0005154),0.33988394556764606,0.806464847461972,0.6841294298921418,1.0,1.0,6/25,16.74%,HIP1;ATXN2;AREG;HBEGF;SNX1;SNX4
prerank,dynactin binding (GO:0034452),0.3901283449493076,0.8046384604153286,0.6928571428571428,1.0,1.0,2/12,6.20%,BICD2;MAPT
prerank,neuropeptide hormone activity (GO:0005184),-0.27412221918047586,-0.8028329563349307,0.7359550561797753,0.9095685411029032,1.0,15/22,58.63%,PPY;ADCYAP1;PENK;CCK;SPX;GRP;NPFF;PNOC;NMB;AGRP;VIP;CRH;GAL;CALCB;UCN
prerank,"intramolecular oxidoreductase activity, transposing C=C bonds (GO:0016863)",0.3823003994810819,0.8013871661577275,0.7090592334494773,1.0,1.0,4/13,17.43%,IDI1;SREBF2;ECI1;MIF
prerank,nucleosomal DNA binding (GO:0031492),0.3513783477597682,0.7995819395870616,0.6772247360482655,1.0,1.0,7/21,19.24%,H1-0;ACTB;SMARCB1;HNRNPC;CHD4;HDAC1;ACTL6A
prerank,RNA 7-methylguanosine cap binding (GO:0000340),-0.3235298773225683,-0.798765263644137,0.7289719626168224,0.9118950699302331,1.0,2/12,4.71%,CYFIP2;DCPS
prerank,outward rectifier potassium channel activity (GO:0015271),-0.3392040505229603,-0.798218011718264,0.7321428571428571,0.9082270048697992,1.0,3/11,9.54%,KCNK2;PKD2;KCND3
prerank,zinc ion binding (GO:0008270),0.2594162504147192,0.795079516714808,0.8442871587462083,1.0,1.0,23/293,7.48%,CRIP1;PAPPA2;TRIM54;MSRB3;CSRP1;POLR2L;LIMS1;TRIM2;RBAK;SIRT3;ITGB1BP2;ATAD3A;PIAS4;ARHGEF2;KLF7;LNPEP;RNPEP;SUV39H2;TP53;CALB1;PTPN1;ENPEP;RASGRP1
prerank,peptide N-acetyltransferase activity (GO:0034212),0.39126153908898037,0.7946981337637093,0.6824561403508772,1.0,1.0,2/10,8.23%,NAA25;NAA20
prerank,protein kinase regulator activity (GO:0019887),0.28067880566559433,0.7940220496259909,0.7647058823529411,1.0,1.0,21/95,17.38%,FGF13;CCNA2;CCND2;CCNQ;HEXIM1;TPX2;ANKRD54;PRKAR1B;CCND1;CCNT1;PARVA;TAOK3;DNAJC3;CCNJL;ELP3;AGAP2;MT3;CCNF;KIDINS220;MARK2;FAF1
prerank,anion:anion antiporter activity (GO:0015301),-0.2902361359245036,-0.7933802597839342,0.7538071065989848,0.9113349767371606,1.0,4/17,17.12%,SLC26A7;SLC4A2;SLC26A2;SLC25A11
prerank,organic cation transmembrane transporter activity (GO:0015101),0.3643926180181199,0.7932743954976881,0.7101694915254237,1.0,1.0,4/16,11.97%,SLC44A1;SLC7A8;SLC25A26;SLC22A5
prerank,glutamate receptor binding (GO:0035254),0.36283349130668113,0.7925929080021936,0.7026578073089701,1.0,1.0,5/17,15.14%,HIP1;NSF;HOMER1;SHANK2;SHISA6
prerank,retinoic acid binding (GO:0001972),0.378121945410075,0.7922649203914741,0.676950998185118,1.0,1.0,1/12,4.22%,NR2F2
prerank,phosphatidylinositol 3-kinase regulator activity (GO:0035014),0.35768113733221346,0.7896885780359283,0.6913996627318718,1.0,1.0,3/18,5.04%,SOCS5;SOCS6;SOCS4
prerank,myosin II binding (GO:0045159),0.3985016214784731,0.7896064902051287,0.6721611721611722,1.0,1.0,1/10,2.60%,MYL3
prerank,RNA polymerase II transcription regulatory region sequence-specific DNA binding (GO:0000977),0.25594351697949225,0.7869064970678609,0.953,1.0,1.0,122/831,16.23%,SOX6;PRDM16;SOX5;MEF2C;HEY2;ACTN4;ZFHX3;NR1H4;TBX2;EBF1;ZEB2;ALX4;RORA;NR4A1;EBF2;SIM2;PRRX1;TEAD3;GABPA;HEYL;ETS2;IRX5;HINFP;ZNF436;RBAK;FOSL2;NACC2;PRDM1;NR2F2;NR2C1;VEZF1;SP7;OSR2;TBX18;KCNIP3;KLF7;MEF2A;GBX1;KLF16;FOXJ3;RXRG;DBP;KLF15;JUND;CHD2;TAF1;ZNF418;TP53;ZBTB38;GRHL1;SNAI2;HOXC4;AR;ZFP28;ZNF431;HSF4;SOX9;ZFP62;RELA;CUX2;ZKSCAN4;PPARA;BBX;CARF;RUNX1;NR1D1;SKI;NR4A2;LRRFIP1;ZBTB33;HIF1A;ZBTB41;ZNF3;HNRNPU;TEAD1;NR2C2;NKX6-1;ZKSCAN1;SREBF2;RB1;ATF3;HOXC8;ZBTB7A;NFX1;ESRRA;BCL6;ZBTB10;POU3F3;NR6A1;MED8;MXD4;ZNF83;ZFP69;ZBTB5;CASZ1;IKZF1;MEF2B;RFX7;CLOCK;FOXJ1;ZKSCAN7;SP4;MTA1;ZBTB4;STAT1;RFX1;EBF3;KLF6;ZSCAN22;HOXB2;MLXIPL;STAT3;NR5A1;HOXC5;CALCOCO1;RFX3;SARS1;ZBTB9;SP1;MLXIP;IKZF4;ZSCAN18
prerank,bicarbonate transmembrane transporter activity (GO:0015106),0.37121101899249076,0.7863585849623159,0.7,1.0,1.0,2/15,5.66%,SLC4A8;SLC4A3
prerank,nuclease activity (GO:0004518),-0.22525953577744612,-0.785902834604915,0.8506787330316742,0.9182521868206623,1.0,19/52,29.01%,REXO5;MRE11;N4BP2;ERCC5;SAMHD1;DIS3;RNASE4;REXO1;ISG20L2;ENPP1;ZC3H12A;NME1;RNASEL;AEN;EXOG;SND1;OGG1;DNA2;PDE12
prerank,protein kinase inhibitor activity (GO:0004860),0.30704494444333136,0.7857625185066887,0.7325268817204301,1.0,1.0,6/42,13.66%,INKA2;HEXIM1;PARVA;TAOK3;DNAJC3;CEP43
prerank,syntaxin binding (GO:0019905),0.29010354968756497,0.7856620379829216,0.7531486146095718,1.0,1.0,3/61,4.51%,STXBP2;SYPL2;SYT10
prerank,amyloid-beta binding (GO:0001540),0.2768001662142712,0.7816654810738265,0.7559808612440191,1.0,1.0,15/79,17.95%,CD36;APBA1;FZD5;FZD4;ITM2C;TGFB2;CACNA1B;CHRNA7;CLU;LDLRAP1;ATP1A3;HSPG2;PGRMC1;CLSTN1;VBP1
prerank,RNA binding (GO:0003723),0.2534180372384581,0.7801875020838422,0.991,1.0,1.0,324/1321,20.32%,FLNA;SORBS2;MAP3K20;RBPMS;ACTN1;NOL6;RBPMS2;XIRP1;LSM8;ACTN4;RPL3L;CSRP1;CAVIN1;TNS1;SYNE1;KHDRBS3;MYH9;HNRNPR;VIM;HSD17B10;NUDT7;RAVER2;RPUSD3;FASTKD5;RBM38;SAMD4A;DENR;MRPS31;RBMS3;MRPL13;H1-0;NAT10;PRPF38B;PARN;MCRS1;UTP14A;NUDT4;HARS2;DDX23;SRP68;RAD51AP1;WDR33;PCF11;UPF1;CSDE1;ZNF638;CNOT4;MYO18A;SF3B5;TYW5;MTDH;ATXN2;TRMT10C;POLR2G;APEH;U2AF2;FAM32A;MYBBP1A;CHD2;TERT;MAPT;EIF1;WDR46;PARP1;HEXIM1;RCC1L;PTPN1;KTN1;ZCCHC7;RPS27L;CIRBP;YTHDF2;RPF1;RPL8;SFPQ;FKBP3;RCAN3;WDR36;PA2G4;CELF1;PPARGC1A;CLNS1A;RTCB;PPARGC1B;DICER1;REXO4;GOT2;RPS19BP1;DUSP14;FASTKD1;SRSF4;MRPL43;NAF1;PYM1;SRRM3;MRM1;API5;EIF4A1;MBNL2;PSTK;GPKOW;PWP2;FUS;MRPS35;MRPS28;LONP1;PKN2;PPIE;TDRD3;SEPSECS;ZC3H11A;MRPL45;LRRFIP1;RBM19;SECISBP2L;SRP72;HADHB;SAMSN1;RPL5;KIF1C;MRPL21;DDX59;MRPL23;DHX8;FNDC3B;U2AF1;PTBP2;RBM8A;EIF3E;MBNL1;HNRNPU;EIF2AK2;PPP1R10;MRPL16;RPS23;ROCK2;EIF5A;CCT3;TFB2M;DDX1;GSPT1;OTUD4;SRSF10;ALDOA;RBM3;DCP1A;DDX25;MAK16;BAZ2A;SF3A3;EIF3H;NFX1;NOP58;RBM6;HNRNPC;PSPC1;KPNA2;MRPL9;AIMP1;YTHDC2;DRG2;SRRM1;ZFP36L1;ALG13;TSFM;XPO5;COL14A1;OASL;DROSHA;SF3B2;SF3B1;RBM27;DCP1B;ZC3H4;CPEB3;ZCRB1;NUFIP2;SYNCRIP;PCBP3;CPNE3;NSUN2;MRPL42;DXO;SON;RBM25;DGCR8;DHX30;TRIM28;CCDC9B;MTCL1;RPUSD4;MAP4;GIGYF2;SRP19;CSNK1E;SARS2;NUP98;EPRS1;RPL15;G3BP1;TMSB4X;GDI2;BZW1;IMP4;DDX55;RFTN1;DDX56;EDF1;CWC22;EIF4E;UBA1;STAU2;EIF4G2;KARS1;GLRX3;SRPK2;TEP1;FASTKD2;NOL4;DDX18;PELP1;RBM15;STAT3;IREB2;SF1;RPL22;NANOS1;LAS1L;NELFCD;PUF60;SF3A1;SARS1;FARS2;DHX32;SEC61B;FIP1L1;PRRC2C;LSM10;ETF1;WBP4;RPL31;ANXA11;IMMT;WDR6;RBM45;MRPL14;DHX9;ACIN1;MARK2;DDX49;USP36;RPS6;MRPL4;TRUB2;BOP1;FKBP4;LUC7L;EIF2AK4;DHX29;PDCD11;NAP1L4;RPS17;NDUFV3;FAM98B;AKAP1;RBM33;MRPS21;CEBPZ;EEF2;MDH2;FAM120C;HDLBP;RBM14;TEFM;HNRNPUL2;LGALS1;MRPL40;MRPL22;SNRPD3;ILF3;EXOSC10;CLTC;HABP4;RPS27A;FRG1;TRMT6;CMSS1;N4BP1;RTCA;NIFK;PPRC1;KIN;SLC4A1AP;SNIP1;PKM;SUMO1;NTPCR;UBE2I;CDK13;RPS14;ZRANB2;UCHL5;RPGR;ADARB1;AGO1;PRKRA;AARS2;TIAL1;SRP14;ERI1;PRMT1;MRPS14;PNN;QKI;DDX10;SPATS2L;ALDH18A1;CS;JUN;DHX37;NSUN5;NSRP1;YY1;SERBP1
prerank,DNA binding (GO:0003677),0.2529335384411483,0.7789066060849081,0.9629258517034068,1.0,1.0,98/694,13.83%,SOX6;PRDM16;HEY2;NR1H4;TBX2;ZEB2;ALX4;RORA;TRNP1;MLF1;NR4A1;SIM2;ARID5B;ETS2;CGAS;HINFP;BRIP1;H1-0;SIRT3;NR2F2;CHRAC1;RAD51AP2;GTF2H4;ARID1A;BCL2;NR2C1;GTF3C4;RAD51AP1;CBFB;SP7;OSR2;ZNF638;MEF2A;FOXJ3;POLR2G;MYBBP1A;MBD5;CHD2;SMARCB1;ARID5A;TERT;TAF1;MAPT;TP53;TIPIN;GRHL1;SNAI2;HDGFL3;SFPQ;TDP1;MBD4;PPARGC1A;CHTF18;REXO4;SOX9;ERCC6;RELA;KMT2D;CUX2;PPARA;CARF;CCNT1;MSL3;LONP1;NR4A2;LRRFIP1;ZBTB33;HIF1A;CRLF3;ZDHHC1;DEDD2;SYCP2;ZNF3;HNRNPU;TEAD1;NR2C2;MCMDC2;POLD1;ZBTB7A;POLG;RBM6;ESRRA;LIN9;TSG101;CSRNP3;BCL6;POU3F3;HDGFL2;OASL;NR6A1;DEDD;SMARCA5;CHD4;IKZF1;CLOCK;FOXJ1;TRIM28;DNASE1L1
prerank,ribosomal small subunit binding (GO:0043024),-0.2840769105107638,-0.7748701524943346,0.7864077669902912,0.9309485974643985,1.0,2/17,2.62%,CPEB2;DDX3X
prerank,lysine N-methyltransferase activity (GO:0016278),0.3439582855757721,0.7727873061154874,0.7133655394524959,1.0,1.0,5/20,15.26%,SETD6;SETD3;ATPSCKMT;VCPKMT;EEF1AKMT2
prerank,ubiquitin-like protein conjugating enzyme activity (GO:0061650),0.3145681745218978,0.7707054149508757,0.7610619469026548,1.0,1.0,12/34,19.48%,TAF1;UBE2W;UBE2F;UBE2E1;UBE2D1;AKTIP;UBE2J1;UBE2K;UBE2L6;UBE2A;UBE2Q1;UBE2I
prerank,NAD+ binding (GO:0070403),0.3713481381117144,0.7699964943496469,0.724709784411277,1.0,1.0,4/12,16.62%,SIRT3;SIRT2;HADH;SIRT6
prerank,endodeoxyribonuclease activity (GO:0004520),-0.269011485927523,-0.7692876023912564,0.7896103896103897,0.9344852641043936,1.0,8/20,32.22%,MRE11;RAD50;ERCC5;ERCC1;ERCC4;EXOG;DNA2;ENDOV
prerank,"endoribonuclease activity, producing 5'-phosphomonoesters (GO:0016891)",-0.24698678979206562,-0.7679209672534896,0.8322981366459627,0.9319180355510592,1.0,11/28,35.18%,AGO3;POP1;EDC3;DBR1;ELAC2;POP4;ENDOV;RPP38;NUDT16;MRPL44;RPP21
prerank,acetyltransferase activity (GO:0016407),0.3222875606976168,0.7675044723818492,0.7727910238429172,1.0,1.0,5/31,10.54%,NAT10;SAT2;NAT8L;NAT8;NAT14
prerank,chloride transmembrane transporter activity (GO:0015108),0.3561530994586899,0.7661951612716827,0.7257240204429302,1.0,1.0,2/16,6.00%,SLC4A8;CLCN6
prerank,"endodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016888)",0.36160364991329386,0.7640798090876553,0.7173524150268337,1.0,1.0,3/13,13.83%,DICER1;SLX4;DNASE1L1
prerank,ubiquitin-like protein ligase activity (GO:0061659),0.25314777093384827,0.7637260819132234,0.8869294605809128,1.0,1.0,30/232,11.15%,TRIM54;RNF152;TRIM55;TRIM63;TRIM2;FBXL22;RNF150;PDZRN3;RNF114;UBR5;ASB2;ASB1;PIAS4;RNF7;CBLL1;NEDD4;NEURL4;RNF180;TRIM68;CBX4;NEURL1B;UHRF2;TRIM7;AMFR;NHLRC1;FBXO6;PELI2;UBE2D1;TRIM35;PIAS2
prerank,RNA stem-loop binding (GO:0035613),-0.3081645089616287,-0.7632797471320504,0.7751196172248804,0.9342725771937239,1.0,5/12,20.88%,DDX3X;RC3H2;ZC3H12A;FMR1;METTL16
prerank,N-acyltransferase activity (GO:0016410),0.3104083386937387,0.7623059414238349,0.7507246376811594,1.0,1.0,6/32,10.54%,NAT10;SAT2;NAT8L;NAT8;CERS1;NAT14
prerank,insulin-like growth factor binding (GO:0005520),0.3528468057542558,0.7619618740714156,0.7417763157894737,1.0,1.0,4/15,7.40%,IGFBP5;IGFBP4;IGF2R;ITGB3
prerank,endopeptidase activity (GO:0004175),0.25154724126944905,0.7598670242667475,0.8984615384615384,1.0,1.0,32/257,15.44%,TMPRSS4;MMP17;ADAMTS14;ADAMTS5;KLK2;ADAMTS19;USP2;APEH;AFG3L2;TRABD2B;ADAM17;USP1;MASP2;MIPEP;PSMB1;MBTPS1;PHEX;THSD4;ADAMTS20;ADAMTS16;USP13;PSMB2;DDI2;PMPCB;ADAM19;USP35;USP20;USP30;USP42;PSMB7;PCSK4;ADAMTSL4
prerank,transcription corepressor binding (GO:0001222),0.31783949771749975,0.7569385983984254,0.7402597402597403,1.0,1.0,3/27,11.64%,RORA;NR1D1;ZBTB7A
prerank,RNA polymerase II complex binding (GO:0000993),0.314743414557286,0.7568266657384071,0.7624466571834992,1.0,1.0,11/32,21.94%,SCAF1;PCF11;HNRNPU;URI1;ELOF1;DHX9;BRD4;AGO1;WDR43;RPRD1A;CCAR2
prerank,protein kinase activator activity (GO:0030295),0.28203697117145876,0.7563785925862009,0.7821158690176322,1.0,1.0,7/60,9.18%,FGF13;FAM20A;TPX2;CALM1;ERCC6;MAP2K1;PAK2
prerank,vascular endothelial growth factor receptor binding (GO:0005172),0.3588719992673089,0.7550522988593299,0.7440273037542662,1.0,1.0,3/12,7.40%,DAB2IP;VEGFA;ITGB3
prerank,RNA polymerase binding (GO:0070063),0.33693566149533616,0.7540714388227021,0.7375,1.0,1.0,5/18,12.09%,NEDD4;STOM;CCNT1;PKN2;YTHDC2
prerank,cis-regulatory region sequence-specific DNA binding (GO:0000987),0.24485817163876092,0.753700746178845,0.970970970970971,1.0,1.0,60/732,9.58%,SOX6;PRDM16;SOX5;MEF2C;HEY2;ZFHX3;NR1H4;TBX2;EBF1;ZEB2;RORA;NR4A1;EBF2;PRRX1;TEAD3;GABPA;HEYL;ETS2;IRX5;HINFP;FOSL2;NACC2;PRDM1;NR2F2;NR2C1;SP7;TBX18;KCNIP3;KLF7;MEF2A;KLF16;FOXJ3;RXRG;DBP;KLF15;JUND;CHD2;ZNF418;TP53;ZBTB38;GRHL1;SNAI2;HOXC4;AR;ZFP28;ZNF431;HSF4;SOX9;ZFP62;RELA;ZKSCAN4;PPARA;CARF;RUNX1;NR1D1;SKI;NR4A2;LRRFIP1;ZBTB33;HIF1A
prerank,transcription coactivator binding (GO:0001223),0.3267260174911775,0.751916401904016,0.7313195548489666,1.0,1.0,4/20,7.91%,RORA;TERT;AR;RELA
prerank,ribonuclease P RNA binding (GO:0033204),-0.3249334930054813,-0.7510624003861318,0.7853982300884956,0.946913460814413,1.0,5/10,43.31%,POP1;POP4;RPP38;RPP21;POP7
prerank,GTPase regulator activity (GO:0030695),0.24923294190958795,0.7488515853878014,0.8607329842931937,1.0,1.0,48/212,16.67%,RALGAPA2;DLC1;TBC1D1;RGS6;ABR;MYO9B;ELMOD1;TBC1D20;ARHGAP10;ELMOD2;CHN1;MTSS2;LARS1;RABGAP1;ARHGAP17;PLCB1;RALGAPA1;RIN2;EVI5;ARHGAP39;ARHGAP30;RALGAPB;ARHGAP1;NPRL2;ASAP2;DOCK1;ARHGAP15;DNM1L;SH3BP4;TBCD;RHOH;ARHGAP35;HTR2B;ARHGAP32;BCR;ARHGAP24;LRRK2;GNAQ;RGS5;RUNDC1;IPO7;VAV3;RGS10;TBC1D22B;ARHGAP26;AGAP2;RASGRP3;TBC1D12
prerank,chemokine binding (GO:0019956),0.30737372486656295,0.7480782379083507,0.760932944606414,1.0,1.0,4/30,8.48%,ITGB1;CXCR6;ITGB3;ITGA4
prerank,RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978),0.24309637604607037,0.7475020358714731,0.9719719719719719,1.0,1.0,60/731,9.58%,SOX6;PRDM16;SOX5;MEF2C;HEY2;ZFHX3;NR1H4;TBX2;EBF1;ZEB2;RORA;NR4A1;EBF2;PRRX1;TEAD3;GABPA;HEYL;ETS2;IRX5;HINFP;FOSL2;NACC2;PRDM1;NR2F2;NR2C1;SP7;TBX18;KCNIP3;KLF7;MEF2A;KLF16;FOXJ3;RXRG;DBP;KLF15;JUND;CHD2;ZNF418;TP53;ZBTB38;GRHL1;SNAI2;HOXC4;AR;ZFP28;ZNF431;HSF4;SOX9;ZFP62;RELA;ZKSCAN4;PPARA;CARF;RUNX1;NR1D1;SKI;NR4A2;LRRFIP1;ZBTB33;HIF1A
prerank,chemokine receptor activity (GO:0004950),0.3161246873140652,0.7458693548976895,0.771513353115727,1.0,1.0,2/24,7.75%,CXCR6;GPR17
prerank,Hsp90 protein binding (GO:0051879),-0.232759099442135,-0.7444704802087654,0.8805460750853242,0.9514630803733863,1.0,12/33,26.02%,SLC12A2;USP19;NR3C1;AHR;STUB1;ERN1;KDR;NPAS2;HSF1;TELO2;AHSA1;CSNK2A1
prerank,FAD binding (GO:0071949),0.3208562124449867,0.7426805107556733,0.7941176470588235,1.0,1.0,4/24,14.36%,MICAL2;KMO;MICAL3;CYB5R3
prerank,potassium:proton antiporter activity (GO:0015386),-0.31095647174794305,-0.7408880219105656,0.7913043478260869,0.9518604420904523,1.0,4/10,25.33%,SLC9A2;SLC9A6;SLC9A9;SLC9A5
prerank,"oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor (GO:0016628)",-0.2715681125615004,-0.7397859263075264,0.8190954773869347,0.9486584316070792,1.0,6/17,20.96%,LBR;BLVRB;BDH2;DPYD;DECR2;PECR
prerank,ubiquitin-ubiquitin ligase activity (GO:0034450),0.3702090101392197,0.7396656220146479,0.7370304114490162,1.0,1.0,5/11,18.22%,UBR5;UBE4A;AMFR;UBE2K;ANAPC11
prerank,pre-mRNA binding (GO:0036002),0.31310275304203833,0.7392673136311578,0.7805970149253731,1.0,1.0,5/28,10.43%,RBM24;U2AF2;CELF1;U2AF1;HNRNPU
prerank,single-stranded RNA binding (GO:0003727),-0.21929935350557744,-0.7386176395860574,0.8937007874015748,0.9455274867229996,1.0,6/43,11.40%,AGO3;DDX3X;AQR;STRBP;JMJD6;DDX60
prerank,Lys63-specific deubiquitinase activity (GO:0061578),-0.31699119445936813,-0.7374564216208387,0.8034557235421166,0.9423521956618843,1.0,5/10,37.17%,ATXN3;CYLD;YOD1;TNFAIP3;STAMBP
prerank,ubiquitin protein ligase activity (GO:0061630),0.2436130917318252,0.73686353987879,0.8996897621509824,1.0,1.0,28/228,11.13%,TRIM54;RNF152;TRIM55;TRIM63;TRIM2;FBXL22;RNF150;PDZRN3;RNF114;UBR5;ASB2;ASB1;RNF7;CBLL1;NEDD4;NEURL4;RNF180;TRIM68;UBE4A;NEURL1B;UHRF2;TRIM7;AMFR;NHLRC1;FBXO6;PELI2;UBE2D1;TRIM35
prerank,signal sequence binding (GO:0005048),0.30091230333547864,0.7355145181450511,0.793006993006993,1.0,1.0,8/35,14.50%,CABP1;KPNA4;PEX5L;NUP153;RANBP6;KPNA2;KPNA3;IPO4
prerank,histone deacetylase activity (GO:0004407),0.3275942154953942,0.7345649247910613,0.7771084337349398,1.0,1.0,6/19,19.01%,SIRT3;HDAC9;SIRT2;SIRT6;HDAC1;HDAC6
prerank,protein-cysteine S-palmitoyltransferase activity (GO:0019706),0.3220173464234366,0.7340022752876457,0.7614678899082569,1.0,1.0,8/24,18.42%,GOLGA7B;ZDHHC2;ZDHHC1;ZDHHC14;ZDHHC17;ZDHHC4;ZDHHC8;ZDHHC3
prerank,nucleoside monophosphate kinase activity (GO:0050145),-0.2603043472398312,-0.7327459767150221,0.8575498575498576,0.943468709702303,1.0,5/20,16.80%,TJP2;DLG1;MAGI3;CASK;DTYMK
prerank,translation initiation factor activity (GO:0003743),0.29123011762516027,0.732404029593314,0.7697456492637216,1.0,1.0,9/36,15.32%,EIF1;EIF3M;EIF2D;EIF4A1;EIF3E;EIF3H;EIF4E;EIF4G2;EIF4E3
prerank,clathrin adaptor activity (GO:0035615),-0.27809072570708493,-0.7307709670320909,0.8329355608591885,0.9414616020459988,1.0,4/15,13.24%,DAB2;AP1M1;AP2S1;STON2
prerank,DNA polymerase binding (GO:0070182),-0.26933512501743795,-0.7307078458291052,0.8552278820375335,0.9370421785852685,1.0,5/18,18.36%,HMGB1;HSP90AB1;FANCI;CDK2AP1;SMG6
prerank,RNA cap binding (GO:0000339),-0.2740978934029926,-0.730269243534169,0.7953367875647669,0.9332208338680087,1.0,5/16,20.42%,CYFIP2;DCPS;LSM1;NCBP2;EIF3D
prerank,manganese ion binding (GO:0030145),0.2794544058761472,0.7284617818629652,0.8082010582010583,1.0,1.0,3/48,2.30%,DYRK2;ADCY2;LARGE1
prerank,transcription coregulator binding (GO:0001221),0.27726026371218704,0.7275892402008434,0.8057742782152231,1.0,1.0,7/50,11.64%,RORA;CHD6;TERT;AR;RELA;NR1D1;ZBTB7A
prerank,peptidase activator activity (GO:0016504),0.31630648693309826,0.7275513502581313,0.7789634146341463,1.0,1.0,4/22,10.75%,ADRM1;CAV1;PSME4;CASP8AP2
prerank,phosphatidylinositol-3-phosphatase activity (GO:0004438),0.34537257846453284,0.726961226853346,0.7721088435374149,1.0,1.0,4/14,17.81%,MTMR7;MTMR14;PTEN;MTMR3
prerank,kinase inhibitor activity (GO:0019210),-0.22616561540923022,-0.7236365652386101,0.8989547038327527,0.9367241446576043,1.0,16/33,33.94%,MBIP;NCK1;SNCA;SH3BP5L;TRIB1;QARS1;CDKN1A;MAPK8IP1;SMCR8;CDKN1C;SPRY4;DUSP19;SH3BP5;GMFB;SOCS3;WARS1
prerank,phosphatase inhibitor activity (GO:0019212),0.3256629357156767,0.723434901057784,0.774294670846395,1.0,1.0,7/20,15.59%,SET;SAG;TESC;ENSA;CABIN1;ARPP19;URI1
prerank,histone methyltransferase activity (H3-K36 specific) (GO:0046975),0.35297941730194715,0.721942770134865,0.7641843971631206,1.0,1.0,3/10,8.86%,ASH1L;SETD3;NSD3
prerank,non-membrane spanning protein tyrosine kinase activity (GO:0004715),0.28739678216442255,0.7210357438305165,0.8044077134986226,1.0,1.0,4/35,9.32%,FRK;PEAK1;DYRK1A;SLA
prerank,mRNA binding (GO:0003729),0.23983078400144597,0.7206820890035328,0.9114954221770092,1.0,1.0,45/249,15.71%,RBPMS;RBPMS2;RBM24;KHDRBS3;HNRNPR;CRYZ;SAMD4A;DENR;RBMS3;MRPL13;PARN;PCF11;CPEB1;TP53;CIRBP;YTHDF2;CELF1;SRSF4;SRRM3;EIF4A1;PPIE;ZC3H11A;SECISBP2L;RPL5;PTBP2;RBM8A;HNRNPU;DCP1A;HNRNPC;ZFP36L1;XPO5;SF3B1;DCP1B;CPEB3;SYNCRIP;PCBP3;DXO;RBM25;NUP98;G3BP1;EIF4G2;RBM15;IREB2;SF1;NANOS1
prerank,"phosphotransferase activity, phosphate group as acceptor (GO:0016776)",-0.23790252842373702,-0.7198715638158625,0.8611111111111112,0.9368887642299043,1.0,13/24,37.07%,IP6K1;IP6K2;PPIP5K2;DTYMK;ITPKB;NME1;PMVK;AK4;AK1;PPIP5K1;NME2;AK5;AK3
prerank,DNA polymerase activity (GO:0034061),0.3144125815931964,0.7197055920386427,0.7993779160186625,1.0,1.0,4/22,11.72%,CHRAC1;TERT;POLD1;POLG
prerank,sequence-specific double-stranded DNA binding (GO:1990837),0.23297942497273633,0.7170430481995669,0.9769539078156313,1.0,1.0,47/597,9.47%,SOX6;PRDM16;SOX5;MEF2C;HEY2;TBX2;ALX4;NR4A1;GABPA;ARID5B;ETS2;IRX5;HINFP;PRDM1;NR2C1;MTERF3;OSR2;TBX18;KLF16;FOXJ3;RXRG;DBP;KLF15;SUV39H2;JUND;MLH3;ARID5A;TP53;GRHL1;SNAI2;HOXC4;SFPQ;YAP1;AR;MBD4;HSF4;SOX9;RELA;KMT2D;CUX2;MBNL2;BBX;RUNX1;NR1D1;NR4A2;KAT7;ZBTB33
prerank,peptide alpha-N-acetyltransferase activity (GO:0004596),0.3474675523672345,0.715532035059002,0.7588028169014085,1.0,1.0,2/11,8.23%,NAA25;NAA20
prerank,phosphatidate phosphatase activity (GO:0008195),-0.2829169703672521,-0.706828891170766,0.8560794044665012,0.9472932959478335,1.0,8/13,44.94%,LPIN2;PLPP5;LPIN3;LPIN1;PLPPR3;PLPP2;PLPP1;PLPPR4
prerank,ribonuclease P activity (GO:0004526),-0.2942449963549764,-0.7030494183576532,0.8539823008849557,0.9469427818603702,1.0,4/11,35.18%,POP1;POP4;RPP38;RPP21
prerank,voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization (GO:1902282),0.34350366942823873,0.7016732778143824,0.763302752293578,1.0,1.0,1/11,4.18%,KCNE4
prerank,GABA receptor binding (GO:0050811),0.3368206180378291,0.701084254621215,0.7693661971830986,1.0,1.0,2/11,8.47%,GABARAP;TRAK1
prerank,O-acyltransferase activity (GO:0008374),0.29243638616298445,0.6982072836570473,0.8366477272727273,1.0,1.0,9/30,20.89%,LPCAT3;DGAT1;PLA2G4A;PLA2G4C;PRDX6;MBOAT7;GPAT3;LPCAT1;PLA2G15
prerank,3'-5' exonuclease activity (GO:0008408),0.26862333100488234,0.6966599569851667,0.8319783197831978,1.0,1.0,14/45,19.80%,PARN;ERI2;RAD9A;REXO4;DIS3L2;DIS3L;POLD1;POLG;CNOT7;EXD2;REV3L;REXO2;EXOSC10;ERI1
prerank,enoyl-CoA hydratase activity (GO:0004300),0.33676397703852345,0.6948390827138382,0.8057040998217468,1.0,1.0,4/10,16.01%,HSD17B4;HADHB;ECI1;HADHA
prerank,acetylcholine-gated cation-selective channel activity (GO:0022848),0.3388065619284816,0.6932228809523416,0.7893772893772893,1.0,1.0,2/11,15.53%,CHRNA7;CHRNA4
prerank,tRNA methyltransferase activity (GO:0008175),0.3122864496470191,0.6924723104833168,0.7983050847457627,1.0,1.0,2/16,5.49%,TRDMT1;FTSJ1
prerank,RNA methyltransferase activity (GO:0008173),0.3081119410418171,0.6910008504766076,0.8283333333333334,1.0,1.0,3/19,12.06%,TRDMT1;FTSJ1;TGS1
prerank,phosphatase activity (GO:0016791),0.2514954353716968,0.6909490325954883,0.8789346246973365,1.0,1.0,12/73,13.61%,DUSP5;ACP3;PRUNE1;LHPP;SACM1L;DUSP3;PLPPR1;PPP1CB;PPP1CA;SBF1;DUSP16;NT5M
prerank,phospholipase inhibitor activity (GO:0004859),0.33842420661760103,0.6902476288197902,0.7661596958174905,1.0,1.0,2/10,10.87%,ANXA1;ANXA9
prerank,mRNA 3'-UTR binding (GO:0003730),0.2524415404304515,0.6886639425263894,0.8763250883392226,1.0,1.0,14/79,12.85%,RBM24;CRYZ;RBMS3;PARN;CPEB1;TP53;CIRBP;CELF1;SECISBP2L;RPL5;HNRNPU;HNRNPC;ZFP36L1;CPEB3
prerank,endopeptidase activator activity (GO:0061133),0.34247488698155926,0.686452956675204,0.8032200357781754,1.0,1.0,1/10,3.01%,ADRM1
prerank,cysteine-type endopeptidase inhibitor activity involved in apoptotic process (GO:0043027),-0.24753008493941314,-0.6814761308270156,0.9,0.9643437621304735,1.0,4/18,15.61%,RPS6KA3;BIRC2;SNCA;BIRC3
prerank,methylation-dependent protein binding (GO:0140034),-0.18766210277642778,-0.6803673157905448,0.9666666666666667,0.9609434500626549,1.0,13/57,21.78%,KDM7A;KMT2E;CBX5;ZMYND8;TRIM24;MORC4;CHD1;NCAPG2;MPHOSPH8;RRP8;FMR1;MSH6;PHF13
prerank,endopeptidase regulator activity (GO:0061135),0.2684905200184718,0.6798531026590223,0.8609179415855355,1.0,1.0,2/40,3.01%,ITIH4;ADRM1
prerank,cAMP binding (GO:0030552),0.33491501837863635,0.6764595377236683,0.8133802816901409,1.0,1.0,2/11,11.32%,PDE4A;PDE4D
prerank,ubiquitin conjugating enzyme activity (GO:0061631),0.2770324819305493,0.6761470095761137,0.8433734939759037,1.0,1.0,10/31,19.27%,TAF1;UBE2W;UBE2E1;UBE2D1;AKTIP;UBE2J1;UBE2K;UBE2L6;UBE2A;UBE2Q1
prerank,sequence-specific DNA binding (GO:0043565),0.22038587969692092,0.674957667195909,0.9939879759519038,1.0,1.0,63/590,12.60%,PRDM16;MEF2C;HEY2;NR1H4;TBX2;ZEB2;ALX4;RORA;NR4A1;GABPA;ETS2;IRX5;PRDM1;SIRT3;NR2F2;BCL2;NR2C1;CBFB;UPF1;OSR2;ZCWPW1;TBX18;MEF2A;KLF16;FOXJ3;RXRG;DBP;KLF15;JUND;MYBBP1A;ARID5A;TERT;TAF1;MAPT;ZBTB38;GRHL1;SNAI2;HOXC4;PPARGC1A;HSF4;SOX9;CUX2;MBNL2;PPARA;BBX;NR1D1;LONP1;NR4A2;ZBTB33;HIF1A;HNRNPU;TEAD1;NR2C2;SREBF2;ATF3;TERF2;HOXC8;ZBTB7A;ESRRA;CSRNP3;BCL6;POU3F3;NR6A1
prerank,N-methyltransferase activity (GO:0008170),0.296796108654202,0.6745363309868948,0.8409785932721713,1.0,1.0,5/20,14.57%,SETD3;TFB2M;ZCCHC4;N6AMT1;NNMT
prerank,cAMP-dependent protein kinase regulator activity (GO:0008603),0.32871693469337754,0.6695532363024084,0.828996282527881,1.0,1.0,3/10,8.60%,PKIB;PKIA;PRKAR1B
prerank,"catalytic activity, acting on a tRNA (GO:0140101)",0.2676540669688535,0.6653544731023397,0.8760563380281691,1.0,1.0,4/35,7.94%,TRDMT1;FTSJ1;GATB;FTO
prerank,dipeptidyl-peptidase activity (GO:0008239),0.32134022193242884,0.6625474561649918,0.8243478260869566,1.0,1.0,2/10,12.82%,DPP10;DPP8
prerank,protein phosphatase activator activity (GO:0072542),0.32230074204563935,0.662000571678852,0.8180300500834724,1.0,1.0,2/13,7.15%,PPP2R5A;CALM1
prerank,peptidase activator activity involved in apoptotic process (GO:0016505),-0.25678842794256007,-0.6588561486282853,0.9175,0.976302523430388,1.0,4/14,16.65%,NOD1;CTSH;MAL;APAF1
prerank,cytochrome-c oxidase activity (GO:0004129),0.29508278927785886,0.6587978587901183,0.8344947735191638,1.0,1.0,2/15,7.52%,COX7A2L;COX8A
prerank,basic amino acid transmembrane transporter activity (GO:0015174),-0.2633929989890375,-0.658754625108102,0.8985849056603774,0.9719197310173522,1.0,5/13,19.63%,SLC66A1;SLC38A5;SLC38A7;SLC15A4;SLC7A7
prerank,cysteine-type endopeptidase inhibitor activity (GO:0004869),-0.21012877908387492,-0.6568300077674566,0.9235880398671097,0.9691302955273563,1.0,5/30,15.61%,BIRC6;RPS6KA3;BIRC2;SNCA;BIRC3
prerank,disordered domain specific binding (GO:0097718),0.28235435908720685,0.6555908746566859,0.8571428571428571,1.0,1.0,5/23,11.46%,TP53;CALM1;BCL2L2;PPIL1;RB1
prerank,"hydrolase activity, hydrolyzing N-glycosyl compounds (GO:0016799)",-0.24794009881347948,-0.6548043191323762,0.900497512437811,0.9663241810415741,1.0,11/16,47.26%,CD38;SMUG1;ADPRS;TDG;NEIL1;NEIL3;NTHL1;ADPRH;NEIL2;BST1;MACROD2
prerank,ribosome binding (GO:0043022),0.2561566887237971,0.6521138489157047,0.8853904282115869,1.0,1.0,15/46,21.28%,SRP68;CPEB1;PYM1;SRP72;CPEB3;SRP19;SEC61B;ETF1;EEF2;ERI1;SERBP1;EIF2S1;EIF2A;C1QBP;OXA1L
prerank,"acyltransferase activity, transferring groups other than amino-acyl groups (GO:0016747)",0.24077648997062426,0.6515209434327369,0.9199029126213593,1.0,1.0,22/69,21.66%,ZDHHC2;LPCAT3;CERS1;HHAT;ZDHHC1;SCP2;ZDHHC14;ZDHHC17;DGAT1;PLA2G4A;PLA2G4C;ELP3;ZDHHC13;ZDHHC8;ZDHHC5;ZDHHC3;ESCO1;MBOAT7;KAT8;PLA2G15;KAT6A;NMT1
prerank,channel activity (GO:0015267),0.25043778747557893,0.6507137592785761,0.9004149377593361,1.0,1.0,5/41,12.41%,BCL2;TRPV2;PANX1;KCNK3;CHRNA7
prerank,steroid hydroxylase activity (GO:0008395),0.30189511966613125,0.6500500811871714,0.866779089376054,1.0,1.0,1/16,2.91%,CYP7B1
prerank,ubiquitin protein ligase binding (GO:0031625),0.2152013249618933,0.6479993985952307,0.9813664596273292,1.0,1.0,46/254,15.22%,VCL;FZD5;FZD4;ACTG1;BCL2;MFHAS1;USP2;PIAS4;CUL2;FZD8;GABARAP;FBXW7;TP53;UBE2W;PA2G4;PPARGC1A;TRAF3;DIO2;AUP1;RELA;PRKACB;WASHC1;SKI;HIF1A;RPL5;TRAF5;UBE2D1;DNM1L;MFN2;ANKRA2;CCDC50;RB1;ACVR1B;NDUFS2;USP13;TSG101;SNX9;CLU;UBE2J1;MUL1;TRIM28;HM13;CKB;PRKACA;UBE2K;UBE2L6
prerank,GDP-dissociation inhibitor activity (GO:0005092),0.30600464592791715,0.643926602552177,0.8178571428571428,1.0,1.0,4/13,18.99%,ARHGDIG;SH3BP4;GDI2;RANBP1
prerank,lipid phosphatase activity (GO:0042577),0.30448281352204914,0.64355434579808,0.8538961038961039,1.0,1.0,2/14,9.97%,PLPPR1;PLPP7
prerank,G protein-coupled chemoattractant receptor activity (GO:0001637),-0.24342409593684083,-0.6425214791327721,0.9195979899497487,0.97136150020791,1.0,1/15,4.70%,CCR9
prerank,cysteine-type endopeptidase activator activity involved in apoptotic process (GO:0008656),0.31229518152332447,0.6421893772278313,0.8522920203735145,1.0,1.0,3/12,10.75%,RPS27L;ATP2A3;CASP8AP2
prerank,phosphatase activator activity (GO:0019211),0.309778163862503,0.6359445438316994,0.8731218697829716,1.0,1.0,2/14,7.15%,PPP2R5A;CALM1
prerank,signaling receptor complex adaptor activity (GO:0030159),0.25457366675074494,0.6316310886264727,0.8945908460471568,1.0,1.0,10/38,15.85%,NUP62;IRS1;SORBS1;SAV1;DEDD2;SHANK2;NCK2;LDLRAP1;LRRK2;SPAG9
prerank,"ATPase activity, coupled to transmembrane movement of ions, rotational mechanism (GO:0044769)",0.2858232526102924,0.6277672955408831,0.8580441640378549,1.0,1.0,3/16,13.29%,ATP6V0A2;ATP6V1C1;ATP6V0D2
prerank,"proton-transporting ATPase activity, rotational mechanism (GO:0046961)",0.2858232526102924,0.6277672955408831,0.8580441640378549,1.0,1.0,3/16,13.29%,ATP6V0A2;ATP6V1C1;ATP6V0D2
prerank,flavin adenine dinucleotide binding (GO:0050660),0.23787552079339086,0.6251455669055576,0.9308578745198464,1.0,1.0,11/53,15.71%,MICAL2;LDHD;DLD;KMO;ETFA;FOXRED2;GFER;SDHA;MICAL3;CYB5R3;NOS1
prerank,MHC class II protein complex binding (GO:0023026),0.3024364823228296,0.6242254347612206,0.8498233215547704,1.0,1.0,3/11,19.46%,ATP1B1;ANXA11;PKM
prerank,phosphotyrosine residue binding (GO:0001784),0.24158487902691966,0.6242044835668654,0.9084604715672677,1.0,1.0,11/37,19.65%,BCAR3;SHD;IRS1;SAMSN1;VAV1;NCK2;LDLRAP1;YES1;ABL1;PIK3R2;SHC1
prerank,kinesin binding (GO:0019894),0.26034833729809564,0.619487083160803,0.9084302325581395,1.0,1.0,6/27,17.14%,FAM83D;ACTB;ATCAY;KIFAP3;SPAG9;CLSTN1
prerank,"exodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016895)",0.30627443005003196,0.6166636690244289,0.8555347091932458,1.0,1.0,3/10,16.84%,POLD1;EXD2;MGME1
prerank,ionotropic glutamate receptor activity (GO:0004970),0.28083020806817643,0.6163803620948018,0.8946488294314381,1.0,1.0,2/17,8.64%,GRIN2C;GRIK5
prerank,CCR chemokine receptor binding (GO:0048020),0.2551165781796611,0.6137190440494394,0.900887573964497,1.0,1.0,4/28,18.76%,CCL5;CCL14;CCL25;CCL19
prerank,histone methyltransferase activity (GO:0042054),0.2509512747571241,0.6128677818705593,0.9087078651685393,1.0,1.0,3/32,8.94%,SMYD1;NSD3;PRMT7
prerank,NF-kappaB binding (GO:0051059),0.2595389279756205,0.6096545413133185,0.9029275808936826,1.0,1.0,3/24,7.91%,SETD6;MTDH;RELA
prerank,low-density lipoprotein particle receptor binding (GO:0050750),0.26077325098019233,0.6096485591154013,0.8948170731707317,1.0,1.0,7/22,19.02%,ANKRA2;CLU;LDLRAP1;SNX17;HSPG2;LANCL1;CLTC
prerank,CoA hydrolase activity (GO:0016289),0.27842627448620555,0.6074699174789747,0.9,1.0,1.0,1/16,3.04%,NUDT7
prerank,O-methyltransferase activity (GO:0008171),-0.2629602606337174,-0.6006232602232016,0.9224137931034483,0.9936740271699143,1.0,5/10,37.94%,FTSJ3;CMTR1;COQ3;BCDIN3D;CMTR2
prerank,basal RNA polymerase II transcription machinery binding (GO:0001099),0.248543794138009,0.5999778955514252,0.9090909090909091,1.0,1.0,10/33,21.94%,PCF11;AR;HNRNPU;URI1;ELOF1;DHX9;AGO1;WDR43;RPRD1A;CCAR2
prerank,MHC protein binding (GO:0042287),0.2644650592679667,0.5969368516583008,0.898021308980213,1.0,1.0,1/20,4.08%,LAG3
prerank,mitogen-activated protein kinase binding (GO:0051019),0.24641479708211872,0.5946312749553828,0.9355300859598854,1.0,1.0,3/29,8.30%,DUSP5;MAPKAPK2;TNIP1
prerank,triglyceride lipase activity (GO:0004806),0.2635084872900625,0.5935171856349539,0.8995363214837713,1.0,1.0,1/20,3.09%,LPL
prerank,MAP kinase kinase activity (GO:0004708),0.27375280043596784,0.5921282374334764,0.924496644295302,1.0,1.0,4/15,15.10%,MAP2K1;MAP2K3;LRRK2;MAP2K4
prerank,exopeptidase activity (GO:0008238),0.22293644854447164,0.5872392481733301,0.9417989417989417,1.0,1.0,12/50,20.67%,LNPEP;RNPEP;BLMH;ENPEP;DPP10;DPP8;CTSA;METAP1;CNDP2;TRHDE;KDM8;XPNPEP3
prerank,histone acetyltransferase activity (GO:0004402),0.2443198735590423,0.5812430370072692,0.9195906432748538,1.0,1.0,10/30,21.30%,TAF1;EPC2;KAT7;MCM3AP;HAT1;CLOCK;TADA3;KAT8;KAT14;KAT6A
prerank,glutathione transferase activity (GO:0004364),0.24908158365929844,0.5811409639412146,0.9290030211480362,1.0,1.0,3/23,12.15%,GSTT1;GSTP1;GSTA4
prerank,NAD binding (GO:0051287),0.24393287216945028,0.5798764651600753,0.9260869565217391,1.0,1.0,6/26,16.62%,CRYZ;SIRT3;SIRT2;QDPR;HADH;SIRT6
prerank,poly(A)-specific ribonuclease activity (GO:0004535),0.27897697725978443,0.5796722698446126,0.9084507042253521,1.0,1.0,2/12,11.85%,PARN;CNOT7
prerank,core promoter sequence-specific DNA binding (GO:0001046),0.23702939737165243,0.5785649163534402,0.9367977528089888,1.0,1.0,11/35,21.41%,SMARCB1;TAF1;TP53;RELA;BAZ2A;STAT1;HDAC1;AGO1;POU2F1;RRN3;H3-3A
prerank,myosin V binding (GO:0031489),0.2715882668798454,0.5784236800589418,0.9032815198618307,0.9993378070869315,1.0,3/15,16.37%,RAB3A;RAB14;RAB8A
prerank,chemokine receptor binding (GO:0042379),-0.17996299762159793,-0.5774501318859443,0.9859649122807017,1.0,1.0,4/35,15.26%,ITCH;CXCL16;CX3CL1;CKLF
prerank,adenyl nucleotide binding (GO:0030554),-0.24560267754315873,-0.576682763033604,0.9590909090909091,0.9918803466125781,1.0,3/11,13.25%,BAG4;BAG1;PFN1
prerank,adenyl-nucleotide exchange factor activity (GO:0000774),-0.24560267754315873,-0.576682763033604,0.9590909090909091,0.9918803466125781,1.0,3/11,13.25%,BAG4;BAG1;PFN1
prerank,"exoribonuclease activity, producing 5'-phosphomonoesters (GO:0016896)",0.2303240616166537,0.5710433501200365,0.9309838472834068,1.0,1.0,9/33,19.80%,PARN;ERI2;DIS3L2;DIS3L;CNOT7;EXD2;REXO2;EXOSC10;ERI1
prerank,mRNA methyltransferase activity (GO:0008174),-0.22788076637699667,-0.5700742686231342,0.960880195599022,0.9902363423241708,1.0,4/12,21.32%,METTL3;METTL14;METTL16;CMTR1
prerank,methyl-CpG binding (GO:0008327),0.25019501329738697,0.5695083740273085,0.9154078549848943,1.0,1.0,4/22,14.63%,ZCWPW1;ZBTB38;ZBTB33;ZBTB4
prerank,3'-5'-exoribonuclease activity (GO:0000175),0.22941124083593054,0.5662483010597797,0.9517543859649122,1.0,1.0,9/34,19.80%,PARN;ERI2;DIS3L2;DIS3L;CNOT7;EXD2;REXO2;EXOSC10;ERI1
prerank,histone methyltransferase activity (H3-K4 specific) (GO:0042800),0.26397249097116166,0.5649926290976108,0.9108910891089109,0.9989082424242975,1.0,2/15,8.07%,KMT2D;SETD3
prerank,protein binding involved in heterotypic cell-cell adhesion (GO:0086080),-0.24496448290710063,-0.5633716055136141,0.9548693586698337,0.9886744852155503,1.0,2/10,12.39%,CXADR;SIRPA
prerank,"oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor (GO:0016646)",-0.21687620424452148,-0.5621532302082067,0.9696202531645569,0.9848561139188357,1.0,3/14,17.47%,ALDH4A1;BLVRB;ALDH1L1
prerank,RNA polymerase core enzyme binding (GO:0043175),0.23308576751931814,0.56109056204959,0.9377652050919377,0.9990570216981134,1.0,11/33,21.94%,PCF11;HNRNPU;URI1;ELOF1;DHX9;AGO1;RRN3;WDR43;ERBB2;RPRD1A;CCAR2
prerank,S-adenosylmethionine-dependent methyltransferase activity (GO:0008757),-0.16805178850613187,-0.5594545328179338,0.99609375,0.9816975594096404,1.0,10/40,23.23%,PCMTD1;HNMT;TARBP1;AS3MT;THUMPD3;ARMT1;RRP8;TPMT;SUV39H1;THUMPD2
prerank,cyclin-dependent protein serine/threonine kinase inhibitor activity (GO:0004861),0.27396480612701857,0.5549599129759066,0.9204545454545454,1.0,1.0,1/10,6.50%,HEXIM1
prerank,calcium-dependent cysteine-type endopeptidase activity (GO:0004198),-0.21331319985112163,-0.5463969338432437,0.9708029197080292,0.9815744455397286,1.0,2/14,16.60%,CAPNS1;CAPN10
prerank,snoRNA binding (GO:0030515),0.22095138420945393,0.5451105798264241,0.9553956834532374,1.0,1.0,2/30,4.41%,NUDT7;NUDT4
prerank,chemokine activity (GO:0008009),0.2235521900493793,0.5413263528832116,0.9646017699115044,1.0,1.0,4/31,18.76%,CCL5;CCL14;CCL25;CCL19
prerank,nucleotide diphosphatase activity (GO:0004551),0.2460290864870825,0.5354573879584703,0.9279731993299832,1.0,1.0,2/14,10.23%,NUDT4;NUDT13
prerank,phosphate ion binding (GO:0042301),0.26685921766839565,0.532796652977076,0.9351145038167938,1.0,1.0,3/10,17.93%,RELA;ADSS1;RPH3A
prerank,DNA-directed DNA polymerase activity (GO:0003887),0.23492868867262745,0.5307778414052171,0.9571428571428572,1.0,1.0,3/21,11.72%,CHRAC1;POLD1;POLG
prerank,protein serine/threonine kinase activator activity (GO:0043539),0.2146423725668954,0.529479893527672,0.957983193277311,0.9999569652097174,1.0,5/34,11.71%,FAM20A;CALM1;MAP2K1;CCNT1;RICTOR
prerank,C-C chemokine receptor activity (GO:0016493),0.23076317483458453,0.5288843083663747,0.9512195121951219,0.9979978995312598,1.0,1/21,5.63%,CXCR6
prerank,aspartic-type endopeptidase activity (GO:0004190),0.2424568526467299,0.5129145313355862,0.9455535390199638,1.0,1.0,3/12,14.50%,DDI2;HM13;SPPL2B
prerank,deoxyribonuclease activity (GO:0004536),0.24108537821219223,0.5097615682045709,0.9443507588532883,1.0,1.0,4/14,17.78%,MBD4;ZRANB3;DNASE1L1;MAP1S
prerank,methylated histone binding (GO:0035064),0.18449265936917958,0.5052652180175176,0.9872935196950444,1.0,1.0,7/62,9.26%,ZCWPW1;NCAPD3;TAF1;L3MBTL2;MSL3;TDRD3;CDYL
prerank,nucleoside diphosphate kinase activity (GO:0004550),0.24044393070153425,0.504243668741743,0.9503205128205128,0.9994672919506183,1.0,3/14,18.51%,AK7;CMPK1;CMPK2
prerank,adrenergic receptor binding (GO:0031690),0.22718267429813863,0.5040514655942342,0.966499162479062,0.9973067490852717,1.0,3/16,11.32%,NEDD4;SAV1;PDE4D
prerank,proton transmembrane transporter activity (GO:0015078),0.19829559059172105,0.498235551185045,0.9873772791023843,0.9972612574030706,1.0,11/39,22.04%,COX7A2L;COX8A;UQCRFS1;UQCRH;COX5B;UQCRQ;SLC11A2;CLCN5;SLC9A1;COX6A1;ATP6V1F
prerank,aspartic-type peptidase activity (GO:0070001),-0.2120559372849234,-0.4858003765493747,0.9810924369747899,0.9911388585678408,1.0,5/10,45.13%,BACE2;CTSD;PSEN1;CTSE;BACE1
prerank,ligand-gated ion channel activity (GO:0015276),0.19465759956573794,0.4738541949153758,0.9912152269399708,1.0,1.0,2/30,8.64%,GRIN2C;GRIK5
prerank,C-C chemokine binding (GO:0019957),0.2054904538239022,0.4733738346152488,0.9846390168970814,1.0,1.0,1/22,5.63%,CXCR6
prerank,ligand-gated channel activity (GO:0022834),0.19626878937402514,0.4708039779383245,0.991044776119403,0.9991520173408254,1.0,2/29,8.64%,GRIN2C;GRIK5
prerank,"hydrolase activity, hydrolyzing O-glycosyl compounds (GO:0004553)",0.19224380340191352,0.46279142220088465,0.9888268156424581,0.9989679385227297,1.0,4/29,11.29%,NEU3;GLA;GANC;PARG
prerank,purinergic nucleotide receptor activity (GO:0001614),0.20619074527531864,0.44376405165520005,0.987783595113438,1.0,1.0,15/15,79.40%,P2RX4;P2RY14;GPR34;P2RX6;P2RX7;P2RX2;P2RY13;GPR87;P2RX1;GPR171;P2RX5;P2RX3;PTAFR;P2RY12;P2RY1
prerank,DNA replication origin binding (GO:0003688),0.1861272972190446,0.43818472246916323,0.9895678092399404,0.9996421232976124,1.0,4/23,16.92%,KAT7;MCMDC2;ORC2;DHX9
prerank,1-phosphatidylinositol binding (GO:0005545),0.1986882573127192,0.42162061104571286,0.9932885906040269,1.0,1.0,4/15,21.54%,SNX9;SNAP91;ZFYVE16;ZFYVE9
prerank,neuropeptide receptor binding (GO:0071855),0.19801607232546456,0.4145482934362559,0.9862542955326461,0.9987077500008482,1.0,14/14,80.22%,NTS;NPY;UCN3;APELA;QRFP;GHRH;NPPA;UCN2;GAL;AGRP;APLN;SHANK1;NMU;PPY
prerank,excitatory extracellular ligand-gated ion channel activity (GO:0005231),0.17556525484916705,0.4038488048162735,0.9951845906902087,0.9977604324914148,1.0,3/21,18.06%,CHRNA7;CHRNA4;P2RX4
prerank,nucleobase-containing compound kinase activity (GO:0019205),0.1827236632456071,0.3917167843081101,0.995253164556962,0.9966948289858558,1.0,1/17,4.91%,AK7
